0001493152-20-004732.txt : 20200325 0001493152-20-004732.hdr.sgml : 20200325 20200325172424 ACCESSION NUMBER: 0001493152-20-004732 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 53 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200325 DATE AS OF CHANGE: 20200325 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Wellness Center USA, Inc. CENTRAL INDEX KEY: 0001516887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272980395 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-173216 FILM NUMBER: 20743256 BUSINESS ADDRESS: STREET 1: 2500 WEST HIGGINS ROAD, STE. 780 CITY: HOFFMAN ESTATES STATE: IL ZIP: 60169 BUSINESS PHONE: (847) 925-1885 MAIL ADDRESS: STREET 1: 2500 WEST HIGGINS ROAD, STE. 780 CITY: HOFFMAN ESTATES STATE: IL ZIP: 60169 10-Q 1 form10-q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2019

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

WELLNESS CENTER USA, INC.

(Name of small business issuer in its charter)

NEVADA

333-173216

27-2980395

(State or other jurisdiction of

incorporation or organization)

Commission

File Number

(IRS Employee

Identification No.)

145 E. University Boulevard, Tucson, AZ 85705

(Address of Principal Executive Offices)

(847) 925-1885

(Issuer Telephone number)

(Former name or former address, if changed since last report)

2500 West Higgins Road, Ste. 780, Hoffman Estates, IL, 60169

Securities registered under Section 12(b) of the Exchange Act:

Title of each class registered:		Name of each exchange on which registered:
None		None

Securities registered under Section 12(g) of the Exchange Act:
Common Stock, par value $0.001 (Title of class)

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or smaller reporting company filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act (Check one):

Large Accelerated Filer [ ]

Accelerated Filer [ ]

Non-Accelerated Filer [ ]

Smaller Reporting Company [X]

Emerging growth Company [ ]

Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.

Yes [ ] No [X]

The number of shares issued and outstanding of each of the issuer’s classes of common equity as of December 31, 2019 was 107,497,077.

FORM 10-Q

WELLNESS CENTER USA, INC.

DECEMBER 31, 2019

TABLE OF CONTENTS

PART I— FINANCIAL INFORMATION

Item 1.	Condensed Consolidated Financial Statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 3	Quantitative and Qualitative Disclosures About Market Risk	24
Item 4.	Control and Procedures	24

PART II— OTHER INFORMATION

Item 1	Legal Proceedings	26
Item 1A	Risk Factors	27
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	27
Item 3.	Defaults Upon Senior Securities	27
Item 4.	Mine Safety Disclosures.	27
Item 5.	Other Information	27
Item 6.	Exhibits	27

SIGNATURE		28

Wellness Center USA, Inc.

Condensed Consolidated Balance Sheets

	December 31, 2019			September 30, 2019
	(Unaudited)
ASSETS
Current Assets
Cash	$	42,363		$	53,147
Prepaid expenses and other current assets		55,500			55,000
Total Current Assets		97,863			108,147

Property and equipment, net		-			1,562
Right of use asset		22,697			-
Total Other Assets		22,697			1,562

TOTAL ASSETS	$	120,560		$	109,709

LIABILITIES AND SHAREHOLDERS’ DEFICIT
Current Liabilities
Accounts payable and accrued expenses	$	775,566		$	691,619
Payroll taxes payable		102,899			102,834
Lease liability		22,697			-
Loans payable from officers and shareholders		534,250			399,250
Total Current Liabilities		1,435,412			1,193,703

Shareholders’ Deficit
Common stock, par value $0.001, 200,000,000 shares authorized; 107,497,077 shares issued and outstanding, respectively		107,497			107,497
Additional paid-in capital		23,868,885			23,777,647
Accumulated deficit		(25,686,754	)		(25,362,287	)
Total Wellness Center USA shareholders’ deficit		(1,710,372	)		(1,477,143	)

Non-controlling interest		395,520			393,149
Total Shareholder’s deficit		(1,314,852	)		(1,083,994	)

TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$	120,560		$	109,709

The accompanying notes are an integral part of these condensed consolidated financial statements.

Wellness Center USA, Inc.

Condensed Consolidated Statements of Operations

	Three Months Ended
	December 31,
	2019			2018
		(Unaudited)
Sales:
Trade	$	-		$	7,675
Consulting services		-			5,200
Total Sales		-			12,875

Cost of goods sold		-			7,725

Gross profit		-			5,150

Operating expenses		337,273			475,864

Loss from operations		(337,273	)		(470,714	)

Other expenses
Amortization of debt discount		-			(50,689	)
Financing costs		-			(51,434	)
Interest expense		(9,323	)		(4,851	)
Total other expenses		(9,323	)		(106,974	)

NET LOSS		(346,596	)		(577,688	)

Net loss attributable to non-controlling interest		22,129			3,759
Loss from deconsolidation of non-controlling interest		-			(405,383	)

NET LOSS ATTRIBUTABLE TO WELLNESS CENTER USA, INC.		(324,467	)		(979,312	)

BASIC AND DILUTED LOSS PER SHARE	$	(0.00	)	$	(0.01	)

WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING
BASIC AND DILUTED		107,497,077			100,952,569

The accompanying notes are an integral part of these condensed consolidated financial statements.

Wellness Center USA, Inc.

Condensed Consolidated Statements of Shareholders’ Deficit (Unaudited)

					Additional					Total			Non-
	Common Stock				Paid-in		Accumulated			WCUI			controlling
	Shares		Amount		Capital		Deficit			Deficit			Interest			Total


Balance, September 30, 2019		107,497,077	$	107,497	$	23,777,647	$	(25,362,287	)	$	(1,477,143	)	$	393,149		$	(1,083,994	)

Fair value of vested stock options		-		-		65,738		-			65,738			-			65,738

Contribution of capital by joint venture partner		-		-		25,500		-			25,500			24,500			50,000

Net loss for the three months ended December 31, 2019		-		-		-		(324,467	)		(324,467	)		(22,129	)		(346,596	)

Balance, December 31, 2019 (unaudited)		107,497,077	$	107,497	$	23,868,885	$	(25,686,754	)	$	(1,710,372	)	$	395,520		$	(1,314,852	)

Balance, September 30, 2018		100,952,569	$	100,952	$	22,450,252	$	(22,974,740	)	$	(423,536	)	$	(401,624	)	$	(825,160	)

Common shares issued for cash		142,857		143		9,857		-			10,000			-			10,000

Shares issued upon conversions of note payable		2,482,441		2,483		171,300		-			173,783			-			173,783

Fair value of additional shares issued upon conversions of note payable		-		-		51,434		-			51,434			-			51,434

Fair value of vested stock options		-		-		85,951		-			85,951			-			85,951

Fair value of common stock issued for services		120,000		120		9,480		-			9,600			-			9,600

Termination of non-controlling interest agreement		-		-		-		(405,383	)		(405,383	)		405,383			-

Contribution of capital by joint venture partner		-		-		255,000		-			255,000			120,000			375,000

Net loss for the three months ended December 31, 2018		-		-		-		(573,929	)		(573,929	)		(3,759	)		(577,688	)

Balance, December 31, 2018 (unaudited)		103,697,867	$	103,698	$	23,033,274	$	(23,954,052	)	$	(817,080	)	$	120,000		$	(697,080	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

Wellness Center USA, Inc.

Condensed Consolidated Statements of Cash Flows

	Three Months Ended
	December 31,
	2019			2018
		(Unaudited)
Cash Flows from Operating Activities
Net loss	$	(346,596	)	$	(577,688	)

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense		1,562			264
Amortization of right-of-use asset		5,144			-
Amortization of debt discount		-			50,689
Fair value of common shares issued for services		-			9,600
Fair value of stock options issued for services		65,738			85,951
Fair value of additional shares issued upon conversions of note payable		-			51,434
Changes in Assets and Liabilities
(Increase) Decrease in:
Prepaid expenses and other assets		(500	)		1,550
(Decrease) Increase in:
Accounts payable and accrued expenses		84,012			62,615
Lease liability		(5,144	)		-
Deferred revenue		-			1,125
Net cash used in operating activities		(195,784	)		(314,460	)

Cash Flows from Financing Activities
Proceeds from loans payable from officers and shareholders		135,000			60,000
Common stock and warrants issued for cash		-			10,000
Contribution of capital by joint venture partner		50,000			375,000
Net cash provided by financing activities		185,000			445,000

Net increase (decrease) in cash		(10,784	)		130,540

Cash beginning of period		53,147			4,210
Cash end of period	$	42,363		$	134,750

Supplemental cash flows disclosures:
Interest paid	$	-		$	-
Taxes paid	$	-		$	-

Supplemental non-cash financing disclosures:
Initial recognition of right-of-use assets and operating lease liabilities upon adoption of ASC Topic 842	$	27,841		$	-
Conversion of convertible note payable into common shares	$	-		$	173,783
Conversion of accrued interest into common shares	$	-		$	8,783

The accompanying notes are an integral part of these condensed consolidated financial statements.

WELLNESS CENTER USA, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

FOR THE THREE MONTHS ENDED DECEMBER 31, 2019 AND 2018

NOTE 1 – BASIS OF PRESENTATION

Organization and Operations

Wellness Center USA, Inc. (“WCUI” or the “Company”) was incorporated in June 2010 under the laws of the State of Nevada. The Company initially engaged in online sports and nutrition supplements marketing and distribution. The Company subsequently expanded into additional businesses within the healthcare and medical sectors through acquisitions, including Psoria-Shield Inc. (“PSI”) and StealthCo Inc. (“SCI”), d/b/a Stealth Mark, Inc.

The Company currently operates in the following business segments: (i) distribution of targeted Ultra Violet (“UV”) phototherapy devices for dermatology; and (ii) authentication and encryption products and services. The segments are operated, respectively, through PSI and SCI.

Basis of Presentation of Unaudited Financial Information

The accompanying unaudited condensed consolidated financial statements of Wellness Center USA, Inc. and Subsidiaries (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended December 31, 2019 are not necessarily indicative of the results that may be expected for the year ending September 30, 2020.

Going Concern

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying condensed consolidated financial statements, the Company has not yet generated significant revenues and has incurred recurring net losses. During the three months ended December 31, 2019, the Company incurred a net loss of $346,596 and used cash in operations of $195,784, and had a shareholders’ deficit of $1,314,852 as of December 31, 2019. In addition, $102,899 of payroll taxes are past due. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its strategies. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

In addition, the Company’s independent registered public accounting firm, in its report on the Company’s September 30, 2019 financial statements, has raised substantial doubt about the Company’s ability to continue as a going concern.

At December 31, 2019, the Company had cash on hand in the amount of $42,363. The ability to continue as a going concern is dependent on the Company attaining and maintaining profitable operations in the future and raising additional capital soon to meet its obligations and repay its liabilities arising from normal business operations when they come due. Since inception, we have funded our operations primarily through equity and debt financings and we expect to continue to rely on these sources of capital in the future. During the three months ended December 31, 2019, the Company received $185,000 through short-term loans and contributions of capital by a joint venture partner.

No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stock holders, in case of equity financing.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Consolidation

The Company’s consolidated subsidiaries and/or entities are as follows:

Name of consolidated subsidiary or entity	State or other jurisdiction of incorporation or organization	Date of incorporation or formation (date of acquisition/disposition, if applicable)	Attributable interest

Psoria-Shield Inc. (“PSI”)	The State of Florida	June 17, 2009 (August 24, 2012)		100	%

StealthCo, Inc. (“StealthCo”)	The State of Illinois	March 18, 2014		100	%

Psoria Development Company LLC. (“PDC”)	The State of Illinois	January 15, 2015/November 15, 2018		50	%

NEO Phototherapy LLC (“NEO”)	The State of Illinois	December 2018		51	%

Through October 2018, PSI was operated by PDC, a joint venture between PSI and the Medical Alliance, Inc (“TMA”). On November 15, 2018, the Company and TMA entered into a Withdraw and Mutual Release Agreement to terminate their joint venture agreement. In December 2018, the Company and its wholly-owned subsidiary, Psoria-Shield, Inc. (“PSI”), entered into a Joint Venture Agreement with PSI Gen 2 Funding, Inc. (“GEN2”), an Illinois corporation, to further development, marketing, licensing and/or sale of PSI technology and products. The joint venture is conducted through NEO Phototherapy, LLC, a recently formed Illinois limited liability company (“NEO”), with principal offices and records to be maintained at WCUI’s offices. See Non-Controlling Interests in Note 2 for more details.

Use of Estimates

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in the valuation of accounts receivable and allowance for uncollectible amounts, inventory and obsolescence reserves, accruals for potential liabilities, valuations of stock-based compensation, realization of deferred tax assets, among others. Actual results could differ from these estimates.

Income (Loss) Per Share

Basic loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of outstanding common shares during the period. Diluted loss per share is computed by dividing the net loss applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued. For the three months ended December 31, 2019 and 2018, the basic and diluted shares outstanding were the same, as potentially dilutive shares were considered anti-dilutive. At December 31, 2019 and 2018, the dilutive impact of outstanding stock options of 15,037,738 and 17,587,738 shares, respectively, and outstanding warrants for 66,484,049 and 68,192,442 shares, respectively, have been excluded because their impact on the loss per share is anti-dilutive.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Revenue Recognition

In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). This ASU is a comprehensive new revenue recognition model that requires a company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services. The Company adopted this ASU on October 1, 2018 retrospectively, the cumulative effect of the initial application on our accumulated deficit on that date was immaterial.

For trade sales, the Company generates its revenue from sales contracts with customers with revenues being generated upon the shipment of merchandise, or for consulting services, revenue is recognized in the period services are rendered and earned under service arrangements with clients.

We sell our products through two main sales channels: 1) directly to customers who use our products (the “Direct Channel”) and 2) to distribution partners who resell our products (the “Indirect Channel”).

Under the Direct Channel, we sell our products to and we receive payment directly from customers who purchase our products. Under our Indirect Channel, we have entered into distribution agreements that allow the distributors to sell our products and fulfill performance obligations under the agreements.

We determine revenue recognition through the following steps:

●

Identification of the contract, or contracts, with a customer

●

Identification of the performance obligations in the contract

●

Determination of the transaction price

●

Allocation of the transaction price to the performance obligations in the contract

●

Recognition of revenue when, or as, we satisfy a performance obligation.

Revenue is generally recognized upon shipment or when a service has been completed, unless we have significant performance obligations for services still to be completed. We recognize revenue when a material reversal is no longer probable. Payments received before the relevant criteria for revenue recognition are satisfied are recorded as deferred revenue. There was no deferred revenue at December 31, 2019 and 2018.

Non-controlling Interests

Through November 2018, non-controlling interest represented the non-controlling interest holder’s proportionate share of the equity of the Company’s majority-owned subsidiary, PDC. Non-controlling interest is adjusted for the non-controlling interest holder’s proportionate share of the earnings or losses and other comprehensive income (loss), if any, and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.

On November 15, 2018, PSI and TMA entered into a Withdraw and Mutual Release Agreement to terminate their joint venture agreement. On the date of termination, the non-controlling interest’s share of the accumulated losses of the joint venture totaled to $405,383. Upon termination, during the three months ended December 31, 2018, the Company wrote-off the non-controlling interest’s share of the accumulated losses and recorded a loss from the deconsolidation of a non-controlling interest of $405,383.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Non-controlling Interests (continued)

In December 2018, PSI entered into a Joint Venture Agreement with GEN2 to further development, marketing, licensing and/or sale of PSI technology and products. Pursuant to the Joint Venture Agreement, the venture will be conducted through NEO. PSI and GEN2 will be the members of NEO, owning 50.5% and 36.0%, respectively, of the Units issued in connection with the organization of NEO. An additional 13.5% of such Units will be reserved for issuance as incentives for key employees and consultants. Until such shares are distributed, the Company controls 68% of the joint venture and GEN2 the remaining 32%. PSI and GEN2 will manage NEO’s day-to-day operations. PSI will contribute PSI technology to NEO and GEN2 will contribute $700,000. As of December 31, 2019, NEO’s operations required additional funding above the $700,000 documented in the agreement, and as of September 30, 2019, GEN2 had received $925,000 of investments to contribute to NEO. During the three months ended December 30, 2019, an additional $50,000 was contributed by GEN2 to NEO. As of December 31, 2019, GEN2 had received $975,000 of investments to contribute to NEO. As of December 31, 2019, the Company controlled 51% of the joint venture, GEN2 controlled 39% and another individual controlled the remaining 10%. The Company recorded its proportionate share of the contributions received of $497,250 to additional paid-in-capital and $477,750 to non-controlling interest as of that date. During the three months ended December 31, 2019, NEO recorded a loss of $45,162 relating to its operations.

Repayment of the investment by GEN2 will begin through and upon the date which NEO has realized and retained cumulative net income/distributable cash in the amount of $300,000. Distributions thereafter will be made to PSI, GEN2 and other members in proportion to their respective Unit ownership, at the times and in the manner determined from time to time by the managers, in their sole discretion. GEN2 consists of accredited investors, and investment participation of $700,000 from several WCUI officers and directors, including Calvin R. O’Harrow and Roy M. Harsch.

Stock-Based Compensation

The Company periodically grants stock options and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option and stock warrant grants to employees based on the authoritative guidance provided by the Financial Accounting Standards Board where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and stock warrant grants to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option or warrant grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

The fair value of the Company’s common stock option and warrant grants are estimated using a Black-Scholes Merton option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, estimated forfeitures and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes Merton option pricing model could materially affect compensation expense recorded in future periods.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Leases

In February 2016, the FASB issued ASU No. 2016-02, Leases. ASU 2016-02 requires a lessee to record a right of use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than twelve months. ASU 2016-02 is effective for all interim and annual reporting periods beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessees for leases existing at, or entered into after, the beginning of the earliest period presented in the financial statements.

The Company adopted ASU 2016-02 effective October 1, 2019. As a result, we recorded right-of-use assets of $27,841, and lease liabilities of the same amount, as of that date. In accordance with ASU 2016-02, the right-of-use assets are being amortized over the life of the underlying leases, and monthly lease payments are being recorded as reductions to the lease liability and imputed interest expense. See Note 4 for additional information.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”). The standard significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The standard is effective for interim and annual reporting periods beginning after December 15, 2019. The adoption of ASU 2016-13 is not expected to have a material impact on the Company’s financial position, results of operations, and cash flows.

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

NOTE 3 – LOANS PAYABLE FROM OFFICERS AND SHAREHOLDERS

As of September 30, 2019, loans payable from officers and shareholders of $399,250 were outstanding. During the three months ended December 31, 2019, the Company borrowed $135,000 from its officers and shareholders. All of the loans are unsecured, have an interest rate of eight percent and are due one year from the date of issuance. As of December 31, 2019, loans payable to officers and shareholders of $534,250 were outstanding.

NOTE 4 – LEASE LIABILITIES

In February 2019, the Company’s PSI subsidiary entered into a 24-month non-cancellable lease for its office facilities that requires monthly payments of $1,800 through January 2021. The Company adopted ASU 2016-02, Leases, effective October 1, 2019, which requires a lessee to record a right-of-use asset and a corresponding lease liability at the inception of the lease initially measured at the present value of the lease payments. The Company classified the lease as an operating lease and determined that the value of the lease assets and liability at the adoption date was $27,841 using a discount rate of 4.00%. During the three months ended December 31, 2019, the Company made payments of $5,144 towards the lease liability. As of December 31, 2019, lease liability amounted to $22,697.

ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term, generally on a straight-line basis. Rent expense for the three months ended December 31, 2019 was $5,144. During the three months ended December 31, 2019, the Company reflected amortization of right of use asset of $5,144 related to this lease, resulting in a net asset balance of $22,697 as of December 31, 2019.

NOTE 5 – SHAREHOLDERS’ EQUITY

Stock Options

On December 22, 2010, effective retroactively as of June 30, 2010, the Company’s Board of Directors approved the adoption of the “2010 Non-Qualified Stock Option Plan” (“2010 Option Plan”) by unanimous consent. The 2010 Option Plan was initiated to encourage and enable officers, directors, consultants, advisors and key employees of the Company to acquire and retain a proprietary interest in the Company by ownership of its common stock. A total of 7,500,000 of the authorized shares of the Company’s common stock may be subject to, or issued pursuant to, the terms of the plan. Effective January 1, 2018, the Board of Directors approved to increase the number of authorized shares of the Company’s common stock that may be subject to, or issued pursuant to, the terms of the plan from 7,500,000 to 30,000,000.

The Company’s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award. Additionally, the Company’s policy is to issue new shares of common stock to satisfy stock option exercises. The Company applied fair value accounting for all share based payments awards. The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model.

During the three months ended December 31, 2019, the Company granted options to an employee to purchase a total of 62,500 shares of its common stock with an aggregate fair value of $2,313. The options have an exercise price of $0.04 per share and expire five years from the date of grant. The shares vested on December 31, 2019. The Company valued the options using a Black-Scholes option pricing model.

The assumptions used for the option granted during the three months ended December 31, 2019 are as follows:

Exercise price	$	0.04
Expected dividends		-
Expected volatility		157.6	%
Risk free interest rate		1.60	%
Expected life of options		2.5

During the three months ended December 31, 2019, the Company recorded $65,738 of stock compensation for the value of all outstanding options, and as of December 31, 2019, unvested compensation of $314,812 remained that will be amortized over the remaining vesting period.

The table below summarizes the Company’s stock option activities for the three months ended December 31, 2019:

	Number of Option Shares			Exercise Price Range Per Share		Weighted Average Exercise Price		Fair Value at Date of Grant

Balance, September 30, 2019		15,237,738		$	0.03 - 2.00	$	0.27	$	3,255,121
Granted		62,500			0.04		0.04		2,313
Cancelled		-			-		-		-
Exercised		-			-		-		-
Expired		(262,500	)		0.11		0.11		-
Balance, December 31, 2019		15,037,738		$	0.03 – 2.00	$	0.27	$	3,257,434
Vested and exercisable, December 31, 2019		12,350,238		$	0.03 – 2.00	$	0.30	$	2,189,047

Unvested, December 31, 2019		2,687,500		$	0.14	$	0.14	$	1,068,387

There was no aggregate intrinsic value for option shares outstanding at December 31, 2019. As of December 31, 2019, there were 14,962,262 shares of stock options remaining available for issuance under the 2010 Plan.

NOTE 5 – SHAREHOLDERS’ EQUITY (CONTINUED)

Stock Options (continued)

The following table summarizes information concerning outstanding and exercisable options as of December 31, 2019:

		Options Outstanding					Options Exercisable
	Range of Exercise Prices		Number Outstanding	Average Remaining Contractual Life (in years)		Weighted Average Exercise Price		Number Exercisable	Average Remaining Contractual Life (in years)		Weighted Average Exercise Price

$	0.06 - 0.39		13,575,238	2.93	$	0.15		10,887,738	2.85	$	0.15
	0.40 - 0.99		62,500	2.25		0.40		62,500	2.25		0.40
	1.00 - 1.99		750,000	1.00		1.00		750,000	1.00		1.00
	2.00		650,000	1.00		2.00		650,000	1.00		2.00
$	0.06 - 2.00		15,037,738	2.75	$	0.27		12,350,238	2.64	$	0.30

Stock Warrants

The table below summarizes the Company’s warrants activities for the three months ended December 31, 2019:

	Number of Warrant Shares		Exercise Price Range Per Share		Weighted Average Exercise Price		Fair Value at Date of Issuance

Balance, September 30, 2019		66,484,049	$	0.12 - 0.40	$	0.17	$	3,434,560
Granted		-		-		-		-
Cancelled		-		-		-		-
Exercised		-		-		-		-
Expired		-		-		-		-
Balance, December 31, 2019		66,484,049	$	0.12 - 0.40	$	0.17	$	3,434,560
Vested and exercisable, December 31, 2019		66,484,049	$	0.12 - 0.40	$	0.17	$	3,434,560

There was no aggregate intrinsic value for warrant shares outstanding at December 31, 2019.

The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2019:

		Warrants Outstanding					Warrants Exercisable
	Range of Exercise Prices		Number Outstanding	Average Remaining Contractual Life (in years)		Weighted Average Exercise Price		Number Exercisable	Average Remaining Contractual Life (in years)		Weighted Average Exercise Price

$	0.12 – 0.20		59,279,384	1.70	$	0.15		59,279,384	1.70	$	0.15
	0.21 – 0.40		7,204,665	0.61		0.26		7,204,665	0.61		0.26

$	0.12 – 0.67		66,484,049	1.58	$	0.17		66,484,049	1.58	$	0.17

NOTE 6 – SEGMENT REPORTING

Reportable segments are components of an enterprise about which separate financial information is available and that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.

The Company operates in the following business segments:

(i) Medical Devices: which stems from PSI, its wholly-owned subsidiary acquired on August 24, 2012, a developer, manufacturer, marketer and distributer of targeted Ultra Violet (“UV”) phototherapy devices for the treatment of skin diseases.

(ii) Authentication and Encryption Products and Services: which stems from StealthCo, its wholly-owned subsidiary formed on March 18, 2014, which has engaged in the business of selling, licensing or otherwise providing certain authentication and encryption products and services since acquisition of certain assets from SMI on April 4, 2014.

The detailed segment information of the Company is as follows:

Assets By Segment

	December 31, 2019
	Corporate		Medical Devices		Authentication and Encryption		Total
ASSETS
Current Assets
Cash	$	2,273	$	33,330	$	6,760	$	42,363
Prepaid expenses and other current assets		-		55,500		-		55,500
Total current assets		2,273		88,830		6,760		97,863

Right-of-use asset		-		22,697		-		22,697
Total other assets		-		22,697		-		22,697

TOTAL ASSETS	$	2,273	$	111,527	$	6,760	$	120,560

Operations by Segment

	For the Three Months Ended
	December 31, 2019
	Corporate			Medical Devices			Authentication and Encryption			Total
Sales:
Trade	$	-		$	-		$	-		$	-
Consulting services		-			-			-			-
Total Sales		-			-			-			-

Cost of goods sold		-			-			-			-

Gross profit		-			-			-			-

Operating expenses		98,462			175,286			63,525			337,273

Loss from operations	$	(98,462	)	$	(175,286	)	$	(63,525	)	$	(337,273	)

Operations by Segment

	For the Three Months Ended
	December 31, 2018
	Corporate			Medical Devices			Authentication and Encryption			Total
Sales:
Trade	$	-		$	-		$	7,675		$	7,675
Consulting services		-			-			5,200			5,200
Total Sales		-			-			12,875			12,875

Cost of goods sold		-			-			7,725			7,725

Gross profit		-			-			5,150			5,150

Operating expenses		254,429			119,720			101,715			475,864

Loss from operations	$	(254,429	)	$	(119,720	)	$	(96,565	)	$	(470,714	)

NOTE 7 – LEGAL MATTERS

The Company is periodically engaged in legal proceedings arising from and relating to its business operations. We currently are not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting our Company, our common stock, any of our subsidiaries or of our Company’s or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect on our financial condition or results of operations. However, we recently decided to attempt to preserve revenue and reduce operating expenses through actions including, but not limited to, facilities consolidation and staff reductions, which we hope to implement through negotiated transactions with lessors, employees and other third parties. Such actions may result in disputes with and claims by such parties which, if not resolved through negotiations, may impact negatively the Company’s ability to continue as a going concern. To date, we have negotiated settlement of all but $89,302 in ex-employee wage and benefits claims, with agreement to pay such remaining amount, together with interest at the rate of 4% per annum on the principal amount from time to time outstanding, when and as cash flow permits. One of the employees claims additional amounts due for certain statutory damages under the Illinois Wage Payment and Collection which currently could exceed $21,600 and would increase at the rate of 2% of the wages due per month plus attorneys’ fees if the employee elects to file suit for a violation of the Act and is successful in obtaining a judgment on his claim.

NOTE 8 – COMMITMENTS

Operating Leases

The Company leased its corporate office facility in Hoffman Estates, Illinois pursuant to a non-cancellable lease initiated in July 2016 and expiring February 28, 2024. The lease terms require a monthly payment of approximately $11,000. The Company vacated the facility in April 2019, in favor of its present facilities in Tucson AZ, which are provided by a shareholder on a rent-free basis. The Company is in negotiations with the owners regarding the settlement of its lease obligations and expects that the property will be subleased or a settlement with the landlord will be reached at an amount significantly less than the remaining payment obligations. At the date of abandonment, the Company had a remaining lease obligation of $631,587. During the year ended September 30, 2019, the Company recorded an accrual for the estimated potential settlement and wrote-off its $15,000 security deposit relating to the lease. During the three months ended December 31, 2019, the Company recorded an additional expense of $37,815 relating to the lease obligation.

NOTE 9 – PROPOSED SALE OF STEALTHCO, INC.

On September 3, 2019, the Company’s Board of Directors unanimously approved, subject to stockholder approval: (1) execution and delivery of a proposed Share Exchange Agreement with DTI Holdings, Inc. (“DTI”) relating to the share exchange and transfer of certain assets of StealthCo, Inc. (“SCI”) pursuant to the terms and conditions of a Memorandum of Agreement in substantially the form of the copy presented to the Board (“Agreement”). As of September 18, 2019, holders of a majority of the outstanding shares of voting capital stock have executed written stockholder consents approving this action.

The Agreement provides, among other things, that: (1) DTI will pay the Company $500,000 upon the execution of a definitive share exchange agreement (“Share Exchange Agreement”) which the parties will endeavor to negotiate and execute as quickly as possible, and not later than October 15, 2019; (2) DTI will pay the Company an additional $500,000 within seven days following the completion date of the transfer of all assets and/or full ownership of SCI to DTI, with such date to occur within 120 days following execution of the Share Exchange Agreement; (3) DTI will issue to the Company 3,112,000 shares of DTI common stock and will guaranty that the value of the 3,112,000 shares of DTI common stock will have a value of at least $4.50 per share ($14,004,000, in the aggregate), as of December 31, 2021; (4) To the extent that the value of the DTI common shares, as of December 31, 2021, is less than $4.50 per share ($14,004,000, in the aggregate), DTI will issue additional shares of DTI common stock, at the then current fair market value, in an amount sufficient to cause the resulting aggregate value of all shares of DTI common stock issued to the Company to be $14,004,000, in the aggregate; (5) DTI will assign the assets transferred by SCI, including trademarks, intellectual properties, and patents, to its subsidiary, Femtobitz, Inc., a Delaware corporation, and will pay to the Company 1% of annual gross revenue arising from or relating to operation of Femtobitz, Inc.; and (6) Upon closing of the share exchange, the Company’s Chairman will be appointed an advisory board member of DTI and a board member of Femtobitz, Inc.

As of September 18, 2019, stockholders holding a majority of our outstanding common stock approved the share exchange and the Company began discussions and negotiations with DTI, which are currently on-going as of the date of this filing. There can be no assurance that the proposed transaction will be concluded successfully on the terms described or any alternate terms that may be proposed hereafter.

NOTE 10 – SUBSEQUENT EVENTS

Subsequent to December 31, 2019, the Company borrowed $235,000 from its officers and shareholders. All of the loans are unsecured, have an interest rate of eight percent and are due one year from the date of issuance.

Commencing on October 1, 2016, the Company’s wholly-owned subsidiary, StealthCo, entered into a non-cancellable lease agreement to lease its office facilities in Oak Ridge, Tennessee. The term of the lease is five years and expires September 30, 2021. On January 6, 2020, the Company entered into an agreement with the owners to terminate the agreement effective January 1, 2020. Under the agreement, the Company agreed to pay $11,000 and abandon certain Company property as documented in the agreement.

Effective January 1, 2020, the Company’s Board of Directors approved the extension of the Company’s unexpired stock warrants as of December 31, 2019, by an additional one year period. This change would affect approximately 66 million warrant shares and approximately 20 million warrant shares that were set to expire by the year ending September 30, 2020. The 20 million warrant shares that were set to expire by September 30, 2020, had exercise prices ranging from $0.15 per share to $0.25 per share. The 66 million warrant shares had exercise prices ranging from $0.12 per share to $0.40 per share. The incremental fair value of the warrants resulting from modification is approximately $700,000 that will be recognized as an expense beginning with the period ending March 31, 2020, as the options vest.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

Except for historical information, the following discussion contains forward-looking statements based upon current expectations that involve certain risks and uncertainties. Such forward-looking statements include statements regarding, among other things, (a) our projected sales and profitability, (b) our growth strategies, (c) anticipated trends in our industry, (d) our future financing plans, (e) our anticipated needs for working capital, (f) our lack of operational experience and (g) the benefits related to ownership of our common stock. Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. This information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking statements. These statements may be found under “Description of Business,” and “Analysis of Financial Condition and Results of Operations”, as well as in this Report generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the risks outlined under “Risk Factors” in our Annual Report on Form 10-K and in other Reports we have filed with the Securities and Exchange Commission, as well as matters described in this Report generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this Report will in fact occur as projected.

The following discussion and analysis provides information which management believes is relevant to an assessment and understanding of our results of operations and financial condition. The discussion should be read along with our financial statements and notes thereto. This section includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. You should not place undue certainty on these forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our predictions.

Description of Business

Background

Wellness Center USA, Inc. (“WCUI” or the “Company”) was incorporated in June 2010 under the laws of the State of Nevada. We initially engaged in online sports and nutrition supplements marketing and distribution. We subsequently expanded into additional businesses within the healthcare and medical sectors through acquisitions, including Psoria-Shield Inc. (“PSI”) and StealthCo Inc. (“SCI”), d/b/a Stealth Mark, Inc.

The Company currently operates in two business segments: (i) distribution of targeted Ultra Violet (“UV”) phototherapy devices for dermatology; and (ii) authentication and encryption products and services. The segments are conducted through our wholly-owned subsidiaries, PSI and SCI.

PSI

PSI was incorporated under the laws of the state of Florida on June 17, 2009. We acquired all of the issued and outstanding shares of stock in PSI on August 24, 2012.

Joint Ventures

We conducted PSI operations through Psoria Development Company LLC, an Illinois limited liability company (“PDC”), from January 15, 2015 through October, 2018. PDC was a joint venture between WCUI/PSI and The Medical Alliance, Inc., a Florida corporation (“TMA”). On November 15, 2018, PSI and TMA terminated the PDC joint venture. On the termination date, the non-controlling interest’s share of the accumulated losses of the joint venture totaled $405,383. During the year ended September 30, 2019, the Company wrote-off the non-controlling interest’s share of the accumulated losses and recorded a loss from deconsolidation of non-controlling interest of $405,383.

In December 2018, the Company and PSI entered into a Joint Venture Agreement with PSI GEN2 Funding, Inc., an Illinois corporation (“GEN2”), to further develop, market, license and/or sell PSI technology and products. The Joint Venture Agreement provides for the venture to be conducted through NEO Phototherapy, LLC, an Illinois limited liability company (“NEO”), with PSI and GEN2 to hold membership Units representing 50.5% and 36.0% ownership, respectively. It provides for an additional 13.5% of such Units to be reserved for issuance as incentive awards to key employees and consultants. PSI and GEN2 are to jointly manage NEO’s day-to-day operations.

According to the Joint Venture Agreement, PSI would contribute PSI technology to NEO in consideration for its Units and GEN2 would contribute $700,000 for its Units. Once NEO has realized and retained cumulative net income/distributable cash in the amount of $300,000, the next $700,000 of realized and retained cumulative net income/distributable cash would be distributed to GEN2. Distributions thereafter would be made to PSI, GEN2 and other members, if any, in proportion to their respective Unit ownership, at the times and in the manner determined from time to time by the managers, in their sole discretion.

As of December 31, 2019, NEO’s operations required funding in excess of the $700,000 initially anticipated by the joint venture. As of that date, GEN2 had contributed $975,000 to NEO, for which GEN2 received Units representing a cumulative total of 39.0% ownership of NEO. Additional Units representing a 10% ownership interest in NEO were awarded to one individual as a key staff incentive from the reserve initially established for such awards, with no further awards currently anticipated. As a result, once NEO has realized and retained cumulative net income/distributable cash in the amount of $300,000, the next $975,000 of realized and retained cumulative net income/distributable cash would be distributed to GEN2. Distributions thereafter would be made to PSI, GEN2 and the other member, in proportion to their respective Unit ownership, at the times and in the manner determined from time to time by the managers, in their sole discretion.

GEN2 contributions to NEO were derived from its shareholders, which consist of accredited investors, and which include several WCUI officers and directors, including Calvin R. O’Harrow, Roy M. Harsch, William E. Kingsford, Douglas Samuelson, Paul D. Jones and Thomas E. Scott. GEN2 shareholders, including said officers and directors of WCUI, will share any realized and retained cumulative net income/distributable cash that may be distributed to GEN2.

As of September 30, 2019, the Company interest was adjusted to 51% of the joint venture, GEN2 controlled 39% and another individual controlled the remaining 10%. As of December 31, 2019, the Company recorded its proportionate share of $497,250 to additional paid-in-capital and $477,750 to non-controlling interest as of that date. During the three months ended December 31, 2019, NEO recorded a loss of $45,162 relating to its operations.

Psoria-Light

PSI designs, develops and markets a targeted ultraviolet (“UV”) phototherapy device called the Psoria-Light. The Psoria-Light is designated for use in targeted PUVA photochemistry and UVB phototherapy and is designed to treat certain skin conditions including psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma.

Psoriasis, eczema, and vitiligo, are common skin conditions that can be challenging to treat, and often cause the client significant psychosocial stress. Clients may undergo a variety of treatments to address these skin conditions, including routine consumption of systemic and biologic drug therapies which are highly toxic, reduce systemic immune system function, and come with a host of chemotherapy-like side effects. Ultraviolet (UV) phototherapy is a clinically validated alternate treatment modality for these disorders.

Traditionally, “non-targeted” UV phototherapy was administered by lamps that emitted either UVA or UVB light to both diseased and healthy skin. While sunblocks or other UV barriers may be used to protect healthy skin, the UV administered in this manner must be low dosage to avoid excessive exposure of healthy tissue. Today, “targeted” UV phototherapy devices administer much higher dosages of light only to affected tissue, resulting in “clearance” in the case of psoriasis and eczema, and “repigmentation” in the case of vitiligo, at much faster rates than non-targeted (low dosage) UV treatments.

Targeted UV treatments are typically administered to smaller total body surface areas, and are therefore used to treat the most intense parts of a client’s disease. Non-targeted UV treatment is typically used as a follow-up and for maintenance, capable of treating large surfaces of the body. Excimer laser devices (UVB at 308nm) are expensive and consume dangerous chemicals (Xenon and Chlorine). Mercury lamp devices (UVB and/or UVA) require expensive lamp replacements regularly and require special disposal (due to mercury content). Additionally, mercury lamp devices typically deliver wavelengths of light below 300nm. While within the UVB spectrum, it has been shown that wavelengths below 300nm produce significantly more “sunburn” type side effects than do wavelengths between 300 and 320nm without improvement in therapeutic benefit.

The Psoria-Light is a targeted UV phototherapy device that produces UVB light between 300 and 320 nm as well as UVA light between 350 and 395nm. It does not require consumption of dangerous chemicals or require special environmental disposal, and is cost effective for clinicians, which should result in increased patient access to this type of treatment. It has several unique and advanced features that we believe will distinguish it from the non-targeted and targeted UV phototherapy devices that are currently being used by dermatologists and other healthcare providers. These features include the following: the utilization of deep narrow-band UVB (“NB-UVB”) LEDs as light sources; the ability to produce both UVA or NB-UVB therapeutic wavelengths; an integrated high resolution digital camera and client record integration capabilities; the ability to export to an external USB memory device a PDF file of treatment information including a patent pending graph that includes digital images plotted against user tracked metrics which can be submitted to improve medical reimbursements; an accessory port and ability to update software; ease of placement and portability; advanced treatment site detection safety sensor; international language support; a warranty which includes the UV lamp(s); and a non-changeable treatment log (that does not include HIPPA information).

The Psoria-Light consists of three components: a base console, a color display with touchscreen control, and a hand-held delivery device with a conduit (or tether) between the handheld device and the base console. PSI requires clearance by the United States Food and Drug Administration (“FDA”) to market and sell the device in the United States as well as permission from TUV SUD America Inc., PSI’s Notified Body, to affix the CE mark to the Psoria-Light in order to market and sell the device in countries of the European Union.

To obtain FDA clearance and permission to affix the CE mark, PSI was required to conduct EMC and electrical safety testing, which it completed in the second quarter of 2011. PSI received FDA clearance on February 11, 2011 (no. K103540) and was granted permission to affix the CE mark on November 10, 2011. In its 510(k) application with the FDA (application number K103540), PSI asserted that the Psoria-Light was “substantially equivalent” in intended use and technology to two predicate devices, the X -Trac Excimer Laser, which has wide acceptance in the medical billing literature and has a large installed base in the U.S., and the Dualight, another competing targeted UV phototherapy device.

PSI has established an ISO 13485 compliant quality system for the Psoria-Light, which was first audited in the third quarter of 2011. This system is intended to ensure PSI devices will be manufactured in a controlled and reliable environment and that its resources follow similar practices and is required for sales in countries requiring a CE mark. PSI has also received Certified Space Technology designation from the Space Foundation, based on PSI’s incorporation of established NASA-funded LED technology.

PSI began Psoria-Light Beta deployment in January 2012. It is currently operating at a loss, and there is no assurance that its business development plans and strategies will ever be successful. PSI’s success depends upon the acceptance by healthcare providers and clients of Psoria-Light treatment as a preferred method of treatment for psoriasis and other UV-treatable skin conditions. Psoria-Light treatment appears to have been beneficial to clients, without demonstrable harmful side effects or safety issues, as evidenced by more than 10,000 treatments completed on more than 1,000 clients, domestically and Mexico, since 2012. In order for the Company to continue PSI operations, it will need additional capital and it will have to successfully coordinate integration of PSI operations without materially and adversely affecting continuation and development of other Company operations.

SCI

SCI was incorporated under the laws of the state of Illinois on March 18, 2014. SCI acquired certain Stealth Mark assets on April 4, 2014 and operates as a wholly-owned subsidiary of the Company. It is a provider of: a) Stealth Mark encryption and authentication solutions offering advanced technologies within the security and supply chain management vertical sectors (Intelligent Microparticles), and b) advanced data intelligence services offering proprietary, unprecedented, and actionable technology for industries, companies, and agencies on a global scale (ActiveDuty™).

Intelligent Microparticles

SCI provides clients premiere authentication technology for the protection of a variety of products and brands from illicit counterfeiting and diversion activities. Its technology is applicable to a wide range of industries affected by counterfeiting, diversion and theft including, but not limited to, pharmaceuticals, defense/aerospace, automotive, electronics, technology, consumer and personal care goods, designer products, beverage/spirits, and many others.

SCI delivers the client a complete, simple to use, easy to implement, and cost effective turnkey system that is extremely difficult to compromise. SCI’s technology includes a combination of proprietary software and intelligent microparticle marks that are unduplicatable and undetectable to the human eye. These taggants are created with proprietary materials that create unique numerical codes that are assigned meaning by the client and are machine readable without the use of rare earth or chemical tracers. They have been used in covert and overt operations with easy to implement technology and do-it-yourself in-the-field forensic caliber verification.

In April 2018, the Company’s subsidiary, SCI, concluded licensing of a patent for technology that is the next generation of Stealth Mark. Working with researchers at the Oak Ridge National Labs, the patent signifies development of a new technology that will generate an invisible marking system with attributes currently unavailable in the anti-counterfeit marketplace today. The formula and techniques have been shown through extensive testing to be resilient to manufacturing processes and can be used on a wide range of materials from woven and non-woven fabrics, cardboard, metal, concrete, plastics, leather, wood, and paper. In addition, the complexity of the information that can be encoded with the system makes counterfeiting difficult.

ActiveDuty™

SCI’s ActiveDuty™ data intelligence services offer unique, unprecedented, actionable technology for industries, companies, and agencies on a global scale. Comprised of a suite of powerful analytical tools, including artificial intelligence and social-psychology, the service provides timely and actionable intelligence to clients. ActiveDuty™ is adaptable to a broad spectrum of illicit activities within both private and public sectors such as, but not limited to, counterfeiting, sex and human trafficking, money laundering, and a variety of other markets.

The proprietary algorithmic architecture of ActiveDuty™ creates the first systemic reporting mechanism to deliver strategic and tactical results supported by an intense worldwide analysis of patterns of human behavior. The ActiveDuty™ global framework is heuristic in nature, capable of comprehending big data across the digital spectrum and speaks all the major languages. Up until now, there has not existed a unified system that could actively measure this lifecycle that is a collection of discreet and seemingly random behaviors of criminals anywhere within the digital domain. Criminals change their identities but not their basic behaviors.

SCI was managed initially by Ricky Howard, who brought over thirty years of experience in operations management and executive positions in a variety of industries ranging from entrepreneurial startups to Fortune 500 companies. He played an integral role in bringing the company’s capabilities to its present status including design and creation of its manufacturing capabilities, implementation of its ERP inventory controls system, software and hardware development, marketing and sales materials processes and day-to-day operational procedures and processes. In November 2018, Mr. Howard passed away suddenly and Mr. O’Harrow took over operations of SCI’s business on an interim basis.

Proposed Share Exchange

On September 3, 2019, our Board unanimously approved, subject to stockholder approval, the execution and delivery of a proposed Share Exchange Agreement relating to the share exchange and transfer of certain assets of SCI to DTI Holdings, Inc. (“DTI”) pursuant to the terms and conditions of a Memorandum of Agreement providing, among other things, as follows:

● DTI will pay the Company $500,000 upon execution of a definitive share exchange agreement (“Share Exchange Agreement”) which the parties will endeavor to negotiate and execute as quickly as possible, and not later than October 15, 2019.

● DTI will pay the Company an additional $500,000 within seven days following the completion date of the transfer of all assets and/or full ownership of SCI to DTI, with such date to occur within 120 days following execution of the Share Exchange Agreement.

● DTI will issue to the Company 3,112,000 shares of DTI common stock and will guaranty that the value of the 3,112,000 shares of DTI common stock will have a value of at least $4.50 per share ($14,004,000, in the aggregate), as of December 31, 2021.

● To the extent that the value of the DTI common shares, as of December 31, 2021, is less than $4.50 per share ($14,004,000, in the aggregate), DTI will issue additional shares of DTI common stock, at the then current fair market value, in an amount sufficient to cause the resulting aggregate value of all shares of DTI common stock issued to the Company to be $14,004,000, in the aggregate.

● DTI will assign the assets transferred by SCI, including trademarks, intellectual properties, and patents, to its subsidiary, Femtobitz, Inc., a Delaware corporation, and will pay to the Company 1% of annual gross revenue arising from or relating to operation of Femtobitz, Inc.

● Upon closing of the share exchange, the Company’s Chairman will be appointed an advisory board member of DTI and a board member of Femtobitz, Inc.

The 3,112,000 shares of DTI common stock to be issued to us in exchange for all of our shares of SCI common stock will represent a minority of the issued and outstanding shares of DTI common stock as of the date of issuance. The DTI shares will be issued in reliance upon the exemption from registration requirements under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(2) thereof and Regulation D thereunder. As such, such shares may not be offered or sold by us unless they are registered under the Securities Act or qualify for an exemption from the registration requirements under the Securities Act.

Analysis of Financial Condition and Results of Operations

Results of Operations for the three months ended December 31, 2019 compared to the three months ended December 31, 2018.

Revenue and Cost of Goods Sold

Revenue for the three months ended December 31, 2018 was $12,875. There was no revenue, cost of sales or gross profit for the three months ended December 31, 2019. The decrease in 2019 was due to the decrease in revenues at SCI, as there was no revenue at PSI for each period. Cost of sales for the three months ended December 31, 2018 was $7,725. Gross profit for the three months ended December 31, 2018 was $5,150.

Operating Expenses

Operating expenses for the three months ended December 31, 2019 and 2018 were $337,273 and $475,864, respectively. The decrease in operating expenses of $138,591 was due primarily to the decrease in consulting fees and stock compensation during the three months ended December 31, 2019.

Other Expenses

Other expenses during the three months ended December 31, 2019 consisted of $9,323 of interest expense. Other expenses during the three months ended December 31, 2018 consisted of $50,689 of amortization of debt discount, $51,434 of financing costs and $4,851 of interest expense, totaling to $106,974.

Net Loss

Our net loss for the three months ended December 31, 2019 was $346,596, compared to a net loss of $577,688 for the three months ended December 31, 2018. The decrease in the net loss of $231,091 was primarily due to the decrease in operating and other expenses.

Results of Operations by Segment

The Company currently maintains two business segments:

	(i)	Medical Devices: which it provided through PSI, its wholly-owned subsidiary acquired on August 24, 2012, a developer, manufacturer, marketer and distributer of targeted Ultra Violet (“UV”) phototherapy devices for the treatment of skin diseases; and

	(ii)	Authentication and Encryption Products and Services: which it provided through SCI, its wholly-owned subsidiary that on April 4, 2014 acquired certain assets of SMI Holdings, Inc. d/b/a Stealth Mark, Inc., including Stealth Mark tradenames and marks, and related encryption and authentication solutions offering advanced product security technologies within the security and supply chain management vertical sectors.

The detailed segment information of the Company is as follows:

Operations by Segment

	For the Three Months Ended
	December 31, 2019
	Corporate			Medical Devices			Authentication and Encryption			Total
Sales:
Trade	$	-		$	-		$	-		$	-
Consulting services		-			-			-			-
Total Sales		-			-			-			-

Cost of goods sold		-			-			-			-

Gross profit		-			-			-			-

Operating expenses		98,462			175,286			63,525			337,273

Loss from operations	$	(98,462	)	$	(175,286	)	$	(63,525	)	$	(337,273	)

Operations by Segment

	For the Three Months Ended
	December 31, 2018
	Corporate			Medical Devices			Authentication and Encryption			Total
Sales:
Trade	$	-		$	-		$	7,675		$	7,675
Consulting services		-			-			5,200			5,200
Total Sales		-			-			12,875			12,875

Cost of goods sold		-			-			7,725			7,725

Gross profit		-			-			5,150			5,150

Operating expenses		254,429			119,720			101,715			475,864

Loss from operations	$	(254,429	)	$	(119,720	)	$	(96,565	)	$	(470,714	)

There was no revenue or cost of goods sold for the Medical Devices segment for the three months ended December 31, 2019 and 2018. Operating expenses for the three months ended December 31, 2019 and 2018 was $175,286 and $119,720, respectively. The increase in operating expenses of $55,566 in 2019 was due primarily to the increase in contract labor. The loss from operations for the three months ended December 31, 2019 and 2018 was $175,286 and $119,720, respectively.

Revenue for the Authentication and Encryption segment for the three months ended December 31, 2018 was $12,875. There was no revenue or cost of sales for the Authentication and Encryption segment for the three months ended December 31, 2019. The decrease in 2019 was due to the decrease in trade sales and consulting services. Cost of goods sold for the three months ended December 31, 2018 was $7,725 and the gross profit was $5,150. The gross profit decrease in 2019 was primarily due to the decrease in sales. Operating expenses for the three months ended December 31, 2019 and 2018 was $63,525 and $101,715, respectively. The decrease in operating expenses of $38,190 in 2019 was due primarily to the decrease in stock compensation costs and salaries and wages. The loss from operations for the three months ended December 31, 2019 and 2018 was $63,525 and $96,565, respectively.

The Corporate segment primarily provides executive management services for the Company. Operating expenses for the three months ended December 31, 2019 and 2018 was $60,647 and $254,429, respectively. The decrease in operating expenses of $193,782 in 2019 was due primarily to the decrease in professional fees and stock compensation. The loss from operations for the three months ended December 31, 2019 and 2018 was $60,647 and $254,429, respectively.

Liquidity and Capital Resources

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying condensed consolidated financial statements, the Company has not yet generated significant revenues and has incurred recurring net losses. During the three months ended December 31, 2019, the Company incurred a net loss of $346,596 and used cash in operations of $195,784, and had a shareholders’ deficit of $1,314,852 as of December 31, 2019. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its strategies. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Comparison of three months ended December 31, 2019 and 2018

As of December 31, 2019, we had $42,363 in cash, negative working capital of $1,337,549 and an accumulated deficit of $25,686,754.

As of December 31, 2018, we had $134,750 in cash, negative working capital of $716,195 and an accumulated deficit of $23,954,052.

Cash flows used in operating activities

During the three months ended December 31, 2019, the Company used cash flows in operating activities of $195,784, compared to $314,460 used in the three months ended December 31, 2018. During the three months ended December 31, 2019, the Company incurred a net loss of $346,596 and $67,300 of non-cash expenses, compared to a net loss of $577,688 and $197,938 of non-cash expenses during the three months ended December 31, 2018.

Cash flows used in investing activities

During the three months ended December 31, 2019 and 2018, the Company had no cash flows from investing activities.

Cash flows provided by financing activities

During the three months ended December 31, 2019, the Company had proceeds from loans payable from officers and shareholders of $135,000 and proceeds of $50,000 from contributions of capital by its joint venture partner. During the three months ended December 31, 2018, the Company had proceeds from loans payable from officers and shareholders of $60,000, from the sale of common stock of $10,000 and from contributions of capital by its joint venture partner of $375,000.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Summary of Critical Accounting Policies.

The Company has identified critical accounting policies that, as a result of the judgments, uncertainties, uniqueness and complexities of the underlying accounting standards and operations involved could result in material changes to its financial condition or results of operations under different conditions or using different assumptions. The Company’s most critical accounting policies include, but are not limited to, those related to fair value of financial instruments, revenue recognition, stock based compensation for obtaining employee services, and equity instruments issued to parties other than employees for acquiring goods or services. Details regarding the Company’s use of these policies and the related estimates are described in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019, filed with the Securities and Exchange Commission on January 28, 2020. There have been no material changes to the Company’s critical accounting policies that impact the Company’s financial condition, results of operations or cash flows for the three months ended December 31, 2019.

Recently Issued Accounting Pronouncements

See Management’s discussion of recent accounting policies included in footnote 2 to the condensed consolidated financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting Companies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Regulations under the Securities Exchange Act of 1934 (the “Exchange Act”) require public companies to maintain “disclosure controls and procedures,” which are defined as controls and other procedures that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. A material weakness is a control deficiency (within the meaning of the Public Company Accounting Oversight Board (PCAOB) Auditing Standard No. 2) or combination of control deficiencies that result in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected.

The Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer (“CEO”), of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of December 31, 2019, the end of the period covered by this report. Based upon that evaluation, the Company’s CEO concluded that the Company’s disclosure controls and procedures are not effective at the reasonable assurance level due to the material weaknesses described below:

1. The lack of an independent audit committee and the lack of internal personnel necessary to provide accurate and timely regulatory filings.

2. The Company does not have written documentation of its internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act which is applicable to the Company. Management evaluated the impact of its failure to have written documentation of its internal controls and procedures on its assessment of its disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

3. The Company does not have sufficient segregation of duties within its accounting functions, which is a basic internal control. Due to its size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals. Management evaluated the impact of its failure to have segregation of duties on its assessment of its disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

4. The Company does not have sufficient segregation of duties so that one person can initiate, authorize and execute transactions.

In light of the material weaknesses, the management of the Company performed additional analysis and other post-closing procedures to ensure our consolidated financial statements were prepared in accordance with the accounting principles generally accepted in the United States of America. Accordingly, we believe that our consolidated financial statements included herein fairly present, in all material respects, our consolidated financial condition, consolidated results of operations and cash flows as of and for the reporting periods then ended.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the issuer’s principal executive and principal financial officer and effected by the issuer’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America and includes those policies and procedures that:

● Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the issuer;

● Only in accordance with authorizations of management and directors of the issuer; and provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the Company are being made;

● Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the issuer’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

As of the end of our most recent fiscal year, management assessed the effectiveness of our internal control over financial reporting based on the criteria for effective internal control over financial reporting established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and SEC guidance on conducting such assessments. Based on that evaluation, they concluded that, as of September 30, 2019, such internal control over financial reporting was not effective. This was due to deficiencies that existed in the design or operation of our internal control over financial reporting that adversely affected our internal controls and that may be considered to be material weaknesses.

The matters involving internal control over financial reporting that our management considered to be material weaknesses under the standards of the Public Company Accounting Oversight Board were: (1) lack of a functioning audit committee due to a lack of a majority of independent members and a lack of a majority of outside directors on our board of directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures; and (2) inadequate segregation of duties consistent with control objectives of having segregation of the initiation of transactions, the recording of transactions and the custody of assets. The aforementioned material weaknesses were identified by our Chief Executive Officer in connection with the review of our financial statements as of December 31, 2019.

To address the material weaknesses set forth in items (2) and (3) discussed above, management performed additional analyses and other procedures to ensure that the financial statements included herein fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented.

This Report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to the rules of the SEC that permit the Company to provide only the management’s report in this Report.

Management’s Remediation Initiatives

In response to the above identified weaknesses in our internal control over financial reporting, we plan to work on documenting in writing our internal control policies and procedures and implement sufficient segregation of duties within our accounting functions, so that one person cannot initiate, authorize and execute transactions, and so that one person cannot record transactions in the accounting records without sufficient review by a separate person. We do not have a specific timeline within which we expect to conclude these remediation initiatives but do expect it to be an on-going process for the foreseeable future. We continue to evaluate testing of our internal control policies and procedures, including assessing internal and external resources that may be available to complete these tasks, but do not know when these tasks will be completed.

Our CEO and CFO, along with other Board members, are and will be active participants in these remediation processes. We believe the steps taken to date have improved the effectiveness of our internal control over financial reporting.

Changes in internal control over financial reporting.

There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15 (f) under the Exchange Act) during the fourth quarter of our fiscal year 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

The Company is periodically engaged in legal proceedings arising from and relating to its business operations. We currently are not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting our Company, our common stock, any of our subsidiaries or of our Company’s or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect on our financial condition or results of operations. However, we recently decided to attempt to preserve revenue and reduce operating expenses through actions including, but not limited to, facilities consolidation and staff reductions, which we hope to implement through negotiated transactions with lessors, employees and other third parties. Such actions may result in disputes with and claims by such parties which, if not resolved through negotiations, may impact negatively the Company’s ability to continue as a going concern. To date, we have negotiated settlement of all but $89,301.87 in ex-employee wage and benefits claims, with agreement to pay such remaining amount, together with interest at the rate of 4% per annum on the principal amount from time to time outstanding, when and as cash flow permits. One of the employees claims additional amounts due for certain statutory damages under the Illinois Wage Payment and Collection which currently could exceed $21,600.00 and would increase at the rate of 2% of the wages due per month plus attorneys’ fees if the employee elects to file suit for a violation of the Act and is successful in obtaining a judgment on his claim.

Item 1A. Risk Factors

Not required for smaller reporting companies.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None

Item 6. Exhibits

Exhibit No.		Description
31.1		Certification of Principal Executive Officer Pursuant to Rule 13a-14*
31.2		Certification of Principal Financial Officer Pursuant to Rule 13a-14*
32.1		CEO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act*
32.2		CFO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act*
101.INS		XBRL Instance Document**
101.SCH		XBRL Taxonomy Extension Schema**
101.CAL		XBRL Taxonomy Extension Calculation Linkbase**
101.DEF		XBRL Taxonomy Extension Definition Linkbase**
101.LAB		XBRL Taxonomy Extension Label Linkbase**
101.PRE		XBRL Taxonomy Extension Presentation Linkbase**

* Filed herewith.

**Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, there unto duly authorized.

	WELLNESS CENTER USA, INC.

Date: March 25, 2020	By:	/s/ Paul D. Jones
		Paul D. Jones President (Duly Authorized Principal Executive Officer)

	WELLNESS CENTER USA, INC.

Date: March 25, 2020	By:	/s/ Douglas W. Samuelson
		Douglas W. Samuelson Chief Financial Officer and Principal Accounting Officer (Duly Authorized Principal Accounting Officer)

POWER OF ATTORNEY

Each person whose signature appears below hereby constitutes and appoints severally Paul D. Jones, his true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SIGNATURE	TITLE	DATE

/s/ Calvin O’Harrow	Chief Executive Officer, Director	March 25, 2020
Calvin O’Harrow

/s/ Douglas W. Samuelson	Chief Financial Officer and Principal Accounting Officer	March 25, 2020
Douglas W. Samuelson

/s/ Paul D. Jones	Director, President	March 25, 2020
Paul D. Jones

/s/ Thomas E. Scott		Director, Secretary		March 25, 2020
Thomas E. Scott

/s/ William E. Kingsford

Director

March 25, 2020

William E. Kingsford

/s/ Roy M. Harsch

Director, Chairman

March 25, 2020

Roy M. Harsch

EX-31.1 2 ex31-1.htm

Exhibit 31.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Calvin O’Harrow, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Wellness Center USA, Inc. for the quarterly period ended December 31, 2019;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such internal control over financial reporting to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, if any, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period cover by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting;

Date: March 25, 2020

/s/ Calvin O’Harrow
Name:	Calvin O’Harrow
Title:	Chief Executive Officer and Director

EX-31.2 3 ex31-2.htm

Exhibit 31.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Douglas W. Samuelson, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Wellness Center USA, Inc. for the quarterly period ended December 31, 2019;

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting;

Date: March 25, 2020

/s/ Douglas W. Samuelson
Name:	Douglas W. Samuelson
Title:	Chief Accounting Officer and Chief Financial Officer

EX-32.1 4 ex32-1.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2019 of Wellness Center USA, Inc., a Nevada corporation (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Calvin O’Harrow, Chief Executive Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or15(d) of the Securities and Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date: March 25, 2020

/s/ Calvin O’Harrow
Name:	Calvin O’Harrow
Title:	Chief Executive Officer and Director

EX-32.2 5 ex32-2.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2019 of Wellness Center USA, Inc., a Nevada corporation (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Douglas W. Samuelson, Chief Accounting Officer and Chief Financial Officer of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or15(d) of the Securities and Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date: March 25, 2020

/s/ Douglas W. Samuelson
Name:	Douglas W. Samuelson
Title:	Chief Accounting Officer and Chief Financial Officer

EX-101.INS 6 wcui-20191231.xml XBRL INSTANCE FILE 0001516887 2019-10-01 2019-12-31 0001516887 2018-09-30 0001516887 us-gaap:CommonStockMember 2018-09-30 0001516887 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001516887 us-gaap:RetainedEarningsMember 2018-09-30 0001516887 WCUI:TotalWCUIDeficitMember 2018-09-30 0001516887 us-gaap:NoncontrollingInterestMember 2018-09-30 0001516887 WCUI:StockOptionsMember 2018-10-01 2018-12-31 0001516887 WCUI:WarrantsMember 2018-10-01 2018-12-31 0001516887 us-gaap:WarrantMember srt:MinimumMember 2019-10-01 2019-12-31 0001516887 us-gaap:WarrantMember srt:MaximumMember 2019-10-01 2019-12-31 0001516887 us-gaap:WarrantMember WCUI:ExercisePriceRangeTwoMember 2019-10-01 2019-12-31 0001516887 us-gaap:WarrantMember WCUI:ExercisePriceRangeTwoMember 2019-12-31 0001516887 WCUI:TwoThousandTenNonQualifiedStockOptionPlanMember 2018-01-02 0001516887 us-gaap:WarrantMember 2019-10-01 2019-12-31 0001516887 WCUI:TradeMember 2019-10-01 2019-12-31 0001516887 WCUI:ConsultingServicesMember 2019-10-01 2019-12-31 0001516887 WCUI:StockOptionsMember WCUI:TwoThousandTenPlanMember 2019-12-31 0001516887 2019-12-31 0001516887 WCUI:TradeMember 2018-10-01 2018-12-31 0001516887 WCUI:ConsultingServicesMember 2018-10-01 2018-12-31 0001516887 us-gaap:CommonStockMember 2019-09-30 0001516887 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001516887 us-gaap:RetainedEarningsMember 2019-09-30 0001516887 WCUI:TotalWCUIDeficitMember 2019-09-30 0001516887 us-gaap:NoncontrollingInterestMember 2019-09-30 0001516887 WCUI:WarrantsMember 2019-10-01 2019-12-31 0001516887 WCUI:PsoriaShieldIncMember 2019-10-01 2019-12-31 0001516887 WCUI:StealthCoIncMember 2019-10-01 2019-12-31 0001516887 WCUI:StealthCoIncMember 2019-12-31 0001516887 WCUI:PsoriaDevelopmentCompanyLLCMember 2019-10-01 2019-12-31 0001516887 WCUI:PsoriaDevelopmentCompanyLLCMember 2019-12-31 0001516887 us-gaap:CorporateMember 2019-12-31 0001516887 WCUI:MedicalDevicesMember 2019-12-31 0001516887 WCUI:AuthenticationandEncryptionMember 2019-12-31 0001516887 us-gaap:CorporateMember WCUI:TradeMember 2019-10-01 2019-12-31 0001516887 WCUI:MedicalDevicesMember WCUI:TradeMember 2019-10-01 2019-12-31 0001516887 WCUI:AuthenticationandEncryptionMember WCUI:TradeMember 2019-10-01 2019-12-31 0001516887 us-gaap:CorporateMember WCUI:ConsultingServicesMember 2019-10-01 2019-12-31 0001516887 WCUI:MedicalDevicesMember WCUI:ConsultingServicesMember 2019-10-01 2019-12-31 0001516887 WCUI:AuthenticationandEncryptionMember WCUI:ConsultingServicesMember 2019-10-01 2019-12-31 0001516887 us-gaap:CorporateMember WCUI:TradeMember 2018-10-01 2018-12-31 0001516887 WCUI:MedicalDevicesMember WCUI:TradeMember 2018-10-01 2018-12-31 0001516887 WCUI:AuthenticationandEncryptionMember WCUI:TradeMember 2018-10-01 2018-12-31 0001516887 us-gaap:CorporateMember WCUI:ConsultingServicesMember 2018-10-01 2018-12-31 0001516887 WCUI:MedicalDevicesMember WCUI:ConsultingServicesMember 2018-10-01 2018-12-31 0001516887 WCUI:AuthenticationandEncryptionMember WCUI:ConsultingServicesMember 2018-10-01 2018-12-31 0001516887 us-gaap:CorporateMember 2018-10-01 2018-12-31 0001516887 WCUI:MedicalDevicesMember 2018-10-01 2018-12-31 0001516887 WCUI:AuthenticationandEncryptionMember 2018-10-01 2018-12-31 0001516887 srt:MinimumMember 2019-09-30 0001516887 srt:MaximumMember 2019-09-30 0001516887 WCUI:ExercisePriceRangeOneMember 2019-10-01 2019-12-31 0001516887 WCUI:ExercisePriceRangeOneMember 2019-12-31 0001516887 WCUI:ExercisePriceRangeTwoMember 2019-10-01 2019-12-31 0001516887 WCUI:ExercisePriceRangeTwoMember 2019-12-31 0001516887 WCUI:ExercisePriceRangeThreeMember 2019-10-01 2019-12-31 0001516887 WCUI:ExercisePriceRangeThreeMember 2019-12-31 0001516887 WCUI:ExercisePriceRangeFourMember 2019-10-01 2019-12-31 0001516887 WCUI:ExercisePriceRangeFourMember 2019-12-31 0001516887 2018-11-14 2018-11-15 0001516887 WCUI:GenTwoFundingIncMember 2019-12-31 0001516887 WCUI:EmployeesandConsultantsMember 2018-12-01 2018-12-31 0001516887 2018-12-01 2018-12-31 0001516887 WCUI:NeoPhototherapyLLCMember 2019-10-01 2019-12-31 0001516887 WCUI:NeoPhototherapyLLCMember 2019-12-31 0001516887 WCUI:GenTwoFundingIncMember 2019-10-01 2019-12-31 0001516887 WCUI:IllinoisLimitedLiabilityCompanyMember 2019-12-31 0001516887 us-gaap:SubsequentEventMember WCUI:UnsecuredLoansMember 2020-03-25 0001516887 WCUI:TwoThousandTenNonQualifiedStockOptionPlanMember 2010-06-30 0001516887 us-gaap:WarrantMember 2019-09-30 0001516887 us-gaap:WarrantMember srt:MinimumMember 2019-09-30 0001516887 us-gaap:WarrantMember srt:MaximumMember 2019-09-30 0001516887 us-gaap:WarrantMember WCUI:ExercisePriceRangeOneMember 2019-10-01 2019-12-31 0001516887 us-gaap:WarrantMember WCUI:ExercisePriceRangeOneMember 2019-12-31 0001516887 2018-10-01 2018-12-31 0001516887 WCUI:IllinoisLimitedLiabilityCompanyMember 2019-10-01 2019-12-31 0001516887 srt:ScenarioForecastMember WCUI:ShareExchangeAgreementMember WCUI:DTIHoldingsIncMember 2021-12-31 0001516887 srt:ScenarioForecastMember WCUI:ShareExchangeAgreementMember WCUI:DTIHoldingsIncMember 2021-12-30 2021-12-31 0001516887 WCUI:ShareExchangeAgreementMember WCUI:DTIHoldingsIncMember 2019-09-01 2019-09-03 0001516887 WCUI:PsoriaShieldIncMember 2019-12-31 0001516887 2018-12-31 0001516887 WCUI:ShareExchangeAgreementMember WCUI:FemtobitzIncMember 2018-10-01 2019-09-30 0001516887 WCUI:ShareExchangeAgreementMember WCUI:DTIHoldingsIncMember 2019-12-31 0001516887 WCUI:NEOMember 2019-10-01 2019-12-31 0001516887 WCUI:GEN2Member 2019-09-30 0001516887 us-gaap:IndividualMember 2019-12-31 0001516887 WCUI:StealthCoMember WCUI:NonCancellableLeaseAgreementMember 2016-09-29 2016-10-02 0001516887 WCUI:StealthCoMember WCUI:NonCancellableLeaseAgreementMember 2016-10-02 0001516887 WCUI:StealthCoMember WCUI:OwnershipAgreementMember us-gaap:SubsequentEventMember 2020-01-06 0001516887 us-gaap:SubsequentEventMember WCUI:OfficersandShareholdersMember 2020-03-25 0001516887 us-gaap:SubsequentEventMember 2019-10-03 2020-01-24 0001516887 WCUI:TwentyTwoShortTermUnsecuredLoansMember 2019-09-30 0001516887 WCUI:BoardOfDirectorsMember 2019-12-30 2019-12-31 0001516887 us-gaap:SubsequentEventMember 2020-01-01 0001516887 us-gaap:SubsequentEventMember WCUI:SeptemberThirtyTwoThousandTwentyMember 2020-01-01 0001516887 us-gaap:SubsequentEventMember WCUI:SeptemberThirtyTwoThousandTwentyMember srt:MinimumMember 2020-01-01 0001516887 us-gaap:SubsequentEventMember WCUI:SeptemberThirtyTwoThousandTwentyMember srt:MaximumMember 2020-01-01 0001516887 us-gaap:SubsequentEventMember srt:MinimumMember 2020-01-01 0001516887 us-gaap:SubsequentEventMember srt:MaximumMember 2020-01-01 0001516887 us-gaap:SubsequentEventMember 2020-03-30 2020-03-31 0001516887 2019-09-30 0001516887 us-gaap:CommonStockMember 2019-10-01 2019-12-31 0001516887 us-gaap:CommonStockMember 2018-10-01 2018-12-31 0001516887 us-gaap:CommonStockMember 2019-12-31 0001516887 us-gaap:CommonStockMember 2018-12-31 0001516887 us-gaap:AdditionalPaidInCapitalMember 2019-10-01 2019-12-31 0001516887 us-gaap:AdditionalPaidInCapitalMember 2018-10-01 2018-12-31 0001516887 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001516887 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001516887 us-gaap:RetainedEarningsMember 2019-10-01 2019-12-31 0001516887 us-gaap:RetainedEarningsMember 2018-10-01 2018-12-31 0001516887 us-gaap:RetainedEarningsMember 2019-12-31 0001516887 us-gaap:RetainedEarningsMember 2018-12-31 0001516887 WCUI:TotalWCUIDeficitMember 2019-10-01 2019-12-31 0001516887 WCUI:TotalWCUIDeficitMember 2018-10-01 2018-12-31 0001516887 WCUI:TotalWCUIDeficitMember 2019-12-31 0001516887 WCUI:TotalWCUIDeficitMember 2018-12-31 0001516887 us-gaap:NoncontrollingInterestMember 2019-10-01 2019-12-31 0001516887 us-gaap:NoncontrollingInterestMember 2018-10-01 2018-12-31 0001516887 us-gaap:NoncontrollingInterestMember 2019-12-31 0001516887 us-gaap:NoncontrollingInterestMember 2018-12-31 0001516887 WCUI:GEN2Member 2019-12-31 0001516887 WCUI:OfficersandShareholdersMember 2019-09-30 0001516887 2019-02-28 0001516887 2019-02-01 2019-02-28 0001516887 WCUI:EmployeeMember 2019-10-01 2019-12-31 0001516887 WCUI:EmployeeMember 2019-12-31 0001516887 us-gaap:StockOptionMember 2019-01-01 2019-12-31 0001516887 srt:MinimumMember 2019-10-01 2019-12-31 0001516887 srt:MaximumMember 2019-10-01 2019-12-31 0001516887 srt:MinimumMember 2019-12-31 0001516887 srt:MaximumMember 2019-12-31 0001516887 us-gaap:WarrantMember 2019-12-31 0001516887 us-gaap:WarrantMember srt:MinimumMember 2019-12-31 0001516887 us-gaap:WarrantMember srt:MaximumMember 2019-12-31 0001516887 us-gaap:CorporateMember 2019-10-01 2019-12-31 0001516887 WCUI:MedicalDevicesMember 2019-10-01 2019-12-31 0001516887 WCUI:AuthenticationandEncryptionMember 2019-10-01 2019-12-31 0001516887 WCUI:StockOptionsMember 2019-10-01 2019-12-31 0001516887 2019-10-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure Wellness Center USA, Inc. 0001516887 10-Q 2019-12-31 false --09-30 Non-accelerated Filer Q1

42363

2273

33330

6760

53147

1562

534250

235000

399250

107497

395520

477750

393149

0.001

30000000

200000000

7500000

200000000

107497077

5150

337273

254429

119720

101715

475864

98462

175286

63525

-337273

-254429

-119720

-96565

-470714

45162

-98462

-175286

-63525

9323

4851

-9323

-106974

-346596

-577688

-324467

-573929

-324467

-573929

-22129

-3759

-22129

-3759

-324467

-979312

-0.00

-0.01

100952569

107497077

103697867

9600

120

9480

9600

120000

1562

264

9600

500

-1550

-195784

-314460

10000

185000

445000

66000000

20000000

0.15

0.25

0.12

0.40

135000

60000

3112000

142857

62500

2313

P2Y7M21D

P7M10D

P1Y6M29D

P2Y10M6D

P2Y2M30D

P1Y

P1Y8M12D

P5Y

314812

-51434

23868885

497250

23777647

7725

10000

14004000

143

9857

10000

true false

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   Basis of Consolidation   The Company’s consolidated subsidiaries and/or entities are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"> Name of consolidated subsidiary or entity</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">State or other jurisdiction of incorporation or organization</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> Date of incorporation or formation (date of acquisition/disposition, if applicable)</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid">Attributable interest</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 26%">Psoria-Shield Inc. (“PSI”)</td> <td style="width: 1%"> </td> <td style="width: 26%">The State of Florida</td> <td style="width: 1%"> </td> <td style="width: 32%">June 17, 2009 (August 24, 2012)</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">100</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> StealthCo, Inc. (“StealthCo”)</td> <td> </td> <td>The State of Illinois</td> <td> </td> <td>March 18, 2014</td> <td> </td> <td> </td> <td style="text-align: right">100</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> Psoria Development Company LLC. (“PDC”)</td> <td> </td> <td>The State of Illinois</td> <td> </td> <td>January 15, 2015/November 15, 2018</td> <td> </td> <td> </td> <td style="text-align: right">50</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> NEO Phototherapy LLC (“NEO”)</td> <td> </td> <td>The State of Illinois</td> <td> </td> <td>December 2018</td> <td> </td> <td> </td> <td style="text-align: right">51</td> <td>%</td></tr> </table>   Through October 2018, PSI was operated by PDC, a joint venture between PSI and the Medical Alliance, Inc (“TMA”). On November 15, 2018, the Company and TMA entered into a Withdraw and Mutual Release Agreement to terminate their joint venture agreement. In December 2018, the Company and its wholly-owned subsidiary, Psoria-Shield, Inc. (“PSI”), entered into a Joint Venture Agreement with PSI Gen 2 Funding, Inc. (“GEN2”), an Illinois corporation, to further development, marketing, licensing and/or sale of PSI technology and products. The joint venture is conducted through NEO Phototherapy, LLC, a recently formed Illinois limited liability company (“NEO”), with principal offices and records to be maintained at WCUI’s offices. See Non-Controlling Interests in Note 2 for more details.   Use of Estimates   The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in the valuation of accounts receivable and allowance for uncollectible amounts, inventory and obsolescence reserves, accruals for potential liabilities, valuations of stock-based compensation, realization of deferred tax assets, among others. Actual results could differ from these estimates.   Income (Loss) Per Share   Basic loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of outstanding common shares during the period. Diluted loss per share is computed by dividing the net loss applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued. For the three months ended December 31, 2019 and 2018, the basic and diluted shares outstanding were the same, as potentially dilutive shares were considered anti-dilutive. At December 31, 2019 and 2018, the dilutive impact of outstanding stock options of 15,037,738 and 17,587,738 shares, respectively, and outstanding warrants for 66,484,049 and 68,192,442 shares, respectively, have been excluded because their impact on the loss per share is anti-dilutive.   Revenue Recognition   In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). This ASU is a comprehensive new revenue recognition model that requires a company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services. The Company adopted this ASU on October 1, 2018 retrospectively, the cumulative effect of the initial application on our accumulated deficit on that date was immaterial.   For trade sales, the Company generates its revenue from sales contracts with customers with revenues being generated upon the shipment of merchandise, or for consulting services, revenue is recognized in the period services are rendered and earned under service arrangements with clients.   We sell our products through two main sales channels: 1) directly to customers who use our products (the “Direct Channel”) and 2) to distribution partners who resell our products (the “Indirect Channel”).   Under the Direct Channel, we sell our products to and we receive payment directly from customers who purchase our products. Under our Indirect Channel, we have entered into distribution agreements that allow the distributors to sell our products and fulfill performance obligations under the agreements.   We determine revenue recognition through the following steps:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 53px"> </td> <td style="width: 53px">●</td> <td>Identification of the contract, or contracts, with a customer</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 53px"> </td> <td style="width: 53px">●</td> <td>Identification of the performance obligations in the contract</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 53px"> </td> <td style="width: 53px">●</td> <td>Determination of the transaction price</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 53px"> </td> <td style="width: 53px">●</td> <td>Allocation of the transaction price to the performance obligations in the contract</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 53px"> </td> <td style="width: 53px">●</td> <td>Recognition of revenue when, or as, we satisfy a performance obligation.</td></tr> </table>   Revenue is generally recognized upon shipment or when a service has been completed, unless we have significant performance obligations for services still to be completed. We recognize revenue when a material reversal is no longer probable. Payments received before the relevant criteria for revenue recognition are satisfied are recorded as deferred revenue. There was no deferred revenue at December 31, 2019 and 2018.   Non-controlling Interests   Through November 2018, non-controlling interest represented the non-controlling interest holder’s proportionate share of the equity of the Company’s majority-owned subsidiary, PDC. Non-controlling interest is adjusted for the non-controlling interest holder’s proportionate share of the earnings or losses and other comprehensive income (loss), if any, and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.   On November 15, 2018, PSI and TMA entered into a Withdraw and Mutual Release Agreement to terminate their joint venture agreement. On the date of termination, the non-controlling interest’s share of the accumulated losses of the joint venture totaled to $405,383. Upon termination, during the three months ended December 31, 2018, the Company wrote-off the non-controlling interest’s share of the accumulated losses and recorded a loss from the deconsolidation of a non-controlling interest of $405,383.   In December 2018, PSI entered into a Joint Venture Agreement with GEN2 to further development, marketing, licensing and/or sale of PSI technology and products. Pursuant to the Joint Venture Agreement, the venture will be conducted through NEO. PSI and GEN2 will be the members of NEO, owning 50.5% and 36.0%, respectively, of the Units issued in connection with the organization of NEO. An additional 13.5% of such Units will be reserved for issuance as incentives for key employees and consultants. Until such shares are distributed, the Company controls 68% of the joint venture and GEN2 the remaining 32%. PSI and GEN2 will manage NEO’s day-to-day operations. PSI will contribute PSI technology to NEO and GEN2 will contribute $700,000. As of December 31, 2019, NEO’s operations required additional funding above the $700,000 documented in the agreement, and as of September 30, 2019, GEN2 had received $925,000 of investments to contribute to NEO. During the three months ended December 30, 2019, an additional $50,000 was contributed by GEN2 to NEO. As of December 31, 2019, GEN2 had received $975,000 of investments to contribute to NEO. As of December 31, 2019, the Company controlled 51% of the joint venture, GEN2 controlled 39% and another individual controlled the remaining 10%. The Company recorded its proportionate share of the contributions received of $497,250 to additional paid-in-capital and $477,750 to non-controlling interest as of that date. During the three months ended December 31, 2019, NEO recorded a loss of $45,162 relating to its operations.   Repayment of the investment by GEN2 will begin through and upon the date which NEO has realized and retained cumulative net income/distributable cash in the amount of $300,000. Distributions thereafter will be made to PSI, GEN2 and other members in proportion to their respective Unit ownership, at the times and in the manner determined from time to time by the managers, in their sole discretion. GEN2 consists of accredited investors, and investment participation of $700,000 from several WCUI officers and directors, including Calvin R. O’Harrow and Roy M. Harsch.   Stock-Based Compensation   The Company periodically grants stock options and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option and stock warrant grants to employees based on the authoritative guidance provided by the Financial Accounting Standards Board where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and stock warrant grants to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option or warrant grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.   The fair value of the Company’s common stock option and warrant grants are estimated using a Black-Scholes Merton option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, estimated forfeitures and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes Merton option pricing model could materially affect compensation expense recorded in future periods.   Leases   In February 2016, the FASB issued ASU No. 2016-02, Leases. ASU 2016-02 requires a lessee to record a right of use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than twelve months. ASU 2016-02 is effective for all interim and annual reporting periods beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessees for leases existing at, or entered into after, the beginning of the earliest period presented in the financial statements.   The Company adopted ASU 2016-02 effective October 1, 2019. As a result, we recorded right-of-use assets of $27,841, and lease liabilities of the same amount, as of that date. In accordance with ASU 2016-02, the right-of-use assets are being amortized over the life of the underlying leases, and monthly lease payments are being recorded as reductions to the lease liability and imputed interest expense. See Note 4 for additional information.   Recently Issued Accounting Pronouncements   In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”). The standard significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The standard is effective for interim and annual reporting periods beginning after December 15, 2019. The adoption of ASU 2016-13 is not expected to have a material impact on the Company’s financial position, results of operations, and cash flows.   Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

NOTE 3 – LOANS PAYABLE FROM OFFICERS AND SHAREHOLDERS   As of September 30, 2019, loans payable from officers and shareholders of $399,250 were outstanding. During the three months ended December 31, 2019, the Company borrowed $135,000 from its officers and shareholders. All of the loans are unsecured, have an interest rate of eight percent and are due one year from the date of issuance. As of December 31, 2019, loans payable to officers and shareholders of $534,250 were outstanding.

NOTE 5 – SHAREHOLDERS’ EQUITY   Stock Options   On December 22, 2010, effective retroactively as of June 30, 2010, the Company’s Board of Directors approved the adoption of the “2010 Non-Qualified Stock Option Plan” (“2010 Option Plan”) by unanimous consent. The 2010 Option Plan was initiated to encourage and enable officers, directors, consultants, advisors and key employees of the Company to acquire and retain a proprietary interest in the Company by ownership of its common stock. A total of 7,500,000 of the authorized shares of the Company’s common stock may be subject to, or issued pursuant to, the terms of the plan. Effective January 1, 2018, the Board of Directors approved to increase the number of authorized shares of the Company’s common stock that may be subject to, or issued pursuant to, the terms of the plan from 7,500,000 to 30,000,000.   The Company’s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award. Additionally, the Company’s policy is to issue new shares of common stock to satisfy stock option exercises. The Company applied fair value accounting for all share based payments awards. The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model.   During the three months ended December 31, 2019, the Company granted options to an employee to purchase a total of 62,500 shares of its common stock with an aggregate fair value of $2,313. The options have an exercise price of $0.04 per share and expire five years from the date of grant. The shares vested on December 31, 2019. The Company valued the options using a Black-Scholes option pricing model.   The assumptions used for the option granted during the three months ended December 31, 2019 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%">Exercise price</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 18%; text-align: right">0.04</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected dividends</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">157.6</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.60</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected life of options</td> <td> </td> <td> </td> <td style="text-align: right">2.5</td> <td> </td></tr> </table>   During the three months ended December 31, 2019, the Company recorded $65,738 of stock compensation for the value of all outstanding options, and as of December 31, 2019, unvested compensation of $314,812 remained that will be amortized over the remaining vesting period.   The table below summarizes the Company’s stock option activities for the three months ended December 31, 2019:    <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Number of Option Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Exercise Price Range Per Share</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted  Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Fair Value at Date of Grant</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 31%">Balance, September 30, 2019</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">15,237,738</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">0.03 - 2.00</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">0.27</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">3,255,121</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">62,500</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.04</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.04</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,313</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Cancelled</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercised</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Expired</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(262,500</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.11</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.11</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balance, December 31, 2019</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">15,037,738</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.03 – 2.00</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.27</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">3,257,434</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Vested and exercisable, December 31, 2019</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">12,350,238</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.03 – 2.00</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.30</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,189,047</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Unvested, December 31, 2019</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2,687,500</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.14</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.14</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,068,387</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   There was no aggregate intrinsic value for option shares outstanding at December 31, 2019. As of December 31, 2019, there were 14,962,262 shares of stock options remaining available for issuance under the 2010 Plan.   The following table summarizes information concerning outstanding and exercisable options as of December 31, 2019:    <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center">Options Outstanding</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center">Options Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid">Range of Exercise Prices</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Number Outstanding</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Average Remaining Contractual Life  (in years)</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Number Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Average Remaining Contractual Life  (in years)</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%">$</td> <td style="width: 17%; text-align: right">0.06 - 0.39</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">13,575,238</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">2.93</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">0.15</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">10,887,738</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">2.85</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">0.15</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td style="text-align: right">0.40 - 0.99</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">62,500</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.25</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.40</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">62,500</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.25</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.40</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td style="text-align: right">1.00 - 1.99</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">750,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">750,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.00</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2.00</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">650,000</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">1.00</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2.00</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">650,000</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">1.00</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2.00</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.06 - 2.00</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">15,037,738</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2.75</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.27</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">12,350,238</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2.64</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.30</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>    Stock Warrants   The table below summarizes the Company’s warrants activities for the three months ended December 31, 2019:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Number of Warrant Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Exercise Price Range Per Share</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Fair Value at Date of Issuance</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 28%">Balance, September 30, 2019</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">66,484,049</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">0.12 - 0.40</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">0.17</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">3,434,560</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Cancelled</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercised</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Expired</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Balance, December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">66,484,049</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.12 - 0.40</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.17</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">3,434,560</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Vested and exercisable, December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">66,484,049</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.12 - 0.40</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.17</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">3,434,560</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table>   There was no aggregate intrinsic value for warrant shares outstanding at December 31, 2019.   The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2019:    <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center">Warrants Outstanding</td> <td> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center">Warrants Exercisable</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td style="border-bottom: black 1.5pt solid">Range of Exercise Prices</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Number Outstanding</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Average Remaining Contractual Life (in years)</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Number Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Average Remaining Contractual Life (in years)</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%">$</td> <td style="width: 23%; text-align: right">0.12 – 0.20</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">59,279,384</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">1.70</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">0.15</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">59,279,384</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">1.70</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">0.15</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.21 – 0.40</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">7,204,665</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.61</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.26</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">7,204,665</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.61</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.26</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.12 – 0.67</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">66,484,049</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">1.58</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.17</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">66,484,049</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">1.58</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.17</td></tr> </table>

NOTE 6 – SEGMENT REPORTING   Reportable segments are components of an enterprise about which separate financial information is available and that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.   The Company operates in the following business segments:   (i) Medical Devices: which stems from PSI, its wholly-owned subsidiary acquired on August 24, 2012, a developer, manufacturer, marketer and distributer of targeted Ultra Violet (“UV”) phototherapy devices for the treatment of skin diseases.   (ii) Authentication and Encryption Products and Services: which stems from StealthCo, its wholly-owned subsidiary formed on March 18, 2014, which has engaged in the business of selling, licensing or otherwise providing certain authentication and encryption products and services since acquisition of certain assets from SMI on April 4, 2014.   The detailed segment information of the Company is as follows:   Assets By Segment   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Corporate</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Medical Devices</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Authentication and Encryption</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center">ASSETS</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Current Assets</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%">Cash</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">2,273</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">33,330</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">6,760</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">42,363</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Prepaid expenses and other current assets</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">55,500</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">55,500</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Total current assets</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2,273</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">88,830</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">6,760</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">97,863</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Right-of-use asset</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">22,697</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">22,697</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Total other assets</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">22,697</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">22,697</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">TOTAL ASSETS</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,273</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">111,527</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">6,760</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">120,560</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   Operations by Segment   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="14" style="text-align: center">For the Three Months Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Corporate</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Medical Devices</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Authentication and Encryption</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Sales: </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 44%; padding-left: 10pt">Trade</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Consulting services</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total Sales</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Cost of goods sold</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Gross profit</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Operating expenses</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">98,462</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">175,286</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">63,525</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">337,273</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Loss from operations</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(98,462</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(175,286</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(63,525</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(337,273</td> <td>)</td></tr> </table>   Operations by Segment   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="14" style="text-align: center">For the Three Months Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Corporate</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Medical Devices</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Authentication and Encryption</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Sales:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 44%; padding-left: 10pt">Trade</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">7,675</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">7,675</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Consulting services</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">5,200</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">5,200</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total Sales</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">12,875</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">12,875</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Cost of goods sold</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">7,725</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">7,725</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Gross profit</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5,150</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5,150</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Operating expenses</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">254,429</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">119,720</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">101,715</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">475,864</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Loss from operations</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(254,429</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(119,720</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(96,565</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(470,714</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>

NOTE 7 – LEGAL MATTERS   The Company is periodically engaged in legal proceedings arising from and relating to its business operations. We currently are not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting our Company, our common stock, any of our subsidiaries or of our Company’s or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect on our financial condition or results of operations. However, we recently decided to attempt to preserve revenue and reduce operating expenses through actions including, but not limited to, facilities consolidation and staff reductions, which we hope to implement through negotiated transactions with lessors, employees and other third parties. Such actions may result in disputes with and claims by such parties which, if not resolved through negotiations, may impact negatively the Company’s ability to continue as a going concern. To date, we have negotiated settlement of all but $89,302 in ex-employee wage and benefits claims, with agreement to pay such remaining amount, together with interest at the rate of 4% per annum on the principal amount from time to time outstanding, when and as cash flow permits. One of the employees claims additional amounts due for certain statutory damages under the Illinois Wage Payment and Collection which currently could exceed $21,600 and would increase at the rate of 2% of the wages due per month plus attorneys’ fees if the employee elects to file suit for a violation of the Act and is successful in obtaining a judgment on his claim.

NOTE 10 – SUBSEQUENT EVENTS   Subsequent to December 31, 2019, the Company borrowed $235,000 from its officers and shareholders. All of the loans are unsecured, have an interest rate of eight percent and are due one year from the date of issuance.   Commencing on October 1, 2016, the Company’s wholly-owned subsidiary, StealthCo, entered into a non-cancellable lease agreement to lease its office facilities in Oak Ridge, Tennessee. The term of the lease is five years and expires September 30, 2021. On January 6, 2020, the Company entered into an agreement with the owners to terminate the agreement effective January 1, 2020. Under the agreement, the Company agreed to pay $11,000 and abandon certain Company property as documented in the agreement.   Effective January 1, 2020, the Company’s Board of Directors approved the extension of the Company’s unexpired stock warrants as of December 31, 2019, by an additional one year period. This change would affect approximately 66 million warrant shares and approximately 20 million warrant shares that were set to expire by the year ending September 30, 2020. The 20 million warrant shares that were set to expire by September 30, 2020, had exercise prices ranging from $0.15 per share to $0.25 per share. The 66 million warrant shares had exercise prices ranging from $0.12 per share to $0.40 per share. The incremental fair value of the warrants resulting from modification is approximately $700,000 that will be recognized as an expense beginning with the period ending March 31, 2020, as the options vest.

Basis of Consolidation   The Company’s consolidated subsidiaries and/or entities are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"> Name of consolidated subsidiary or entity</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">State or other jurisdiction of incorporation or organization</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> Date of incorporation or formation (date of acquisition/disposition, if applicable)</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid">Attributable interest</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 26%">Psoria-Shield Inc. (“PSI”)</td> <td style="width: 1%"> </td> <td style="width: 26%">The State of Florida</td> <td style="width: 1%"> </td> <td style="width: 32%">June 17, 2009 (August 24, 2012)</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">100</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> StealthCo, Inc. (“StealthCo”)</td> <td> </td> <td>The State of Illinois</td> <td> </td> <td>March 18, 2014</td> <td> </td> <td> </td> <td style="text-align: right">100</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> Psoria Development Company LLC. (“PDC”)</td> <td> </td> <td>The State of Illinois</td> <td> </td> <td>January 15, 2015/November 15, 2018</td> <td> </td> <td> </td> <td style="text-align: right">50</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> NEO Phototherapy LLC (“NEO”)</td> <td> </td> <td>The State of Illinois</td> <td> </td> <td>December 2018</td> <td> </td> <td> </td> <td style="text-align: right">51</td> <td>%</td></tr> </table>   Through October 2018, PSI was operated by PDC, a joint venture between PSI and the Medical Alliance, Inc (“TMA”). On November 15, 2018, the Company and TMA entered into a Withdraw and Mutual Release Agreement to terminate their joint venture agreement. In December 2018, the Company and its wholly-owned subsidiary, Psoria-Shield, Inc. (“PSI”), entered into a Joint Venture Agreement with PSI Gen 2 Funding, Inc. (“GEN2”), an Illinois corporation, to further development, marketing, licensing and/or sale of PSI technology and products. The joint venture is conducted through NEO Phototherapy, LLC, a recently formed Illinois limited liability company (“NEO”), with principal offices and records to be maintained at WCUI’s offices. See Non-Controlling Interests in Note 2 for more details.

Use of Estimates   The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in the valuation of accounts receivable and allowance for uncollectible amounts, inventory and obsolescence reserves, accruals for potential liabilities, valuations of stock-based compensation, realization of deferred tax assets, among others. Actual results could differ from these estimates.

Income (Loss) Per Share   Basic loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of outstanding common shares during the period. Diluted loss per share is computed by dividing the net loss applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued. For the three months ended December 31, 2019 and 2018, the basic and diluted shares outstanding were the same, as potentially dilutive shares were considered anti-dilutive. At December 31, 2019 and 2018, the dilutive impact of outstanding stock options of 15,037,738 and 17,587,738 shares, respectively, and outstanding warrants for 66,484,049 and 68,192,442 shares, respectively, have been excluded because their impact on the loss per share is anti-dilutive.

Stock-Based Compensation   The Company periodically grants stock options and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option and stock warrant grants to employees based on the authoritative guidance provided by the Financial Accounting Standards Board where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and stock warrant grants to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option or warrant grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.   The fair value of the Company’s common stock option and warrant grants are estimated using a Black-Scholes Merton option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, estimated forfeitures and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes Merton option pricing model could materially affect compensation expense recorded in future periods.

Recently Issued Accounting Pronouncements   In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”). The standard significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The standard is effective for interim and annual reporting periods beginning after December 15, 2019. The adoption of ASU 2016-13 is not expected to have a material impact on the Company’s financial position, results of operations, and cash flows.   Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

The Company’s consolidated subsidiaries and/or entities are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"> Name of consolidated subsidiary or entity</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">State or other jurisdiction of incorporation or organization</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> Date of incorporation or formation (date of acquisition/disposition, if applicable)</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid">Attributable interest</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 26%">Psoria-Shield Inc. (“PSI”)</td> <td style="width: 1%"> </td> <td style="width: 26%">The State of Florida</td> <td style="width: 1%"> </td> <td style="width: 32%">June 17, 2009 (August 24, 2012)</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">100</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> StealthCo, Inc. (“StealthCo”)</td> <td> </td> <td>The State of Illinois</td> <td> </td> <td>March 18, 2014</td> <td> </td> <td> </td> <td style="text-align: right">100</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> Psoria Development Company LLC. (“PDC”)</td> <td> </td> <td>The State of Illinois</td> <td> </td> <td>January 15, 2015/November 15, 2018</td> <td> </td> <td> </td> <td style="text-align: right">50</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> NEO Phototherapy LLC (“NEO”)</td> <td> </td> <td>The State of Illinois</td> <td> </td> <td>December 2018</td> <td> </td> <td> </td> <td style="text-align: right">51</td> <td>%</td></tr> </table>

The assumptions used for the option granted during the three months ended December 31, 2019 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%">Exercise price</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 18%; text-align: right">0.04</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected dividends</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">157.6</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.60</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected life of options</td> <td> </td> <td> </td> <td style="text-align: right">2.5</td> <td> </td></tr> </table>

The table below summarizes the Company’s stock option activities for the three months ended December 31, 2019:    <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Number of Option Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Exercise Price Range Per Share</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted  Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Fair Value at Date of Grant</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 31%">Balance, September 30, 2019</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">15,237,738</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">0.03 - 2.00</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">0.27</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">3,255,121</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">62,500</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.04</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.04</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,313</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Cancelled</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercised</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Expired</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(262,500</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.11</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.11</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balance, December 31, 2019</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">15,037,738</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.03 – 2.00</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.27</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">3,257,434</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Vested and exercisable, December 31, 2019</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">12,350,238</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.03 – 2.00</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.30</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,189,047</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Unvested, December 31, 2019</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2,687,500</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.14</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.14</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,068,387</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

The following table summarizes information concerning outstanding and exercisable options as of December 31, 2019:    <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center">Options Outstanding</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center">Options Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid">Range of Exercise Prices</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Number Outstanding</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Average Remaining Contractual Life  (in years)</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Number Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Average Remaining Contractual Life  (in years)</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%">$</td> <td style="width: 17%; text-align: right">0.06 - 0.39</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">13,575,238</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">2.93</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">0.15</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">10,887,738</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">2.85</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">0.15</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td style="text-align: right">0.40 - 0.99</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">62,500</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.25</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.40</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">62,500</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.25</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.40</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td style="text-align: right">1.00 - 1.99</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">750,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">750,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.00</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2.00</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">650,000</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">1.00</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2.00</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">650,000</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">1.00</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2.00</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.06 - 2.00</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">15,037,738</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2.75</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.27</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">12,350,238</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2.64</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.30</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2019:    <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center">Warrants Outstanding</td> <td> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center">Warrants Exercisable</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td style="border-bottom: black 1.5pt solid">Range of Exercise Prices</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Number Outstanding</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Average Remaining Contractual Life (in years)</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Number Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Average Remaining Contractual Life (in years)</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%">$</td> <td style="width: 23%; text-align: right">0.12 – 0.20</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">59,279,384</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">1.70</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">0.15</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">59,279,384</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">1.70</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">0.15</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.21 – 0.40</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">7,204,665</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.61</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.26</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">7,204,665</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.61</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.26</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.12 – 0.67</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">66,484,049</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">1.58</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.17</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">66,484,049</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">1.58</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.17</td></tr> </table>

The detailed segment information of the Company is as follows:   Assets By Segment   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Corporate</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Medical Devices</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Authentication and Encryption</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center">ASSETS</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Current Assets</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%">Cash</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">2,273</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">33,330</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">6,760</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">42,363</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Prepaid expenses and other current assets</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">55,500</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">55,500</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Total current assets</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2,273</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">88,830</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">6,760</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">97,863</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Right-of-use asset</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">22,697</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">22,697</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Total other assets</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">22,697</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">22,697</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">TOTAL ASSETS</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,273</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">111,527</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">6,760</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">120,560</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

Operations by Segment   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="14" style="text-align: center">For the Three Months Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Corporate</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Medical Devices</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Authentication and Encryption</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Sales: </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 44%; padding-left: 10pt">Trade</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Consulting services</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total Sales</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Cost of goods sold</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Gross profit</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Operating expenses</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">98,462</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">175,286</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">63,525</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">337,273</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Loss from operations</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(98,462</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(175,286</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(63,525</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(337,273</td> <td>)</td></tr> </table>   Operations by Segment   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="14" style="text-align: center">For the Three Months Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Corporate</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Medical Devices</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Authentication and Encryption</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Sales:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 44%; padding-left: 10pt">Trade</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">7,675</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">7,675</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Consulting services</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">5,200</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">5,200</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total Sales</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">12,875</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">12,875</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Cost of goods sold</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">7,725</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">7,725</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Gross profit</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5,150</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5,150</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Operating expenses</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">254,429</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">119,720</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">101,715</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">475,864</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Loss from operations</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(254,429</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(119,720</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(96,565</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(470,714</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>

-825160

100952

22450252

-22974740

-423536

-401624

-1314852

107497

23777647

-25362287

-1477143

393149

-697080

-1083994

107497

103698

23868885

23033274

-25686754

-23954052

-1710372

-817080

395520

120000

97863

2273

88830

6760

108147

22697

27841

22697

1562

120560

2273

111527

6760

109709

107497077

2482441

173783

2483

171300

173783

65738

85951

65738

85951

65738

85951

405383

-405383

65738 85951 Non-controlling Interests   Through November 2018, non-controlling interest represented the non-controlling interest holder’s proportionate share of the equity of the Company’s majority-owned subsidiary, PDC. Non-controlling interest is adjusted for the non-controlling interest holder’s proportionate share of the earnings or losses and other comprehensive income (loss), if any, and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.   On November 15, 2018, PSI and TMA entered into a Withdraw and Mutual Release Agreement to terminate their joint venture agreement. On the date of termination, the non-controlling interest’s share of the accumulated losses of the joint venture totaled to $405,383. Upon termination, during the three months ended December 31, 2018, the Company wrote-off the non-controlling interest’s share of the accumulated losses and recorded a loss from the deconsolidation of a non-controlling interest of $405,383.   In December 2018, PSI entered into a Joint Venture Agreement with GEN2 to further development, marketing, licensing and/or sale of PSI technology and products. Pursuant to the Joint Venture Agreement, the venture will be conducted through NEO. PSI and GEN2 will be the members of NEO, owning 50.5% and 36.0%, respectively, of the Units issued in connection with the organization of NEO. An additional 13.5% of such Units will be reserved for issuance as incentives for key employees and consultants. Until such shares are distributed, the Company controls 68% of the joint venture and GEN2 the remaining 32%. PSI and GEN2 will manage NEO’s day-to-day operations. PSI will contribute PSI technology to NEO and GEN2 will contribute $700,000. As of December 31, 2019, NEO’s operations required additional funding above the $700,000 documented in the agreement, and as of September 30, 2019, GEN2 had received $925,000 of investments to contribute to NEO. During the three months ended December 30, 2019, an additional $50,000 was contributed by GEN2 to NEO. As of December 31, 2019, GEN2 had received $975,000 of investments to contribute to NEO. As of December 31, 2019, the Company controlled 51% of the joint venture, GEN2 controlled 39% and another individual controlled the remaining 10%. The Company recorded its proportionate share of the contributions received of $497,250 to additional paid-in-capital and $477,750 to non-controlling interest as of that date. During the three months ended December 31, 2019, NEO recorded a loss of $45,162 relating to its operations.   Repayment of the investment by GEN2 will begin through and upon the date which NEO has realized and retained cumulative net income/distributable cash in the amount of $300,000. Distributions thereafter will be made to PSI, GEN2 and other members in proportion to their respective Unit ownership, at the times and in the manner determined from time to time by the managers, in their sole discretion. GEN2 consists of accredited investors, and investment participation of $700,000 from several WCUI officers and directors, including Calvin R. O’Harrow and Roy M. Harsch.

The table below summarizes the Company’s warrants activities for the three months ended December 31, 2019:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Number of Warrant Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Exercise Price Range Per Share</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Fair Value at Date of Issuance</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 28%">Balance, September 30, 2019</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">66,484,049</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">0.12 - 0.40</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">0.17</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">3,434,560</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Cancelled</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercised</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Expired</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Balance, December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">66,484,049</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.12 - 0.40</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.17</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">3,434,560</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Vested and exercisable, December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">66,484,049</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.12 - 0.40</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.17</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">3,434,560</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table>

1125

0.04

Yes Yes false Nevada The State of Florida The State of Illinois The State of Illinois The State of Illinois

50689

7675

5200

7675

5200

12875

Revenue Recognition   In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). This ASU is a comprehensive new revenue recognition model that requires a company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services. The Company adopted this ASU on October 1, 2018 retrospectively, the cumulative effect of the initial application on our accumulated deficit on that date was immaterial.   For trade sales, the Company generates its revenue from sales contracts with customers with revenues being generated upon the shipment of merchandise, or for consulting services, revenue is recognized in the period services are rendered and earned under service arrangements with clients.   We sell our products through two main sales channels: 1) directly to customers who use our products (the “Direct Channel”) and 2) to distribution partners who resell our products (the “Indirect Channel”).   Under the Direct Channel, we sell our products to and we receive payment directly from customers who purchase our products. Under our Indirect Channel, we have entered into distribution agreements that allow the distributors to sell our products and fulfill performance obligations under the agreements.   We determine revenue recognition through the following steps:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 53px"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 53px">●</td> <td style="font: 12pt Times New Roman, Times, Serif">Identification of the contract, or contracts, with a customer</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 53px"> </td> <td style="width: 53px">●</td> <td>Identification of the performance obligations in the contract</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 53px"> </td> <td style="width: 53px">●</td> <td>Determination of the transaction price</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 53px"> </td> <td style="width: 53px">●</td> <td>Allocation of the transaction price to the performance obligations in the contract</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 53px"> </td> <td style="width: 53px">●</td> <td>Recognition of revenue when, or as, we satisfy a performance obligation.</td></tr> </table>   Revenue is generally recognized upon shipment or when a service has been completed, unless we have significant performance obligations for services still to be completed. We recognize revenue when a material reversal is no longer probable. Payments received before the relevant criteria for revenue recognition are satisfied are recorded as deferred revenue. There was no deferred revenue at December 31, 2019 and 2018.

14962262

2020

120560

109709

-1710372

-1477143

-25686754

-25362287

1435412

1193703

775566

691619

55500

55000

-10784

130540

4210

42363

134750

53147

173783 51434 51434 51434 51434

84012

62615

-50000 -375000 NOTE 9 – PROPOSED SALE OF STEALTHCO, INC.   On September 3, 2019, the Company’s Board of Directors unanimously approved, subject to stockholder approval: (1) execution and delivery of a proposed Share Exchange Agreement with DTI Holdings, Inc. (“DTI”) relating to the share exchange and transfer of certain assets of StealthCo, Inc. (“SCI”) pursuant to the terms and conditions of a Memorandum of Agreement in substantially the form of the copy presented to the Board (“Agreement”). As of September 18, 2019, holders of a majority of the outstanding shares of voting capital stock have executed written stockholder consents approving this action.   The Agreement provides, among other things, that: (1) DTI will pay the Company $500,000 upon the execution of a definitive share exchange agreement (“Share Exchange Agreement”) which the parties will endeavor to negotiate and execute as quickly as possible, and not later than October 15, 2019; (2) DTI will pay the Company an additional $500,000 within seven days following the completion date of the transfer of all assets and/or full ownership of SCI to DTI, with such date to occur within 120 days following execution of the Share Exchange Agreement; (3) DTI will issue to the Company 3,112,000 shares of DTI common stock and will guaranty that the value of the 3,112,000 shares of DTI common stock will have a value of at least $4.50 per share ($14,004,000, in the aggregate), as of December 31, 2021; (4) To the extent that the value of the DTI common shares, as of December 31, 2021, is less than $4.50 per share ($14,004,000, in the aggregate), DTI will issue additional shares of DTI common stock, at the then current fair market value, in an amount sufficient to cause the resulting aggregate value of all shares of DTI common stock issued to the Company to be $14,004,000, in the aggregate; (5) DTI will assign the assets transferred by SCI, including trademarks, intellectual properties, and patents, to its subsidiary, Femtobitz, Inc., a Delaware corporation, and will pay to the Company 1% of annual gross revenue arising from or relating to operation of Femtobitz, Inc.; and (6) Upon closing of the share exchange, the Company’s Chairman will be appointed an advisory board member of DTI and a board member of Femtobitz, Inc.   As of September 18, 2019, stockholders holding a majority of our outstanding common stock approved the share exchange and the Company began discussions and negotiations with DTI, which are currently on-going as of the date of this filing. There can be no assurance that the proposed transaction will be concluded successfully on the terms described or any alternate terms that may be proposed hereafter.

17587738

68192442

66484049

15037738

405383

0.360

0.505

0.135

700000

50000

700000

925000

975000

0.51 0.10 0.39

700000

0.08

Due one year from the date of issuance

89302

0.04

21600

0.02

2024-02-28

2021-09-30

11000

631587

37815

15000

500000

4.50

On September 3, 2019, the Company's Board of Directors unanimously approved, subject to stockholder approval: (1) execution and delivery of a proposed Share Exchange Agreement with DTI Holdings, Inc. ("DTI") relating to the share exchange and transfer of certain assets of StealthCo, Inc. ("SCI") pursuant to the terms and conditions of a Memorandum of Agreement in substantially the form of the copy presented to the Board ("Agreement"). As of September 18, 2019, holders of a majority of the outstanding shares of voting capital stock have executed written stockholder consents approving this action. The Agreement provides, among other things, that: (1) DTI will pay the Company $500,000 upon the execution of a definitive share exchange agreement ("Share Exchange Agreement") which the parties will endeavor to negotiate and execute as quickly as possible, and not later than October 15, 2019; (2) DTI will pay the Company an additional $500,000 within seven days following the completion date of the transfer of all assets and/or full ownership of SCI to DTI, with such date to occur within 120 days following execution of the Share Exchange Agreement; (3) DTI will issue to the Company 3,112,000 shares of DTI common stock and will guaranty that the value of the 3,112,000 shares of DTI common stock will have a value of at least $4.50 per share ($14,004,000, in the aggregate), as of December 31, 2021; (4) To the extent that the value of the DTI common shares, as of December 31, 2021, is less than $4.50 per share ($14,004,000, in the aggregate), DTI will issue additional shares of DTI common stock, at the then current fair market value, in an amount sufficient to cause the resulting aggregate value of all shares of DTI common stock issued to the Company to be $14,004,000, in the aggregate; (5) DTI will assign the assets transferred by SCI, including trademarks, intellectual properties, and patents, to its subsidiary, Femtobitz, Inc., a Delaware corporation, and will pay to the Company 1% of annual gross revenue arising from or relating to operation of Femtobitz, Inc.; and (6) Upon closing of the share exchange, the Company's Chairman will be appointed an advisory board member of DTI and a board member of Femtobitz, Inc. As of September 18, 2019, stockholders holding a majority of our outstanding common stock approved the share exchange and the Company began discussions and negotiations with DTI, which are currently on-going. There can be no assurance that the proposed transaction will be concluded successfully on the terms described or any alternate terms that may be proposed hereafter.

0.01

7204665

15037738

13575238

62500

750000

650000

59279384

15237738

66484049

262500

12350238

2687500

0.26

0.27

0.03

2.00

0.15

0.40

1.00

2.00

0.15

0.27

0.03

2.00

0.17

0.04

0.11

0.30

0.14

3257434

3255121

2313

2189047

1068387

0.06

0.21

0.12

0.06

0.40

1.00

0.12

2.00

0.40

0.67

0.39

0.99

1.99

2.00

0.20

P2Y9M

P7M10D

P1Y6M29D

P2Y11M4D

P2Y2M30D

P1Y

P1Y8M12D

7204665

12350238

10887738

62500

750000

650000

59279384

66484049

0.26

0.30

0.15

0.40

1.00

2.00

0.15

0.17

66484049

66484049 0.17 0.12 0.40 0.17 0.12 0.40 0.12 0.40 0.17 3434560 3434560 3434560

0.04

1.576

0.0160

P2Y6M

107497077

100952569

More than 50 percent

Pursuant to the Joint Venture Agreement, the venture will be conducted through NEO. PSI and GEN2 will be the members of NEO, owning 50.5% and 36.0%, respectively, of the Units issued in connection with the organization of NEO. An additional 13.5% of such Units will be reserved for issuance as incentives for key employees and consultants. Until such shares are distributed, the Company controls 68% of the joint venture and GEN2 the remaining 32%. PSI and GEN2 will manage NEO's day-to-day operations. PSI will contribute PSI technology to NEO and GEN2 will contribute $700,000. Repayment of the investment by GEN2 will begin through and upon the date which NEO has realized and retained cumulative net income/distributable cash in the amount of $300,000.

Psoria-Shield Inc. ("PSI") StealthCo, Inc. ("StealthCo") Psoria Development Company LLC. ("PDC") NEO Phototherapy LLC ("NEO") 2009-06-17 2014-03-18 2015-01-15 2018-12-31

2012-08-24

2018-11-15

1.00

0.50

0.51

1.00

11000

P5Y

135000

50000 375000 25500 255000 25500 255000 24500 120000 700000 P1Y

102899

102834

22697

27841

5144 -5144 27841 8783

NOTE 4 – LEASE LIABILITIES   In February 2019, the Company’s PSI subsidiary entered into a 24-month non-cancellable lease for its office facilities that requires monthly payments of $1,800 through January 2021. The Company adopted ASU 2016-02, Leases, effective October 1, 2019, which requires a lessee to record a right-of-use asset and a corresponding lease liability at the inception of the lease initially measured at the present value of the lease payments. The Company classified the lease as an operating lease and determined that the value of the lease assets and liability at the adoption date was $27,841 using a discount rate of 4.00%. During the three months ended December 31, 2019, the Company made payments of $5,144 towards the lease liability. As of December 31, 2019, lease liability amounted to $22,697.   ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term, generally on a straight-line basis. Rent expense for the three months ended December 31, 2019 was $5,144. During the three months ended December 31, 2019, the Company reflected amortization of right of use asset of $5,144 related to this lease, resulting in a net asset balance of $22,697 as of December 31, 2019.

Leases   In February 2016, the FASB issued ASU No. 2016-02, Leases. ASU 2016-02 requires a lessee to record a right of use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than twelve months. ASU 2016-02 is effective for all interim and annual reporting periods beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessees for leases existing at, or entered into after, the beginning of the earliest period presented in the financial statements.   The Company adopted ASU 2016-02 effective October 1, 2019. As a result, we recorded right-of-use assets of $27,841, and lease liabilities of the same amount, as of that date. In accordance with ASU 2016-02, the right-of-use assets are being amortized over the life of the underlying leases, and monthly lease payments are being recorded as reductions to the lease liability and imputed interest expense. See Note 4 for additional information.

185000

300000

534250

399250

534250

P24M

2021-01

22697

27841

22697

42467

5144

1800

5144

0.0400

65738

NOTE 8 – COMMITMENTS   Operating Leases   The Company leased its corporate office facility in Hoffman Estates, Illinois pursuant to a non-cancellable lease initiated in July 2016 and expiring February 28, 2024. The lease terms require a monthly payment of approximately $11,000. The Company vacated the facility in April 2019, in favor of its present facilities in Tucson AZ, which are provided by a shareholder on a rent-free basis. The Company is in negotiations with the owners regarding the settlement of its lease obligations and expects that the property will be subleased or a settlement with the landlord will be reached at an amount significantly less than the remaining payment obligations. At the date of abandonment, the Company had a remaining lease obligation of $631,587. During the year ended September 30, 2019, the Company recorded an accrual for the estimated potential settlement and wrote-off its $15,000 security deposit relating to the lease. During the three months ended December 31, 2019, the Company recorded an additional expense of $37,815 relating to the lease obligation.

NOTE 1 – BASIS OF PRESENTATION   Organization and Operations   Wellness Center USA, Inc. (“WCUI” or the “Company”) was incorporated in June 2010 under the laws of the State of Nevada. The Company initially engaged in online sports and nutrition supplements marketing and distribution. The Company subsequently expanded into additional businesses within the healthcare and medical sectors through acquisitions, including Psoria-Shield Inc. (“PSI”) and StealthCo Inc. (“SCI”), d/b/a Stealth Mark, Inc.   The Company currently operates in the following business segments: (i) distribution of targeted Ultra Violet (“UV”) phototherapy devices for dermatology; and (ii) authentication and encryption products and services. The segments are operated, respectively, through PSI and SCI.   Basis of Presentation of Unaudited Financial Information   The accompanying unaudited condensed consolidated financial statements of Wellness Center USA, Inc. and Subsidiaries (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended December 31, 2019 are not necessarily indicative of the results that may be expected for the year ending September 30, 2020.   Going Concern   The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying condensed consolidated financial statements, the Company has not yet generated significant revenues and has incurred recurring net losses. During the three months ended December 31, 2019, the Company incurred a net loss of $346,596 and used cash in operations of $195,784, and had a shareholders’ deficit of $1,314,852 as of December 31, 2019. In addition, $102,899 of payroll taxes are past due. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its strategies. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.   In addition, the Company’s independent registered public accounting firm, in its report on the Company’s September 30, 2019 financial statements, has raised substantial doubt about the Company’s ability to continue as a going concern.   At December 31, 2019, the Company had cash on hand in the amount of $42,363. The ability to continue as a going concern is dependent on the Company attaining and maintaining profitable operations in the future and raising additional capital soon to meet its obligations and repay its liabilities arising from normal business operations when they come due. Since inception, we have funded our operations primarily through equity and debt financings and we expect to continue to rely on these sources of capital in the future. During the three months ended December 31, 2019, the Company received $185,000 through short-term loans and contributions of capital by a joint venture partner.   No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stock holders, in case of equity financing.

EX-101.SCH 7 wcui-20191231.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Loans Payable from Officers and Shareholders link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Lease Liabilities link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Legal Matters link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Proposed Sale of Stealthco, Inc. link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Company's Consolidated Subsidiaries (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Loans Payable from Officers and Shareholders (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Lease Liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Shareholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Shareholders' Equity - Schedule of Assumptions Used for Options Granted (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Shareholders' Equity - Schedule of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Shareholders' Equity - Schedule of Outstanding and Exercisable Options by Exercise Price Range (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Shareholders' Equity - Schedule of Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Shareholders' Equity - Schedule of Outstanding and Exercisable Warrants by Exercise Price Range (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Segment Reporting - Schedule of Assets of Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Segment Reporting - Schedule of Operations of Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Legal Matters (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Commitments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Proposed Sale of Stealthco, Inc. (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 wcui-20191231_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 wcui-20191231_def.xml XBRL DEFINITION FILE EX-101.LAB 10 wcui-20191231_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Total WCUI Deficit [Member] Non-controlling Interest [Member] Antidilutive Securities [Axis] Stock Option [Member] Warrants [Member] Warrant [Member] Range [Axis] Minimum [Member] Maximum [Member] Exercise Price Range [Axis] Exercise Price Range Two [Member] Plan Name [Axis] 2010 Non-Qualified Stock Option Plan [Member] Product and Service [Axis] Trade [Member] Consulting Services [Member] 2010 Non-Qualified Stock Option Plan [Member] Ownership [Axis] Psoria-Shield, Inc [Member] StealthCo, Inc. [Member] Psoria Development Company LLC. [Member] Segments [Axis] Corporate [Member] Medical Devices [Member] Authentication and Encryption [Member] Exercise Price Range One [Member] Exercise Price Range Three [Member] Exercise Price Range Four [Member] Gen 2 Funding, Inc [Member] Title of Individual [Axis] Employees and Consultants [Member] NEO Phototherapy, LLC, [Member] Illinois Limited Liability Company [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Short-term Debt, Type [Axis] Unsecured Loans [Member] Scenario [Axis] Forecast [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Share Exchange Agreement [Member] Legal Entity [Axis] DTI Holdings Inc [Member] Femtobitz, Inc. [Member] NEO [Member] GEN2 [Member] Individual [Member] StealthCo [Member] Non Cancellable Lease Agreement [Member] Award Type [Axis] Ownership Agreement [Member] Officers and Shareholders [Member] 22 Short-Term Unsecured Loans [Member] Board of Directors [Member] September 30, 2020 [Member] Employee [Member] Stock Option [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash Prepaid expenses and other current assets Total Current Assets Property and equipment, net Right of use asset Total Other Assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS' DEFICIT Current Liabilities Accounts payable and accrued expenses Payroll taxes payable Lease liability Loans payable from officers and shareholders Total Current Liabilities Shareholders' Deficit Common stock, par value $0.001, 200,000,000 shares authorized; 107,497,077 shares issued and outstanding, respectively Additional paid-in capital Accumulated deficit Total Wellness Center USA shareholders' deficit Non-controlling interest Total Shareholder's deficit TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT Common stock, par value Common stock, shares authorized Common stock, shares, issued Common stock, shares, outstanding Statement [Table] Statement [Line Items] Sales: Total Sales Cost of goods sold Gross profit Operating expenses Loss from operations Other expenses Amortization of debt discount Financing costs Interest expense Total other expenses NET LOSS Net loss attributable to non-controlling interest Loss from deconsolidation of non-controlling interest NET LOSS ATTRIBUTABLE TO WELLNESS CENTER USA, INC. BASIC AND DILUTED LOSS PER SHARE WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED Balance Balance, shares Common shares issued for cash Common shares issued for cash, shares Shares issued upon conversion of note payable Shares issued upon conversion of note payable, shares Fair value of additional shares issued to conversions of note payable Fair value of vested stock options Fair value of common stock issued for services Fair value of common stock issued for services, shares Termination of non-controlling interest agreement Contribution of capital by joint venture partner Net loss Balance Balance, shares Statement of Cash Flows [Abstract] Cash Flows from Operating Activities Adjustments to reconcile net loss to net cash used in operating activities: Depreciation expense Amortization of right-of-use asset Amortization of debt discount Fair value of common shares issued for services Fair value of stock options issued for services Fair value of additional shares issued upon conversions of note payable Changes in Assets and Liabilities (Increase) Decrease in: Prepaid expenses and other assets (Decrease) Increase in: Accounts payable and accrued expenses Lease liability Deferred revenue Net cash used in operating activities Cash Flows from Financing Activities Proceeds from loans payable from officers and shareholders Common stock and warrants issued for cash Contribution of capital by joint venture partner Net cash provided by financing activities Net increase (decrease) in cash Cash beginning of period Cash end of period Supplemental cash flows disclosures: Interest paid Taxes paid Supplemental non-cash financing disclosures: Initial recognition of right-of-use assets and operating lease liabilities upon adoption of ASC Topic 842 Conversion of convertible note payable into common shares Conversion of accrued interest into common shares Organization, Consolidation and Presentation of Financial Statements [Abstract] Basis of Presentation Accounting Policies [Abstract] Summary of Significant Accounting Policies Debt Disclosure [Abstract] Loans Payable from Officers and Shareholders Leases [Abstract] Lease Liabilities Equity [Abstract] Shareholders' Equity Segment Reporting [Abstract] Segment Reporting Commitments and Contingencies Disclosure [Abstract] Legal Matters Commitments Proposed Sale Of Stealthco Inc. Proposed Sale of Stealthco, Inc. Subsequent Events [Abstract] Subsequent Events Basis of Consolidation Use of Estimates Income (loss) Per Share EX-101.PRE 11 wcui-20191231_pre.xml XBRL PRESENTATION FILE XML 12 R29.htm IDEA: XBRL DOCUMENT

Shareholders' Equity - Schedule of Outstanding and Exercisable Options by Exercise Price Range (Details) - $ / shares	3 Months Ended
	Dec. 31, 2019	Sep. 30, 2019
Range of Exercise Prices, Lower Limit	$ 0.06
Range of Exercise Prices, Upper Limit	$ 2.00
Number of Options, Outstanding, Number	15,037,738	15,237,738
Number of Options, Outstanding, Weighted Average Remaining Contractual Term	2 years 9 months
Number of Options, Outstanding, Weighted Average Exercise Price	$ 0.27	$ 0.27
Number of Options, Exercisable, Number	12,350,238
Number of Options, Exercisable, Weighted Average Remaining Contractual Term	2 years 7 months 21 days
Number of Options, Exercisable, Weighted Average Exercise Price	$ 0.30
Exercise Price Range One [Member]
Range of Exercise Prices, Lower Limit	0.06
Range of Exercise Prices, Upper Limit	$ 0.39
Number of Options, Outstanding, Number	13,575,238
Number of Options, Outstanding, Weighted Average Remaining Contractual Term	2 years 11 months 4 days
Number of Options, Outstanding, Weighted Average Exercise Price	$ 0.15
Number of Options, Exercisable, Number	10,887,738
Number of Options, Exercisable, Weighted Average Remaining Contractual Term	2 years 10 months 6 days
Number of Options, Exercisable, Weighted Average Exercise Price	$ 0.15
Exercise Price Range Two [Member]
Range of Exercise Prices, Lower Limit	0.40
Range of Exercise Prices, Upper Limit	$ 0.99
Number of Options, Outstanding, Number	62,500
Number of Options, Outstanding, Weighted Average Remaining Contractual Term	2 years 2 months 30 days
Number of Options, Outstanding, Weighted Average Exercise Price	$ 0.40
Number of Options, Exercisable, Number	62,500
Number of Options, Exercisable, Weighted Average Remaining Contractual Term	2 years 2 months 30 days
Number of Options, Exercisable, Weighted Average Exercise Price	$ 0.40
Exercise Price Range Three [Member]
Range of Exercise Prices, Lower Limit	1.00
Range of Exercise Prices, Upper Limit	$ 1.99
Number of Options, Outstanding, Number	750,000
Number of Options, Outstanding, Weighted Average Remaining Contractual Term	1 year
Number of Options, Outstanding, Weighted Average Exercise Price	$ 1.00
Number of Options, Exercisable, Number	750,000
Number of Options, Exercisable, Weighted Average Remaining Contractual Term	1 year
Number of Options, Exercisable, Weighted Average Exercise Price	$ 1.00
Exercise Price Range Four [Member]
Range of Exercise Prices, Upper Limit	$ 2.00
Number of Options, Outstanding, Number	650,000
Number of Options, Outstanding, Weighted Average Remaining Contractual Term	1 year
Number of Options, Outstanding, Weighted Average Exercise Price	$ 2.00
Number of Options, Exercisable, Number	650,000
Number of Options, Exercisable, Weighted Average Remaining Contractual Term	1 year
Number of Options, Exercisable, Weighted Average Exercise Price	$ 2.00

XML 13 R25.htm IDEA: XBRL DOCUMENT

Lease Liabilities (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
Lease Liabilities (Details Narrative) - USD ($)	Feb. 28, 2019	Dec. 31, 2019	Dec. 31, 2018
Leases [Abstract]
Lease term	24 months
Payment for lease liability	$ 1,800	$ 5,144
Lease expiration date	2021-01
Right of use assets	$ 27,841	$ 22,697
Lease, discount rate		4.00%
Lease liability	$ 42,467	$ 22,697
Lease rent expense		5,144
Amortization of right of use asset		$ 5,144

XML 14 R21.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Details Narrative) - USD ($)	3 Months Ended
Basis of Presentation (Details Narrative) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Entity incorporation, state country name	Nevada
Net loss	$ (346,596)	$ (577,688)
Cash used in operations	(195,784)	(314,460)
Shareholders' deficit	(1,314,852)	$ (697,080)	$ (1,083,994)	$ (825,160)
Payroll taxes due	102,899		102,834
Cash on hand	42,363		$ 53,147
Proceeds from short-term loans and contributions of capital by joint venture partner	$ 185,000

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686

+ Details

XML 15 R30.htm IDEA: XBRL DOCUMENT

Shareholders' Equity - Schedule of Warrant Activity (Details) - Warrant [Member]	3 Months Ended
	Dec. 31, 2019 USD ($) $ / shares shares
Number of Warrant Shares Outstanding, Number, Beginning Balance \| shares	66,484,049
Number of Warrant Shares Outstanding, Granted \| shares
Number of Warrant Shares Outstanding, Cancelled \| shares
Number of Warrant Shares Outstanding, Exercised \| shares
Number of Warrant Shares Outstanding, Expired \| shares
Number of Warrant Shares Outstanding, Number, Ending Balance \| shares	66,484,049
Number of Warrant Shares Outstanding, Vested and exercisable, Ending Balance \| shares	66,484,049
Weighted Average Exercise Price, Number, Beginning Balance	$ 0.17
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Cancelled
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Expired
Weighted Average Exercise Price, Number, Ending Balance	0.17
Weighted Average Exercise Price, Vested and exercisable, Ending Balance	$ 0.17
Fair Value at Date of Issuance, Beginning Balance \| $	$ 3,434,560
Fair Value at Date of Issuance, Granted \| $
Fair Value at Date of Issuance, Cancelled \| $
Fair Value at Date of Issuance, Exercised \| $
Fair Value at Date of Issuance, Expired \| $
Fair Value at Date of Issuance, Number, Ending Balance \| $	3,434,560
Fair Value at Date of Issuance, Vested and exercisable, Ending Balance \| $	$ 3,434,560
Minimum [Member]
Weighted Average Exercise Price, Number, Beginning Balance	$ 0.12
Weighted Average Exercise Price, Number, Ending Balance	0.12
Weighted Average Exercise Price, Vested and exercisable, Ending Balance	0.12
Maximum [Member]
Weighted Average Exercise Price, Number, Beginning Balance	0.40
Weighted Average Exercise Price, Number, Ending Balance	0.40
Weighted Average Exercise Price, Vested and exercisable, Ending Balance	$ 0.40

XML 16 R34.htm IDEA: XBRL DOCUMENT

Legal Matters (Details Narrative)	3 Months Ended
Legal Matters (Details Narrative)	Dec. 31, 2019 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Payment to negotiated settlement	$ 89,302
Interest rate of negotiated settlement	4.00%
Wages	$ 21,600
Wages increase rate	2.00%

XML 17 R7.htm IDEA: XBRL DOCUMENT

Basis of Presentation

3 Months Ended

Dec. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

NOTE 1 – BASIS OF PRESENTATION

Organization and Operations

Basis of Presentation of Unaudited Financial Information

Going Concern

XML 18 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2019	Sep. 30, 2019
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares, issued	107,497,077	107,497,077
Common stock, shares, outstanding	107,497,077	107,497,077

XML 19 R17.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Basis of Consolidation

Basis of Consolidation

The Company’s consolidated subsidiaries and/or entities are as follows:

Name of consolidated subsidiary or entity	State or other jurisdiction of incorporation or organization	Date of incorporation or formation (date of acquisition/disposition, if applicable)	Attributable interest

Psoria-Shield Inc. (“PSI”)	The State of Florida	June 17, 2009 (August 24, 2012)		100	%

StealthCo, Inc. (“StealthCo”)	The State of Illinois	March 18, 2014		100	%

Psoria Development Company LLC. (“PDC”)	The State of Illinois	January 15, 2015/November 15, 2018		50	%

NEO Phototherapy LLC (“NEO”)	The State of Illinois	December 2018		51	%

Use of Estimates

Use of Estimates

Income (loss) Per Share

Income (Loss) Per Share

Revenue Recognition

Revenue Recognition

We determine revenue recognition through the following steps:

●

Identification of the contract, or contracts, with a customer

●

Identification of the performance obligations in the contract

●

Determination of the transaction price

●

Allocation of the transaction price to the performance obligations in the contract

●

Recognition of revenue when, or as, we satisfy a performance obligation.

Non-controlling Interests

Non-controlling Interests

Stock-based Compensation

Stock-Based Compensation

Leases

Leases

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

XML 20 R13.htm IDEA: XBRL DOCUMENT

Legal Matters

3 Months Ended

Dec. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Legal Matters

NOTE 7 – LEGAL MATTERS

XML 21 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash Flows from Operating Activities
Net loss	$ (346,596)	$ (577,688)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	1,562	264
Amortization of right-of-use asset	5,144
Amortization of debt discount		50,689
Fair value of common shares issued for services		9,600
Fair value of stock options issued for services	65,738	85,951
Fair value of additional shares issued upon conversions of note payable		51,434
(Increase) Decrease in:
Prepaid expenses and other assets	(500)	1,550
(Decrease) Increase in:
Accounts payable and accrued expenses	84,012	62,615
Lease liability	(5,144)
Deferred revenue		1,125
Net cash used in operating activities	(195,784)	(314,460)
Cash Flows from Financing Activities
Proceeds from loans payable from officers and shareholders	135,000	60,000
Common stock and warrants issued for cash		10,000
Contribution of capital by joint venture partner	50,000	375,000
Net cash provided by financing activities	185,000	445,000
Net increase (decrease) in cash	(10,784)	130,540
Cash beginning of period	53,147	4,210
Cash end of period	42,363	134,750
Supplemental cash flows disclosures:
Interest paid
Taxes paid
Supplemental non-cash financing disclosures:
Initial recognition of right-of-use assets and operating lease liabilities upon adoption of ASC Topic 842	27,841
Conversion of convertible note payable into common shares		173,783
Conversion of accrued interest into common shares		$ 8,783

XML 22 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Sep. 30, 2019
Current Assets
Cash	$ 42,363	$ 53,147
Prepaid expenses and other current assets	55,500	55,000
Total Current Assets	97,863	108,147
Property and equipment, net		1,562
Right of use asset	22,697
Total Other Assets	22,697	1,562
TOTAL ASSETS	120,560	109,709
Current Liabilities
Accounts payable and accrued expenses	775,566	691,619
Payroll taxes payable	102,899	102,834
Lease liability	22,697
Loans payable from officers and shareholders	534,250	399,250
Total Current Liabilities	1,435,412	1,193,703
Shareholders' Deficit
Common stock, par value $0.001, 200,000,000 shares authorized; 107,497,077 shares issued and outstanding, respectively	107,497	107,497
Additional paid-in capital	23,868,885	23,777,647
Accumulated deficit	(25,686,754)	(25,362,287)
Total Wellness Center USA shareholders' deficit	(1,710,372)	(1,477,143)
Non-controlling interest	395,520	393,149
Total Shareholder's deficit	(1,314,852)	(1,083,994)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 120,560	$ 109,709

XML 23 R31.htm IDEA: XBRL DOCUMENT

Shareholders' Equity - Schedule of Outstanding and Exercisable Warrants by Exercise Price Range (Details) - $ / shares	3 Months Ended
	Dec. 31, 2019	Sep. 30, 2019
Range of Exercise Prices, Lower Limit	$ 0.06
Range of Exercise Prices, Upper Limit	$ 2.00
Number of Warrants, Outstanding, Number	15,037,738	15,237,738
Number of Warrants, Outstanding, Weighted Average Remaining Contractual Term	2 years 9 months
Number of Warrants, Outstanding, Weighted Average Exercise Price	$ 0.27	$ 0.27
Number of Warrants, Exercisable, Number	12,350,238
Number of Warrants, Exercisable, Weighted Average Remaining Contractual Term	2 years 7 months 21 days
Number of Warrants, Exercisable, Weighted Average Exercise Price	$ 0.30
Exercise Price Range One [Member]
Range of Exercise Prices, Lower Limit	0.06
Range of Exercise Prices, Upper Limit	$ 0.39
Number of Warrants, Outstanding, Number	13,575,238
Number of Warrants, Outstanding, Weighted Average Remaining Contractual Term	2 years 11 months 4 days
Number of Warrants, Outstanding, Weighted Average Exercise Price	$ 0.15
Number of Warrants, Exercisable, Number	10,887,738
Number of Warrants, Exercisable, Weighted Average Remaining Contractual Term	2 years 10 months 6 days
Number of Warrants, Exercisable, Weighted Average Exercise Price	$ 0.15
Exercise Price Range Two [Member]
Range of Exercise Prices, Lower Limit	0.40
Range of Exercise Prices, Upper Limit	$ 0.99
Number of Warrants, Outstanding, Number	62,500
Number of Warrants, Outstanding, Weighted Average Remaining Contractual Term	2 years 2 months 30 days
Number of Warrants, Outstanding, Weighted Average Exercise Price	$ 0.40
Number of Warrants, Exercisable, Number	62,500
Number of Warrants, Exercisable, Weighted Average Remaining Contractual Term	2 years 2 months 30 days
Number of Warrants, Exercisable, Weighted Average Exercise Price	$ 0.40
Warrant [Member]
Range of Exercise Prices, Lower Limit	0.12
Range of Exercise Prices, Upper Limit	$ 0.67
Number of Warrants, Outstanding, Number	66,484,049
Number of Warrants, Outstanding, Weighted Average Remaining Contractual Term	1 year 6 months 29 days
Number of Warrants, Outstanding, Weighted Average Exercise Price	$ 0.17
Number of Warrants, Exercisable, Number	66,484,049
Number of Warrants, Exercisable, Weighted Average Remaining Contractual Term	1 year 6 months 29 days
Number of Warrants, Exercisable, Weighted Average Exercise Price	$ 0.17
Warrant [Member] \| Exercise Price Range One [Member]
Range of Exercise Prices, Lower Limit	0.12
Range of Exercise Prices, Upper Limit	$ 0.20
Number of Warrants, Outstanding, Number	59,279,384
Number of Warrants, Outstanding, Weighted Average Remaining Contractual Term	1 year 8 months 12 days
Number of Warrants, Outstanding, Weighted Average Exercise Price	$ 0.15
Number of Warrants, Exercisable, Number	59,279,384
Number of Warrants, Exercisable, Weighted Average Remaining Contractual Term	1 year 8 months 12 days
Number of Warrants, Exercisable, Weighted Average Exercise Price	$ 0.15
Warrant [Member] \| Exercise Price Range Two [Member]
Range of Exercise Prices, Lower Limit	0.21
Range of Exercise Prices, Upper Limit	$ 0.40
Number of Warrants, Outstanding, Number	7,204,665
Number of Warrants, Outstanding, Weighted Average Remaining Contractual Term	7 months 10 days
Number of Warrants, Outstanding, Weighted Average Exercise Price	$ 0.26
Number of Warrants, Exercisable, Number	7,204,665
Number of Warrants, Exercisable, Weighted Average Remaining Contractual Term	7 months 10 days
Number of Warrants, Exercisable, Weighted Average Exercise Price	$ 0.26

XML 24 R35.htm IDEA: XBRL DOCUMENT

Commitments (Details Narrative) - USD ($)	3 Months Ended
Commitments (Details Narrative) - USD ($)	Dec. 31, 2019	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
Lease expiration date	Feb. 28, 2024
Monthly lease payment	$ 11,000
Lease obligation remaining	631,587
Security deposit relating to the lease	$ 37,815	$ 15,000

XML 25 R16.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Dec. 31, 2019

Subsequent Events [Abstract]

Subsequent Events

NOTE 10 – SUBSEQUENT EVENTS

XML 26 R12.htm IDEA: XBRL DOCUMENT

Segment Reporting

3 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Segment Reporting

NOTE 6 – SEGMENT REPORTING

The Company operates in the following business segments:

The detailed segment information of the Company is as follows:

Assets By Segment

	December 31, 2019
	Corporate		Medical Devices		Authentication and Encryption		Total
ASSETS
Current Assets
Cash	$	2,273	$	33,330	$	6,760	$	42,363
Prepaid expenses and other current assets		-		55,500		-		55,500
Total current assets		2,273		88,830		6,760		97,863

Right-of-use asset		-		22,697		-		22,697
Total other assets		-		22,697		-		22,697

TOTAL ASSETS	$	2,273	$	111,527	$	6,760	$	120,560

Operations by Segment

	For the Three Months Ended
	December 31, 2019
	Corporate			Medical Devices			Authentication and Encryption			Total
Sales:
Trade	$	-		$	-		$	-		$	-
Consulting services		-			-			-			-
Total Sales		-			-			-			-

Cost of goods sold		-			-			-			-

Gross profit		-			-			-			-

Operating expenses		98,462			175,286			63,525			337,273

Loss from operations	$	(98,462	)	$	(175,286	)	$	(63,525	)	$	(337,273	)

Operations by Segment

	For the Three Months Ended
	December 31, 2018
	Corporate			Medical Devices			Authentication and Encryption			Total
Sales:
Trade	$	-		$	-		$	7,675		$	7,675
Consulting services		-			-			5,200			5,200
Total Sales		-			-			12,875			12,875

Cost of goods sold		-			-			7,725			7,725

Gross profit		-			-			5,150			5,150

Operating expenses		254,429			119,720			101,715			475,864

Loss from operations	$	(254,429	)	$	(119,720	)	$	(96,565	)	$	(470,714	)

EXCEL 27 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end ZIP 28 0001493152-20-004732-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-20-004732-xbrl.zip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htm IDEA: XBRL DOCUMENT v3.20.1

Loans Payable from Officers and Shareholders (Details Narrative) - USD ($)

Dec. 31, 2019

Sep. 30, 2019

Loans payable from officers and shareholders $ 534,250 $ 399,250

Due to officers and shareholders $ 135,000

22 Short-Term Unsecured Loans [Member]

Debt instrument, interest rate, stated percentage 8.00%

Officers and Shareholders [Member]

Loans payable to related parties $ 534,250

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
For an unclassified balance sheet, amounts due from owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.3)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864
+ Details

Name: us-gaap_DueFromOfficersOrStockholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(4))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04.12(a)(1))
-URI http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864
+ Details

Name: us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of obligations due all related parties.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(3),(4))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_DueToRelatedPartiesCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=WCUI_TwentyTwoShortTermUnsecuredLoansMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=WCUI_OfficersandShareholdersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.20.1

Segment Reporting (Tables)
3 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Schedule of Assets of Reportable Segments

The detailed segment information of the Company is as follows:

Assets By Segment

December 31, 2019

Corporate Medical Devices Authentication and Encryption Total

ASSETS

Current Assets

Cash $ 2,273 $ 33,330 $ 6,760 $ 42,363

Prepaid expenses and other current assets - 55,500 - 55,500

Total current assets 2,273 88,830 6,760 97,863

Right-of-use asset - 22,697 - 22,697

Total other assets - 22,697 - 22,697

TOTAL ASSETS $ 2,273 $ 111,527 $ 6,760 $ 120,560

Schedule of Operations of Reportable Segments

Operations by Segment

For the Three Months Ended

December 31, 2019

Corporate Medical Devices Authentication and Encryption Total

Sales: 

Trade $ - $ - $ - $ -

Consulting services - - - -

Total Sales - - - -

Cost of goods sold - - - -

Gross profit - - - -

Operating expenses 98,462 175,286 63,525 337,273

Loss from operations $ (98,462 ) $ (175,286 ) $ (63,525 ) $ (337,273 )

Operations by Segment

For the Three Months Ended

December 31, 2018

Corporate Medical Devices Authentication and Encryption Total

Sales:

Trade $ - $ - $ 7,675 $ 7,675

Consulting services - - 5,200 5,200

Total Sales - - 12,875 12,875

Cost of goods sold - - 7,725 7,725

Gross profit - - 5,150 5,150

Operating expenses 254,429 119,720 101,715 475,864

Loss from operations $ (254,429 ) $ (119,720 ) $ (96,565 ) $ (470,714 )

X

- Definition
Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599
+ Details

Name: us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599
+ Details

Name: us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 31 R28.htm IDEA: XBRL DOCUMENT v3.20.1

Shareholders' Equity - Schedule of Stock Option Activity (Details)
3 Months Ended

Dec. 31, 2019

USD ($)

$ / shares

shares

Number of Option Shares Outstanding, Number, Beginning Balance | shares 15,237,738

Number of Option Shares Outstanding, Granted | shares 62,500

Number of Option Shares Outstanding, Cancelled | shares

Number of Option Shares Outstanding, Exercised | shares

Number of Option Shares Outstanding, Expired | shares (262,500)

Number of Option Shares Outstanding, Number, Ending Balance | shares 15,037,738

Number of Option Shares Outstanding, Vested and exercisable, Ending Balance | shares 12,350,238

Number of Option Shares Outstanding, Unvested, Ending Balance | shares 2,687,500

Weighted Average Exercise Price, Number, Beginning Balance $ 0.27

Weighted Average Exercise Price, Granted 0.04

Weighted Average Exercise Price, Cancelled

Weighted Average Exercise Price, Exercised

Weighted Average Exercise Price, Expired 0.11

Weighted Average Exercise Price, Number, Ending Balance 0.27

Weighted Average Exercise Price, Vested and exercisable, Ending Balance 0.30

Weighted Average Exercise Price, Unvested, Ending Balance $ 0.14

Fair Value at Date of Grant, Number, Beginning Balance | $ $ 3,255,121

Fair Value at Date of Grant, Granted | $ 2,313

Fair Value at Date of Grant, Cancelled | $

Fair Value at Date of Grant, Exercised | $

Fair Value at Date of Grant, Expired | $

Fair Value at Date of Grant, Number, Ending Balance | $ 3,257,434

Fair Value at Date of Grant, Vested and exercisable, Ending Balance | $ 2,189,047

Fair Value at Date of Grant, Unvested, Ending Balance | $ $ 1,068,387

Minimum [Member]

Weighted Average Exercise Price, Number, Beginning Balance $ 0.03

Weighted Average Exercise Price, Granted

Weighted Average Exercise Price, Number, Ending Balance 0.03

Maximum [Member]

Weighted Average Exercise Price, Number, Beginning Balance 2.00

Weighted Average Exercise Price, Granted

Weighted Average Exercise Price, Number, Ending Balance $ 2.00

X

- Definition
Fair Value at Date of Grant, Cancelled.
+ References
No definition available.
+ Details

Name: WCUI_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledIntrinsicValue

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair Value at Date of Grant, Expired.
+ References
No definition available.
+ Details

Name: WCUI_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredIntrinsicValue

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair Value at Date of Grant, Granted.
+ References
No definition available.
+ Details

Name: WCUI_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair Value at Date of Grant, Unvested, Ending Balance.
+ References
No definition available.
+ Details

Name: WCUI_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIntrinsicValue

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(4)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of non-vested options outstanding.
+ References
No definition available.
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average grant-date fair value of non-vested options outstanding.
+ References
No definition available.
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 33 R18.htm IDEA: XBRL DOCUMENT v3.20.1

Summary of Significant Accounting Policies (Tables)
3 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Schedule of Company's Consolidated Subsidiaries

The Company’s consolidated subsidiaries and/or entities are as follows:

Name of consolidated

subsidiary or entity
State or other jurisdiction of incorporation or organization
Date of incorporation or formation

(date of acquisition/disposition, if

applicable)
Attributable interest

Psoria-Shield Inc. (“PSI”) The State of Florida June 17, 2009
(August 24, 2012) 100 %

StealthCo, Inc. (“StealthCo”) The State of Illinois March 18, 2014 100 %

Psoria Development Company LLC. (“PDC”) The State of Illinois January 15, 2015/November 15, 2018 50 %

NEO Phototherapy LLC (“NEO”) The State of Illinois December 2018 51 %

X

- Definition
Represents the textual narrative disclosure of Schedule of the Company's Consolidated Subsidiaries, during the indicated time period.
+ References
No definition available.
+ Details

Name: WCUI_ScheduleOfTheCompanysConsolidatedSubsidiariesTableTextBlock

Namespace Prefix: WCUI_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R14.htm IDEA: XBRL DOCUMENT v3.20.1

Commitments
3 Months Ended

Dec. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments

NOTE 8 – COMMITMENTS

Operating Leases

The Company leased its corporate office facility in Hoffman Estates, Illinois pursuant to a non-cancellable lease initiated in July 2016 and expiring February 28, 2024. The lease terms require a monthly payment of approximately $11,000. The Company vacated the facility in April 2019, in favor of its present facilities in Tucson AZ, which are provided by a shareholder on a rent-free basis. The Company is in negotiations with the owners regarding the settlement of its lease obligations and expects that the property will be subleased or a settlement with the landlord will be reached at an amount significantly less than the remaining payment obligations. At the date of abandonment, the Company had a remaining lease obligation of $631,587. During the year ended September 30, 2019, the Company recorded an accrual for the estimated potential settlement and wrote-off its $15,000 security deposit relating to the lease. During the three months ended December 31, 2019, the Company recorded an additional expense of $37,815 relating to the lease obligation.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648
+ Details

Name: us-gaap_CommitmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R10.htm IDEA: XBRL DOCUMENT v3.20.1

Lease Liabilities
3 Months Ended

Dec. 31, 2019

Leases [Abstract]

Lease Liabilities

NOTE 4 – LEASE LIABILITIES

In February 2019, the Company’s PSI subsidiary entered into a 24-month non-cancellable lease for its office facilities that requires monthly payments of $1,800 through January 2021. The Company adopted ASU 2016-02, Leases, effective October 1, 2019, which requires a lessee to record a right-of-use asset and a corresponding lease liability at the inception of the lease initially measured at the present value of the lease payments. The Company classified the lease as an operating lease and determined that the value of the lease assets and liability at the adoption date was $27,841 using a discount rate of 4.00%. During the three months ended December 31, 2019, the Company made payments of $5,144 towards the lease liability. As of December 31, 2019, lease liability amounted to $22,697.

ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term, generally on a straight-line basis. Rent expense for the three months ended December 31, 2019 was $5,144. During the three months ended December 31, 2019, the Company reflected amortization of right of use asset of $5,144 related to this lease, resulting in a net asset balance of $22,697 as of December 31, 2019.

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=77888251
+ Details

Name: us-gaap_LesseeOperatingLeasesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R4.htm IDEA: XBRL DOCUMENT v3.20.1

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Sales:

Total Sales $ 12,875

Cost of goods sold 7,725

Gross profit 5,150

Operating expenses 337,273 475,864

Loss from operations (337,273) (470,714)

Other expenses

Amortization of debt discount (50,689)

Financing costs (51,434)

Interest expense (9,323) (4,851)

Total other expenses (9,323) (106,974)

NET LOSS (346,596) (577,688)

Net loss attributable to non-controlling interest 22,129 3,759

Loss from deconsolidation of non-controlling interest (405,383)

NET LOSS ATTRIBUTABLE TO WELLNESS CENTER USA, INC. $ (324,467) $ (979,312)

BASIC AND DILUTED LOSS PER SHARE $ (0.00) $ (0.01)

WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED 107,497,077 100,952,569

Trade [Member]

Sales:

Total Sales $ 7,675

Consulting Services [Member]

Sales:

Total Sales $ 5,200

X

- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_CostOfGoodsAndServicesSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 60
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6402221&loc=d3e15743-112638
+ Details

Name: us-gaap_GainsLossesOnRestructuringOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (210.5-03(11))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: srt_ProductOrServiceAxis=WCUI_TradeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_ProductOrServiceAxis=WCUI_ConsultingServicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 37 R8.htm IDEA: XBRL DOCUMENT v3.20.1

Summary of Significant Accounting Policies
3 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Consolidation

The Company’s consolidated subsidiaries and/or entities are as follows:

Name of consolidated

subsidiary or entity
State or other jurisdiction of incorporation or organization
Date of incorporation or formation

(date of acquisition/disposition, if

applicable)
Attributable interest

Psoria-Shield Inc. (“PSI”) The State of Florida June 17, 2009
(August 24, 2012) 100 %

StealthCo, Inc. (“StealthCo”) The State of Illinois March 18, 2014 100 %

Psoria Development Company LLC. (“PDC”) The State of Illinois January 15, 2015/November 15, 2018 50 %

NEO Phototherapy LLC (“NEO”) The State of Illinois December 2018 51 %

Through October 2018, PSI was operated by PDC, a joint venture between PSI and the Medical Alliance, Inc (“TMA”). On November 15, 2018, the Company and TMA entered into a Withdraw and Mutual Release Agreement to terminate their joint venture agreement. In December 2018, the Company and its wholly-owned subsidiary, Psoria-Shield, Inc. (“PSI”), entered into a Joint Venture Agreement with PSI Gen 2 Funding, Inc. (“GEN2”), an Illinois corporation, to further development, marketing, licensing and/or sale of PSI technology and products. The joint venture is conducted through NEO Phototherapy, LLC, a recently formed Illinois limited liability company (“NEO”), with principal offices and records to be maintained at WCUI’s offices. See Non-Controlling Interests in Note 2 for more details.

Use of Estimates

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in the valuation of accounts receivable and allowance for uncollectible amounts, inventory and obsolescence reserves, accruals for potential liabilities, valuations of stock-based compensation, realization of deferred tax assets, among others. Actual results could differ from these estimates.

Income (Loss) Per Share

Basic loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of outstanding common shares during the period. Diluted loss per share is computed by dividing the net loss applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued. For the three months ended December 31, 2019 and 2018, the basic and diluted shares outstanding were the same, as potentially dilutive shares were considered anti-dilutive. At December 31, 2019 and 2018, the dilutive impact of outstanding stock options of 15,037,738 and 17,587,738 shares, respectively, and outstanding warrants for 66,484,049 and 68,192,442 shares, respectively, have been excluded because their impact on the loss per share is anti-dilutive.

Revenue Recognition

In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). This ASU is a comprehensive new revenue recognition model that requires a company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services. The Company adopted this ASU on October 1, 2018 retrospectively, the cumulative effect of the initial application on our accumulated deficit on that date was immaterial.

For trade sales, the Company generates its revenue from sales contracts with customers with revenues being generated upon the shipment of merchandise, or for consulting services, revenue is recognized in the period services are rendered and earned under service arrangements with clients.

We sell our products through two main sales channels: 1) directly to customers who use our products (the “Direct Channel”) and 2) to distribution partners who resell our products (the “Indirect Channel”).

Under the Direct Channel, we sell our products to and we receive payment directly from customers who purchase our products. Under our Indirect Channel, we have entered into distribution agreements that allow the distributors to sell our products and fulfill performance obligations under the agreements.

We determine revenue recognition through the following steps:

● Identification of the contract, or contracts, with a customer

● Identification of the performance obligations in the contract

● Determination of the transaction price

● Allocation of the transaction price to the performance obligations in the contract

● Recognition of revenue when, or as, we satisfy a performance obligation.

Revenue is generally recognized upon shipment or when a service has been completed, unless we have significant performance obligations for services still to be completed. We recognize revenue when a material reversal is no longer probable. Payments received before the relevant criteria for revenue recognition are satisfied are recorded as deferred revenue. There was no deferred revenue at December 31, 2019 and 2018.

Non-controlling Interests

Through November 2018, non-controlling interest represented the non-controlling interest holder’s proportionate share of the equity of the Company’s majority-owned subsidiary, PDC. Non-controlling interest is adjusted for the non-controlling interest holder’s proportionate share of the earnings or losses and other comprehensive income (loss), if any, and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.

On November 15, 2018, PSI and TMA entered into a Withdraw and Mutual Release Agreement to terminate their joint venture agreement. On the date of termination, the non-controlling interest’s share of the accumulated losses of the joint venture totaled to $405,383. Upon termination, during the three months ended December 31, 2018, the Company wrote-off the non-controlling interest’s share of the accumulated losses and recorded a loss from the deconsolidation of a non-controlling interest of $405,383.

In December 2018, PSI entered into a Joint Venture Agreement with GEN2 to further development, marketing, licensing and/or sale of PSI technology and products. Pursuant to the Joint Venture Agreement, the venture will be conducted through NEO. PSI and GEN2 will be the members of NEO, owning 50.5% and 36.0%, respectively, of the Units issued in connection with the organization of NEO. An additional 13.5% of such Units will be reserved for issuance as incentives for key employees and consultants. Until such shares are distributed, the Company controls 68% of the joint venture and GEN2 the remaining 32%. PSI and GEN2 will manage NEO’s day-to-day operations. PSI will contribute PSI technology to NEO and GEN2 will contribute $700,000. As of December 31, 2019, NEO’s operations required additional funding above the $700,000 documented in the agreement, and as of September 30, 2019, GEN2 had received $925,000 of investments to contribute to NEO. During the three months ended December 30, 2019, an additional $50,000 was contributed by GEN2 to NEO. As of December 31, 2019, GEN2 had received $975,000 of investments to contribute to NEO. As of December 31, 2019, the Company controlled 51% of the joint venture, GEN2 controlled 39% and another individual controlled the remaining 10%. The Company recorded its proportionate share of the contributions received of $497,250 to additional paid-in-capital and $477,750 to non-controlling interest as of that date. During the three months ended December 31, 2019, NEO recorded a loss of $45,162 relating to its operations.

Repayment of the investment by GEN2 will begin through and upon the date which NEO has realized and retained cumulative net income/distributable cash in the amount of $300,000. Distributions thereafter will be made to PSI, GEN2 and other members in proportion to their respective Unit ownership, at the times and in the manner determined from time to time by the managers, in their sole discretion. GEN2 consists of accredited investors, and investment participation of $700,000 from several WCUI officers and directors, including Calvin R. O’Harrow and Roy M. Harsch.

Stock-Based Compensation

The Company periodically grants stock options and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option and stock warrant grants to employees based on the authoritative guidance provided by the Financial Accounting Standards Board where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and stock warrant grants to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option or warrant grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

The fair value of the Company’s common stock option and warrant grants are estimated using a Black-Scholes Merton option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, estimated forfeitures and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes Merton option pricing model could materially affect compensation expense recorded in future periods.

Leases

In February 2016, the FASB issued ASU No. 2016-02, Leases. ASU 2016-02 requires a lessee to record a right of use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than twelve months. ASU 2016-02 is effective for all interim and annual reporting periods beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessees for leases existing at, or entered into after, the beginning of the earliest period presented in the financial statements.

The Company adopted ASU 2016-02 effective October 1, 2019. As a result, we recorded right-of-use assets of $27,841, and lease liabilities of the same amount, as of that date. In accordance with ASU 2016-02, the right-of-use assets are being amortized over the life of the underlying leases, and monthly lease payments are being recorded as reductions to the lease liability and imputed interest expense. See Note 4 for additional information.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”). The standard significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables. The standard will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The standard is effective for interim and annual reporting periods beginning after December 15, 2019. The adoption of ASU 2016-13 is not expected to have a material impact on the Company’s financial position, results of operations, and cash flows.

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R33.htm IDEA: XBRL DOCUMENT v3.20.1

Segment Reporting - Schedule of Operations of Reportable Segments (Details) - USD ($)
3 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Total Sales $ 12,875

Cost of goods sold 7,725

Gross profit 5,150

Operating expenses 337,273 475,864

Loss from operations (337,273) (470,714)

Trade [Member]

Total Sales 7,675

Consulting Services [Member]

Total Sales 5,200

Corporate [Member]

Total Sales

Cost of goods sold

Gross profit

Operating expenses 98,462 254,429

Loss from operations (98,462) (254,429)

Corporate [Member] | Trade [Member]

Total Sales

Corporate [Member] | Consulting Services [Member]

Total Sales

Medical Devices [Member]

Total Sales

Cost of goods sold

Gross profit

Operating expenses 175,286 119,720

Loss from operations (175,286) (119,720)

Medical Devices [Member] | Trade [Member]

Total Sales

Medical Devices [Member] | Consulting Services [Member]

Total Sales

Authentication and Encryption [Member]

Total Sales 12,875

Cost of goods sold 7,725

Gross profit 5,150

Operating expenses 63,525 101,715

Loss from operations (63,525) (96,565)

Authentication and Encryption [Member] | Trade [Member]

Total Sales 7,675

Authentication and Encryption [Member] | Consulting Services [Member]

Total Sales $ 5,200

X

- Definition
The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_CostOfGoodsAndServicesSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: srt_ProductOrServiceAxis=WCUI_TradeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_ProductOrServiceAxis=WCUI_ConsultingServicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=WCUI_MedicalDevicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=WCUI_AuthenticationandEncryptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 39 R37.htm IDEA: XBRL DOCUMENT v3.20.1

Subsequent Events (Details Narrative) - USD ($)
3 Months Ended 4 Months Ended

Mar. 31, 2020

Dec. 31, 2019

Oct. 02, 2016

Dec. 31, 2019

Jan. 24, 2020

Mar. 25, 2020

Jan. 06, 2020

Jan. 01, 2020

Sep. 30, 2019

Loans payable to officers and shareholders $ 534,250 $ 534,250 $ 399,250

Lease expiration date Feb. 28, 2024

StealthCo [Member] | Non Cancellable Lease Agreement [Member]

Lease expiration date Sep. 30, 2021

Lease term 5 years

Board of Directors [Member]

Unexpired stock warrants, extension period 1 year

Subsequent Event [Member]

Debt instrument, payment terms Due one year from the date of issuance

Number of securities called by warrants 66,000,000

Incremental fair value of warrants $ 700,000

Subsequent Event [Member] | Minimum [Member]

Exercise price of warrants $ 0.12

Subsequent Event [Member] | Maximum [Member]

Exercise price of warrants $ 0.40

Subsequent Event [Member] | September 30, 2020 [Member]

Number of securities called by warrants 20,000,000

Subsequent Event [Member] | September 30, 2020 [Member] | Minimum [Member]

Exercise price of warrants $ 0.15

Subsequent Event [Member] | September 30, 2020 [Member] | Maximum [Member]

Exercise price of warrants $ 0.25

Subsequent Event [Member] | StealthCo [Member] | Ownership Agreement [Member]

Non-cancellable lease payment $ 11,000

Subsequent Event [Member] | Unsecured Loans [Member]

Debt instrument, interest rate, stated percentage 8.00%

Subsequent Event [Member] | Officers and Shareholders [Member]

Loans payable to officers and shareholders $ 235,000

X

- Definition
Incremental fair value of warrants.
+ References
No definition available.
+ Details

Name: WCUI_IncrementalFairValueOfWarrants

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Non-cancellable lease payment.
+ References
No definition available.
+ Details

Name: WCUI_NoncancellableLeasePayment

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Unexpired stock warrants, extension period.
+ References
No definition available.
+ Details

Name: WCUI_UnexpiredStockWarrantsExtensionPeriod

Namespace Prefix: WCUI_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823
+ Details

Name: us-gaap_DebtInstrumentPaymentTerms

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DueToRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Date which lease or group of leases is set to expire, in CCYY-MM-DD format.
+ References
No definition available.
+ Details

Name: us-gaap_LeaseExpirationDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseRenewalTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Details

Name: dei_LegalEntityAxis=WCUI_StealthCoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=WCUI_NonCancellableLeaseAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=WCUI_BoardOfDirectorsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=WCUI_SeptemberThirtyTwoThousandTwentyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=WCUI_OwnershipAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=WCUI_UnsecuredLoansMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=WCUI_OfficersandShareholdersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 40 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 141 299 1 false 47 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://wellnesscenterusa.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://wellnesscenterusa.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://wellnesscenterusa.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://wellnesscenterusa.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) Sheet http://wellnesscenterusa.com/role/StatementsOfShareholdersDeficit Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://wellnesscenterusa.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Basis of Presentation Sheet http://wellnesscenterusa.com/role/BasisOfPresentation Basis of Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://wellnesscenterusa.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Loans Payable from Officers and Shareholders Sheet http://wellnesscenterusa.com/role/LoansPayableFromOfficersAndShareholders Loans Payable from Officers and Shareholders Notes 9 false false R10.htm 00000010 - Disclosure - Lease Liabilities Sheet http://wellnesscenterusa.com/role/LeaseLiabilities Lease Liabilities Notes 10 false false R11.htm 00000011 - Disclosure - Shareholders' Equity Sheet http://wellnesscenterusa.com/role/ShareholdersEquity Shareholders' Equity Notes 11 false false R12.htm 00000012 - Disclosure - Segment Reporting Sheet http://wellnesscenterusa.com/role/SegmentReporting Segment Reporting Notes 12 false false R13.htm 00000013 - Disclosure - Legal Matters Sheet http://wellnesscenterusa.com/role/LegalMatters Legal Matters Notes 13 false false R14.htm 00000014 - Disclosure - Commitments Sheet http://wellnesscenterusa.com/role/Commitments Commitments Notes 14 false false R15.htm 00000015 - Disclosure - Proposed Sale of Stealthco, Inc. Sheet http://wellnesscenterusa.com/role/ProposedSaleOfStealthcoInc. Proposed Sale of Stealthco, Inc. Notes 15 false false R16.htm 00000016 - Disclosure - Subsequent Events Sheet http://wellnesscenterusa.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 00000017 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://wellnesscenterusa.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://wellnesscenterusa.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://wellnesscenterusa.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://wellnesscenterusa.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 00000019 - Disclosure - Shareholders' Equity (Tables) Sheet http://wellnesscenterusa.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://wellnesscenterusa.com/role/ShareholdersEquity 19 false false R20.htm 00000020 - Disclosure - Segment Reporting (Tables) Sheet http://wellnesscenterusa.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://wellnesscenterusa.com/role/SegmentReporting 20 false false R21.htm 00000021 - Disclosure - Basis of Presentation (Details Narrative) Sheet http://wellnesscenterusa.com/role/BasisOfPresentationDetailsNarrative Basis of Presentation (Details Narrative) Details http://wellnesscenterusa.com/role/BasisOfPresentation 21 false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://wellnesscenterusa.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://wellnesscenterusa.com/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Company's Consolidated Subsidiaries (Details) Sheet http://wellnesscenterusa.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfCompanysConsolidatedSubsidiariesDetails Summary of Significant Accounting Policies - Schedule of Company's Consolidated Subsidiaries (Details) Details 23 false false R24.htm 00000024 - Disclosure - Loans Payable from Officers and Shareholders (Details Narrative) Sheet http://wellnesscenterusa.com/role/LoansPayableFromOfficersAndShareholdersDetailsNarrative Loans Payable from Officers and Shareholders (Details Narrative) Details http://wellnesscenterusa.com/role/LoansPayableFromOfficersAndShareholders 24 false false R25.htm 00000025 - Disclosure - Lease Liabilities (Details Narrative) Sheet http://wellnesscenterusa.com/role/LeaseLiabilitiesDetailsNarrative Lease Liabilities (Details Narrative) Details http://wellnesscenterusa.com/role/LeaseLiabilities 25 false false R26.htm 00000026 - Disclosure - Shareholders' Equity (Details Narrative) Sheet http://wellnesscenterusa.com/role/ShareholdersEquityDetailsNarrative Shareholders' Equity (Details Narrative) Details http://wellnesscenterusa.com/role/ShareholdersEquityTables 26 false false R27.htm 00000027 - Disclosure - Shareholders' Equity - Schedule of Assumptions Used for Options Granted (Details) Sheet http://wellnesscenterusa.com/role/ShareholdersEquity-ScheduleOfAssumptionsUsedForOptionsGrantedDetails Shareholders' Equity - Schedule of Assumptions Used for Options Granted (Details) Details 27 false false R28.htm 00000028 - Disclosure - Shareholders' Equity - Schedule of Stock Option Activity (Details) Sheet http://wellnesscenterusa.com/role/ShareholdersEquity-ScheduleOfStockOptionActivityDetails Shareholders' Equity - Schedule of Stock Option Activity (Details) Details 28 false false R29.htm 00000029 - Disclosure - Shareholders' Equity - Schedule of Outstanding and Exercisable Options by Exercise Price Range (Details) Sheet http://wellnesscenterusa.com/role/ShareholdersEquity-ScheduleOfOutstandingAndExercisableOptionsByExercisePriceRangeDetails Shareholders' Equity - Schedule of Outstanding and Exercisable Options by Exercise Price Range (Details) Details 29 false false R30.htm 00000030 - Disclosure - Shareholders' Equity - Schedule of Warrant Activity (Details) Sheet http://wellnesscenterusa.com/role/ShareholdersEquity-ScheduleOfWarrantActivityDetails Shareholders' Equity - Schedule of Warrant Activity (Details) Details 30 false false R31.htm 00000031 - Disclosure - Shareholders' Equity - Schedule of Outstanding and Exercisable Warrants by Exercise Price Range (Details) Sheet http://wellnesscenterusa.com/role/ShareholdersEquity-ScheduleOfOutstandingAndExercisableWarrantsByExercisePriceRangeDetails Shareholders' Equity - Schedule of Outstanding and Exercisable Warrants by Exercise Price Range (Details) Details 31 false false R32.htm 00000032 - Disclosure - Segment Reporting - Schedule of Assets of Reportable Segments (Details) Sheet http://wellnesscenterusa.com/role/SegmentReporting-ScheduleOfAssetsOfReportableSegmentsDetails Segment Reporting - Schedule of Assets of Reportable Segments (Details) Details 32 false false R33.htm 00000033 - Disclosure - Segment Reporting - Schedule of Operations of Reportable Segments (Details) Sheet http://wellnesscenterusa.com/role/SegmentReporting-ScheduleOfOperationsOfReportableSegmentsDetails Segment Reporting - Schedule of Operations of Reportable Segments (Details) Details 33 false false R34.htm 00000034 - Disclosure - Legal Matters (Details Narrative) Sheet http://wellnesscenterusa.com/role/LegalMattersDetailsNarrative Legal Matters (Details Narrative) Details http://wellnesscenterusa.com/role/LegalMatters 34 false false R35.htm 00000035 - Disclosure - Commitments (Details Narrative) Sheet http://wellnesscenterusa.com/role/CommitmentsDetailsNarrative Commitments (Details Narrative) Details http://wellnesscenterusa.com/role/Commitments 35 false false R36.htm 00000036 - Disclosure - Proposed Sale of Stealthco, Inc. (Details Narrative) Sheet http://wellnesscenterusa.com/role/ProposedSaleOfStealthcoInc.DetailsNarrative Proposed Sale of Stealthco, Inc. (Details Narrative) Details http://wellnesscenterusa.com/role/ProposedSaleOfStealthcoInc. 36 false false R37.htm 00000037 - Disclosure - Subsequent Events (Details Narrative) Sheet http://wellnesscenterusa.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://wellnesscenterusa.com/role/SubsequentEvents 37 false false All Reports Book All Reports wcui-20191231.xml wcui-20191231.xsd wcui-20191231_cal.xml wcui-20191231_def.xml wcui-20191231_lab.xml wcui-20191231_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true XML 41 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 42 R26.htm IDEA: XBRL DOCUMENT v3.20.1

Shareholders' Equity (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended

Dec. 31, 2019

Dec. 31, 2019

Sep. 30, 2019

Jan. 02, 2018

Jun. 30, 2010

Common stock, shares authorized 200,000,000 200,000,000 200,000,000

Number options to purchase of common stock 62,500

Options exercisable term 2 years 7 months 21 days

Unvested compensation $ 314,812 $ 314,812

Aggregate intrinsic value $ 3,257,434 3,257,434 $ 3,255,121

Stock Option [Member]

Stock based compensation $ 65,738

Employee [Member]

Number options to purchase of common stock 62,500

Fair value of stock options $ 2,313

Stock option exercise price per share $ 0.04 $ 0.04

Options exercisable term 5 years

2010 Non-Qualified Stock Option Plan [Member]

Common stock, shares authorized 30,000,000 7,500,000

2010 Non-Qualified Stock Option Plan [Member] | Stock Option [Member]

Aggregate intrinsic value

Shares of stock options remaining available for issuance 14,962,262 14,962,262

Aggregate intrinsic value for warrant shares outstanding

X

- Definition
Represents the monetary amount of Aggregate intrinsic value for warrant shares outstanding, as of the indicated date.
+ References
No definition available.
+ Details

Name: WCUI_AggregateIntrinsicValueForWarrantSharesOutstanding

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value of stock options.
+ References
No definition available.
+ Details

Name: WCUI_FairValueOfStockOptions

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate number of common shares reserved for future issuance.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockCapitalSharesReservedForFutureIssuance

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of cost not yet recognized for nonvested award under share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_StockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=WCUI_EmployeeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=WCUI_TwoThousandTenNonQualifiedStockOptionPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=WCUI_TwoThousandTenPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=WCUI_StockOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 43 R22.htm IDEA: XBRL DOCUMENT v3.20.1

Summary of Significant Accounting Policies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended

Nov. 15, 2018

Dec. 31, 2018

Dec. 31, 2019

Dec. 31, 2018

Oct. 02, 2019

Sep. 30, 2019

Deferred revenue

Measurement of tax benefit, percentage of realized upon settlement, minimum, description More than 50 percent

Non-controlling interest's share of accumulated losses of joint venture $ 405,383

Loss from deconsolidation of non-controlling interest 405,383

Noncontrolling interest, description Pursuant to the Joint Venture Agreement, the venture will be conducted through NEO. PSI and GEN2 will be the members of NEO, owning 50.5% and 36.0%, respectively, of the Units issued in connection with the organization of NEO. An additional 13.5% of such Units will be reserved for issuance as incentives for key employees and consultants. Until such shares are distributed, the Company controls 68% of the joint venture and GEN2 the remaining 32%. PSI and GEN2 will manage NEO's day-to-day operations. PSI will contribute PSI technology to NEO and GEN2 will contribute $700,000. Repayment of the investment by GEN2 will begin through and upon the date which NEO has realized and retained cumulative net income/distributable cash in the amount of $300,000.

Contributed capital $ 700,000

Joint venture percentage 51.00%

Additional paid-in capital $ 23,868,885 $ 23,777,647

Non-controlling interest 395,520 393,149

Operating loss (337,273) $ (470,714)

Distributable cash 300,000

Right-of-use assets 22,697 $ 27,841

Lease liabilities 22,697 $ 27,841

NEO [Member]

Contributed capital 50,000

Additional funding 700,000

GEN2 [Member]

Investments to others $ 975,000 $ 925,000

Joint venture percentage 39.00%

Employees and Consultants [Member]

Additional units reserved for issuance 13.50%

Individual [Member]

Joint venture percentage 10.00%

Psoria-Shield, Inc [Member]

Ownership percentage 50.50%

Gen 2 Funding, Inc [Member]

Ownership percentage 36.00%

Proceeds from investment $ 700,000

Illinois Limited Liability Company [Member]

Additional paid-in capital 497,250

Non-controlling interest 477,750

Operating loss $ 45,162

Stock Option [Member]

Antidilutive securities excluded from computation of earnings per share 15,037,738 17,587,738

Warrants [Member]

Antidilutive securities excluded from computation of earnings per share 66,484,049 68,192,442

X

- Definition
Additional funding.
+ References
No definition available.
+ Details

Name: WCUI_AdditionalFunding

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Additional units reserved for issuance.
+ References
No definition available.
+ Details

Name: WCUI_AdditionalUnitsReservedForIssuance

Namespace Prefix: WCUI_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Joint venture percentage.
+ References
No definition available.
+ Details

Name: WCUI_JointVenturePercent

Namespace Prefix: WCUI_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Non-controlling interest's share of accumulated losses of joint venture.
+ References
No definition available.
+ Details

Name: WCUI_NoncontrollingInterestsShareOfAccumulatedLossesOfJointVenture

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapitalCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045
+ Details

Name: us-gaap_ContractWithCustomerLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_EquityMethodInvestmentOwnershipPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 15
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=65877542&loc=d3e27249-109313

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319
+ Details

Name: us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of accumulated undistributed tax basis earnings (deficit).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 20
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=66023616&loc=d3e9145-115832

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 20
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66023616&loc=d3e9120-115832
+ Details

Name: us-gaap_InvestmentCompanyDistributableEarnings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all investments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.1(h))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_Investments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(24))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(22))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders.
+ References
No definition available.
+ Details

Name: us-gaap_MinorityInterestDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of noncurrent assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690
+ Details

Name: us-gaap_PaymentsForProceedsFromInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received by a corporation from a shareholder during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromContributedCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: dei_LegalEntityAxis=WCUI_NEOMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=WCUI_GEN2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=WCUI_EmployeesandConsultantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=us-gaap_IndividualMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_OwnershipAxis=WCUI_PsoriaShieldIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_OwnershipAxis=WCUI_GenTwoFundingIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_OwnershipAxis=WCUI_IllinoisLimitedLiabilityCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=WCUI_StockOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=WCUI_WarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 44 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 45 R27.htm IDEA: XBRL DOCUMENT v3.20.1

Shareholders' Equity - Schedule of Assumptions Used for Options Granted (Details)
3 Months Ended

Dec. 31, 2019

$ / shares

Equity [Abstract]

Exercise price $ 0.04

Expected dividends

Expected volatility 157.60%

Risk free interest rate 1.60%

Expected life of options 2 years 6 months

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

XML 46 R23.htm IDEA: XBRL DOCUMENT v3.20.1

Summary of Significant Accounting Policies - Schedule of Company's Consolidated Subsidiaries (Details)
3 Months Ended

Dec. 31, 2019

State or other jurisdiction of incorporation or organization Nevada

Psoria-Shield, Inc [Member]

Name of consolidated subsidiary or entity Psoria-Shield Inc. ("PSI")

State or other jurisdiction of incorporation or organization The State of Florida

Date of incorporation or formation Jun. 17, 2009

Date of acquisition/disposition Aug. 24, 2012

Attributable interest 100.00%

StealthCo, Inc. [Member]

Name of consolidated subsidiary or entity StealthCo, Inc. ("StealthCo")

State or other jurisdiction of incorporation or organization The State of Illinois

Date of incorporation or formation Mar. 18, 2014

Attributable interest 100.00%

Psoria Development Company LLC. [Member]

Name of consolidated subsidiary or entity Psoria Development Company LLC. ("PDC")

State or other jurisdiction of incorporation or organization The State of Illinois

Date of incorporation or formation Jan. 15, 2015

Date of acquisition/disposition Nov. 15, 2018

Attributable interest 50.00%

NEO Phototherapy, LLC, [Member]

Name of consolidated subsidiary or entity NEO Phototherapy LLC ("NEO")

State or other jurisdiction of incorporation or organization The State of Illinois

Date of incorporation or formation Dec. 31, 2018

Attributable interest 51.00%

X

- Definition
Entity incorporation, state country name.
+ References
No definition available.
+ Details

Name: WCUI_EntityIncorporationStateCountryName1

Namespace Prefix: WCUI_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when an entity was incorporated
+ References
No definition available.
+ Details

Name: dei_EntityIncorporationDateOfIncorporation

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity
+ References
No definition available.
+ Details

Name: dei_ParentEntityLegalName

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 25
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=116868678&loc=d3e848-128460

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=116868678&loc=d3e845-128460

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463
+ Details

Name: us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The parent entity's interest in net assets of the subsidiary, expressed as a percentage.
+ References
No definition available.
+ Details

Name: us-gaap_MinorityInterestOwnershipPercentageByParent

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Details

Name: srt_OwnershipAxis=WCUI_PsoriaShieldIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_OwnershipAxis=WCUI_StealthCoIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_OwnershipAxis=WCUI_PsoriaDevelopmentCompanyLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_OwnershipAxis=WCUI_NeoPhototherapyLLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 47 R15.htm IDEA: XBRL DOCUMENT v3.20.1

Proposed Sale of Stealthco, Inc.
3 Months Ended

Dec. 31, 2019

Proposed Sale Of Stealthco Inc.

Proposed Sale of Stealthco, Inc.

NOTE 9 – PROPOSED SALE OF STEALTHCO, INC.

On September 3, 2019, the Company’s Board of Directors unanimously approved, subject to stockholder approval: (1) execution and delivery of a proposed Share Exchange Agreement with DTI Holdings, Inc. (“DTI”) relating to the share exchange and transfer of certain assets of StealthCo, Inc. (“SCI”) pursuant to the terms and conditions of a Memorandum of Agreement in substantially the form of the copy presented to the Board (“Agreement”). As of September 18, 2019, holders of a majority of the outstanding shares of voting capital stock have executed written stockholder consents approving this action.

The Agreement provides, among other things, that: (1) DTI will pay the Company $500,000 upon the execution of a definitive share exchange agreement (“Share Exchange Agreement”) which the parties will endeavor to negotiate and execute as quickly as possible, and not later than October 15, 2019; (2) DTI will pay the Company an additional $500,000 within seven days following the completion date of the transfer of all assets and/or full ownership of SCI to DTI, with such date to occur within 120 days following execution of the Share Exchange Agreement; (3) DTI will issue to the Company 3,112,000 shares of DTI common stock and will guaranty that the value of the 3,112,000 shares of DTI common stock will have a value of at least $4.50 per share ($14,004,000, in the aggregate), as of December 31, 2021; (4) To the extent that the value of the DTI common shares, as of December 31, 2021, is less than $4.50 per share ($14,004,000, in the aggregate), DTI will issue additional shares of DTI common stock, at the then current fair market value, in an amount sufficient to cause the resulting aggregate value of all shares of DTI common stock issued to the Company to be $14,004,000, in the aggregate; (5) DTI will assign the assets transferred by SCI, including trademarks, intellectual properties, and patents, to its subsidiary, Femtobitz, Inc., a Delaware corporation, and will pay to the Company 1% of annual gross revenue arising from or relating to operation of Femtobitz, Inc.; and (6) Upon closing of the share exchange, the Company’s Chairman will be appointed an advisory board member of DTI and a board member of Femtobitz, Inc.

As of September 18, 2019, stockholders holding a majority of our outstanding common stock approved the share exchange and the Company began discussions and negotiations with DTI, which are currently on-going as of the date of this filing. There can be no assurance that the proposed transaction will be concluded successfully on the terms described or any alternate terms that may be proposed hereafter.

X

- References
No definition available.
+ Details

Name: WCUI_ProposedSaleAbstract

Namespace Prefix: WCUI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Proposed Sale.
+ References
No definition available.
+ Details

Name: WCUI_ProposedSaleTextBlock

Namespace Prefix: WCUI_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 48 R11.htm IDEA: XBRL DOCUMENT v3.20.1

Shareholders' Equity
3 Months Ended

Dec. 31, 2019

Equity [Abstract]

Shareholders' Equity

NOTE 5 – SHAREHOLDERS’ EQUITY

Stock Options

On December 22, 2010, effective retroactively as of June 30, 2010, the Company’s Board of Directors approved the adoption of the “2010 Non-Qualified Stock Option Plan” (“2010 Option Plan”) by unanimous consent. The 2010 Option Plan was initiated to encourage and enable officers, directors, consultants, advisors and key employees of the Company to acquire and retain a proprietary interest in the Company by ownership of its common stock. A total of 7,500,000 of the authorized shares of the Company’s common stock may be subject to, or issued pursuant to, the terms of the plan. Effective January 1, 2018, the Board of Directors approved to increase the number of authorized shares of the Company’s common stock that may be subject to, or issued pursuant to, the terms of the plan from 7,500,000 to 30,000,000.

The Company’s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award. Additionally, the Company’s policy is to issue new shares of common stock to satisfy stock option exercises. The Company applied fair value accounting for all share based payments awards. The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model.

During the three months ended December 31, 2019, the Company granted options to an employee to purchase a total of 62,500 shares of its common stock with an aggregate fair value of $2,313. The options have an exercise price of $0.04 per share and expire five years from the date of grant. The shares vested on December 31, 2019. The Company valued the options using a Black-Scholes option pricing model.

The assumptions used for the option granted during the three months ended December 31, 2019 are as follows:

Exercise price $ 0.04

Expected dividends -

Expected volatility 157.6 %

Risk free interest rate 1.60 %

Expected life of options 2.5

During the three months ended December 31, 2019, the Company recorded $65,738 of stock compensation for the value of all outstanding options, and as of December 31, 2019, unvested compensation of $314,812 remained that will be amortized over the remaining vesting period.

The table below summarizes the Company’s stock option activities for the three months ended December 31, 2019:



Number of Option Shares
Exercise

Price Range Per Share

Weighted

Average Exercise Price

Fair Value

at Date of Grant

Balance, September 30, 2019 15,237,738 $ 0.03 - 2.00 $ 0.27 $ 3,255,121

Granted 62,500 0.04 0.04 2,313

Cancelled - - - -

Exercised - - - -

Expired (262,500 ) 0.11 0.11 -

Balance, December 31, 2019 15,037,738 $ 0.03 – 2.00 $ 0.27 $ 3,257,434

Vested and exercisable, December 31, 2019 12,350,238 $ 0.03 – 2.00 $ 0.30 $ 2,189,047

Unvested, December 31, 2019 2,687,500 $ 0.14 $ 0.14 $ 1,068,387

There was no aggregate intrinsic value for option shares outstanding at December 31, 2019. As of December 31, 2019, there were 14,962,262 shares of stock options remaining available for issuance under the 2010 Plan.

The following table summarizes information concerning outstanding and exercisable options as of December 31, 2019:



Options Outstanding Options Exercisable

Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price

$ 0.06 - 0.39 13,575,238 2.93 $ 0.15 10,887,738 2.85 $ 0.15

0.40 - 0.99 62,500 2.25 0.40 62,500 2.25 0.40

1.00 - 1.99 750,000 1.00 1.00 750,000 1.00 1.00

2.00 650,000 1.00 2.00 650,000 1.00 2.00

$ 0.06 - 2.00 15,037,738 2.75 $ 0.27 12,350,238 2.64 $ 0.30



Stock Warrants

The table below summarizes the Company’s warrants activities for the three months ended December 31, 2019:

Number of

Warrant Shares

Exercise

Price Range

Per Share
Weighted Average Exercise Price Fair Value at Date of Issuance

Balance, September 30, 2019 66,484,049 $ 0.12 - 0.40 $ 0.17 $ 3,434,560

Granted - - - -

Cancelled - - - -

Exercised - - - -

Expired - - - -

Balance, December 31, 2019 66,484,049 $ 0.12 - 0.40 $ 0.17 $ 3,434,560

Vested and exercisable, December 31, 2019 66,484,049 $ 0.12 - 0.40 $ 0.17 $ 3,434,560

There was no aggregate intrinsic value for warrant shares outstanding at December 31, 2019.

The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2019:



Warrants Outstanding Warrants Exercisable

Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price

$ 0.12 – 0.20 59,279,384 1.70 $ 0.15 59,279,384 1.70 $ 0.15

0.21 – 0.40 7,204,665 0.61 0.26 7,204,665 0.61 0.26

$ 0.12 – 0.67 66,484,049 1.58 $ 0.17 66,484,049 1.58 $ 0.17

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R19.htm IDEA: XBRL DOCUMENT v3.20.1

Shareholders' Equity (Tables)
3 Months Ended

Dec. 31, 2019

Equity [Abstract]

Schedule of Assumptions Used for Options Granted

The assumptions used for the option granted during the three months ended December 31, 2019 are as follows:

Exercise price $ 0.04

Expected dividends -

Expected volatility 157.6 %

Risk free interest rate 1.60 %

Expected life of options 2.5

Schedule of Stock Option Activity

The table below summarizes the Company’s stock option activities for the three months ended December 31, 2019:



Number of Option Shares
Exercise

Price Range Per Share

Weighted

Average Exercise Price

Fair Value

at Date of Grant

Balance, September 30, 2019 15,237,738 $ 0.03 - 2.00 $ 0.27 $ 3,255,121

Granted 62,500 0.04 0.04 2,313

Cancelled - - - -

Exercised - - - -

Expired (262,500 ) 0.11 0.11 -

Balance, December 31, 2019 15,037,738 $ 0.03 – 2.00 $ 0.27 $ 3,257,434

Vested and exercisable, December 31, 2019 12,350,238 $ 0.03 – 2.00 $ 0.30 $ 2,189,047

Unvested, December 31, 2019 2,687,500 $ 0.14 $ 0.14 $ 1,068,387

Schedule of Outstanding and Exercisable Options by Exercise Price Range

The following table summarizes information concerning outstanding and exercisable options as of December 31, 2019:



Options Outstanding Options Exercisable

Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price

$ 0.06 - 0.39 13,575,238 2.93 $ 0.15 10,887,738 2.85 $ 0.15

0.40 - 0.99 62,500 2.25 0.40 62,500 2.25 0.40

1.00 - 1.99 750,000 1.00 1.00 750,000 1.00 1.00

2.00 650,000 1.00 2.00 650,000 1.00 2.00

$ 0.06 - 2.00 15,037,738 2.75 $ 0.27 12,350,238 2.64 $ 0.30

Schedule of Warrant Activity

The table below summarizes the Company’s warrants activities for the three months ended December 31, 2019:

Number of

Warrant Shares

Exercise

Price Range

Per Share
Weighted Average Exercise Price Fair Value at Date of Issuance

Balance, September 30, 2019 66,484,049 $ 0.12 - 0.40 $ 0.17 $ 3,434,560

Granted - - - -

Cancelled - - - -

Exercised - - - -

Expired - - - -

Balance, December 31, 2019 66,484,049 $ 0.12 - 0.40 $ 0.17 $ 3,434,560

Vested and exercisable, December 31, 2019 66,484,049 $ 0.12 - 0.40 $ 0.17 $ 3,434,560

Schedule of Outstanding and Exercisable Warrants by Exercise Price Range

The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2019:



Warrants Outstanding Warrants Exercisable

Range of Exercise Prices Number Outstanding Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Average Remaining Contractual Life (in years) Weighted Average Exercise Price

$ 0.12 – 0.20 59,279,384 1.70 $ 0.15 59,279,384 1.70 $ 0.15

0.21 – 0.40 7,204,665 0.61 0.26 7,204,665 0.61 0.26

$ 0.12 – 0.67 66,484,049 1.58 $ 0.17 66,484,049 1.58 $ 0.17

X

- Definition
Represents the textual narrative disclosure of Schedule of Outstanding and Exercisable Warrants, during the indicated time period.
+ References
No definition available.
+ Details

Name: WCUI_ScheduleOfOutstandingAndExercisableWarrantsByExercisePriceRangeTableTextBlock

Namespace Prefix: WCUI_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775
+ Details

Name: us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R9.htm IDEA: XBRL DOCUMENT v3.20.1

Loans Payable from Officers and Shareholders
3 Months Ended

Dec. 31, 2019

Debt Disclosure [Abstract]

Loans Payable from Officers and Shareholders

NOTE 3 – LOANS PAYABLE FROM OFFICERS AND SHAREHOLDERS

As of September 30, 2019, loans payable from officers and shareholders of $399,250 were outstanding. During the three months ended December 31, 2019, the Company borrowed $135,000 from its officers and shareholders. All of the loans are unsecured, have an interest rate of eight percent and are due one year from the date of issuance. As of December 31, 2019, loans payable to officers and shareholders of $534,250 were outstanding.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R32.htm IDEA: XBRL DOCUMENT v3.20.1

Segment Reporting - Schedule of Assets of Reportable Segments (Details) - USD ($)

Dec. 31, 2019

Sep. 30, 2019

Feb. 28, 2019

Cash $ 42,363 $ 53,147

Prepaid expenses and other current assets 55,500 55,000

Total current assets 97,863 108,147

Right-of-use asset 22,697 $ 27,841

Total other assets 22,697 1,562

TOTAL ASSETS 120,560 $ 109,709

Corporate [Member]

Cash 2,273

Prepaid expenses and other current assets

Total current assets 2,273

Right-of-use asset

Total other assets

TOTAL ASSETS 2,273

Medical Devices [Member]

Cash 33,330

Prepaid expenses and other current assets 55,500

Total current assets 88,830

Right-of-use asset 22,697

Total other assets 22,697

TOTAL ASSETS 111,527

Authentication and Encryption [Member]

Cash 6,760

Prepaid expenses and other current assets

Total current assets 6,760

Right-of-use asset

Total other assets

TOTAL ASSETS $ 6,760

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(11))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(12))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(17))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(16))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(10))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(7))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=WCUI_MedicalDevicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=WCUI_AuthenticationandEncryptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 52 R36.htm IDEA: XBRL DOCUMENT v3.20.1

Proposed Sale of Stealthco, Inc. (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended

Dec. 31, 2021

Sep. 03, 2019

Dec. 31, 2018

Sep. 30, 2019

Dec. 31, 2019

Common stock new issue value $ 10,000

Share Exchange Agreement [Member] | DTI Holdings Inc [Member]

Due from related party $ 500,000

Due from related party in addition $ 500,000

Agreement description On September 3, 2019, the Company's Board of Directors unanimously approved, subject to stockholder approval: (1) execution and delivery of a proposed Share Exchange Agreement with DTI Holdings, Inc. ("DTI") relating to the share exchange and transfer of certain assets of StealthCo, Inc. ("SCI") pursuant to the terms and conditions of a Memorandum of Agreement in substantially the form of the copy presented to the Board ("Agreement"). As of September 18, 2019, holders of a majority of the outstanding shares of voting capital stock have executed written stockholder consents approving this action. The Agreement provides, among other things, that: (1) DTI will pay the Company $500,000 upon the execution of a definitive share exchange agreement ("Share Exchange Agreement") which the parties will endeavor to negotiate and execute as quickly as possible, and not later than October 15, 2019; (2) DTI will pay the Company an additional $500,000 within seven days following the completion date of the transfer of all assets and/or full ownership of SCI to DTI, with such date to occur within 120 days following execution of the Share Exchange Agreement; (3) DTI will issue to the Company 3,112,000 shares of DTI common stock and will guaranty that the value of the 3,112,000 shares of DTI common stock will have a value of at least $4.50 per share ($14,004,000, in the aggregate), as of December 31, 2021; (4) To the extent that the value of the DTI common shares, as of December 31, 2021, is less than $4.50 per share ($14,004,000, in the aggregate), DTI will issue additional shares of DTI common stock, at the then current fair market value, in an amount sufficient to cause the resulting aggregate value of all shares of DTI common stock issued to the Company to be $14,004,000, in the aggregate; (5) DTI will assign the assets transferred by SCI, including trademarks, intellectual properties, and patents, to its subsidiary, Femtobitz, Inc., a Delaware corporation, and will pay to the Company 1% of annual gross revenue arising from or relating to operation of Femtobitz, Inc.; and (6) Upon closing of the share exchange, the Company's Chairman will be appointed an advisory board member of DTI and a board member of Femtobitz, Inc. As of September 18, 2019, stockholders holding a majority of our outstanding common stock approved the share exchange and the Company began discussions and negotiations with DTI, which are currently on-going. There can be no assurance that the proposed transaction will be concluded successfully on the terms described or any alternate terms that may be proposed hereafter.

Share Exchange Agreement [Member] | Femtobitz, Inc. [Member]

Annual gross revenue 1.00%

Share Exchange Agreement [Member] | Forecast [Member] | DTI Holdings Inc [Member]

Common stock new issues 3,112,000

Common stock value per share $ 4.50

Common stock new issue value $ 14,004,000

X

- Definition
Due from related party in addition.
+ References
No definition available.
+ Details

Name: WCUI_DueFromRelatedPartyInAddition

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592
+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.10(3))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.3)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864
+ Details

Name: us-gaap_DueFromRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Per share or per unit amount of equity securities issued.
+ References
No definition available.
+ Details

Name: us-gaap_SharesIssuedPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662
+ Details

Name: us-gaap_SubsequentEventDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_TypeOfArrangementAxis=WCUI_ShareExchangeAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=WCUI_DTIHoldingsIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=WCUI_FemtobitzIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementScenarioAxis=srt_ScenarioForecastMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 53 R5.htm IDEA: XBRL DOCUMENT v3.20.1

Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($)

Common Stock [Member]

Additional Paid-in Capital [Member]

Accumulated Deficit [Member]

Total WCUI Deficit [Member]

Non-controlling Interest [Member]

Total

Balance at Sep. 30, 2018 $ 100,952 $ 22,450,252 $ (22,974,740) $ (423,536) $ (401,624) $ (825,160)

Balance, shares at Sep. 30, 2018 100,952,569

Common shares issued for cash $ 143 9,857 10,000 10,000

Common shares issued for cash, shares 142,857

Shares issued upon conversion of note payable $ 2,483 171,300 173,783 173,783

Shares issued upon conversion of note payable, shares 2,482,441

Fair value of additional shares issued to conversions of note payable 51,434 51,434 51,434

Fair value of vested stock options 85,951 85,951 85,951

Fair value of common stock issued for services $ 120 9,480 9,600 9,600

Fair value of common stock issued for services, shares 120,000

Termination of non-controlling interest agreement (405,383) (405,383) 405,383 (405,383)

Contribution of capital by joint venture partner 255,000 255,000 120,000 375,000

Net loss (573,929) (573,929) (3,759) (577,688)

Balance at Dec. 31, 2018 $ 103,698 23,033,274 (23,954,052) (817,080) 120,000 (697,080)

Balance, shares at Dec. 31, 2018 103,697,867

Balance at Sep. 30, 2019 $ 107,497 23,777,647 (25,362,287) (1,477,143) 393,149 (1,083,994)

Balance, shares at Sep. 30, 2019 107,497,077

Fair value of vested stock options 65,738 65,738 65,738

Termination of non-controlling interest agreement

Contribution of capital by joint venture partner 25,500 25,500 24,500 50,000

Net loss (324,467) (324,467) (22,129) (346,596)

Balance at Dec. 31, 2019 $ 107,497 $ 23,868,885 $ (25,686,754) $ (1,710,372) $ 395,520 $ (1,314,852)

Balance, shares at Dec. 31, 2019 107,497,077

X

- Definition
Contribution of capital by joint venture partner.
+ References
No definition available.
+ Details

Name: WCUI_ContributionOfCapitalByJointVenturePartner

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Fair value of additional shares issued to induce conversions of note payable.
+ References
No definition available.
+ Details

Name: WCUI_FairValueOfAdditionalSharesIssuedToInduceConversionsOfNotePayable

Namespace Prefix: WCUI_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued during the period as a result of the conversion of convertible securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The gross value of stock issued during the period upon the conversion of convertible securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 54 R1.htm IDEA: XBRL DOCUMENT v3.20.1

Document and Entity Information
3 Months Ended

Dec. 31, 2019

shares

Document And Entity Information

Entity Registrant Name Wellness Center USA, Inc.

Entity Central Index Key 0001516887

Document Type 10-Q

Document Period End Date Dec. 31, 2019

Amendment Flag false

Current Fiscal Year End Date --09-30

Entity Current Reporting Status Yes

Entity Interactive Data Current Yes

Entity Filer Category Non-accelerated Filer

Entity Small Business Flag true

Entity Emerging Growth Company false

Entity Shell Company false

Entity Common Stock, Shares Outstanding 107,497,077

Document Fiscal Period Focus Q1

Document Fiscal Year Focus 2020

X

- References
No definition available.
+ Details

Name: WCUI_DocumentAndEntityInformationAbstract

Namespace Prefix: WCUI_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-T
-Number 232
-Section 405
+ Details

Name: dei_EntityInteractiveDataCurrent

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityShellCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicates that the company is a Smaller Reporting Company (SRC).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntitySmallBusiness

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

Loans Payable from Officers and Shareholders (Details Narrative) - USD ($)	Dec. 31, 2019	Sep. 30, 2019
Loans payable from officers and shareholders	$ 534,250	$ 399,250
Due to officers and shareholders	$ 135,000
22 Short-Term Unsecured Loans [Member]
Debt instrument, interest rate, stated percentage		8.00%
Officers and Shareholders [Member]
Loans payable to related parties		$ 534,250

Shareholders' Equity - Schedule of Stock Option Activity (Details)	3 Months Ended
	Dec. 31, 2019 USD ($) $ / shares shares
Number of Option Shares Outstanding, Number, Beginning Balance \| shares	15,237,738
Number of Option Shares Outstanding, Granted \| shares	62,500
Number of Option Shares Outstanding, Cancelled \| shares
Number of Option Shares Outstanding, Exercised \| shares
Number of Option Shares Outstanding, Expired \| shares	(262,500)
Number of Option Shares Outstanding, Number, Ending Balance \| shares	15,037,738
Number of Option Shares Outstanding, Vested and exercisable, Ending Balance \| shares	12,350,238
Number of Option Shares Outstanding, Unvested, Ending Balance \| shares	2,687,500
Weighted Average Exercise Price, Number, Beginning Balance	$ 0.27
Weighted Average Exercise Price, Granted	0.04
Weighted Average Exercise Price, Cancelled
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Expired	0.11
Weighted Average Exercise Price, Number, Ending Balance	0.27
Weighted Average Exercise Price, Vested and exercisable, Ending Balance	0.30
Weighted Average Exercise Price, Unvested, Ending Balance	$ 0.14
Fair Value at Date of Grant, Number, Beginning Balance \| $	$ 3,255,121
Fair Value at Date of Grant, Granted \| $	2,313
Fair Value at Date of Grant, Cancelled \| $
Fair Value at Date of Grant, Exercised \| $
Fair Value at Date of Grant, Expired \| $
Fair Value at Date of Grant, Number, Ending Balance \| $	3,257,434
Fair Value at Date of Grant, Vested and exercisable, Ending Balance \| $	2,189,047
Fair Value at Date of Grant, Unvested, Ending Balance \| $	$ 1,068,387
Minimum [Member]
Weighted Average Exercise Price, Number, Beginning Balance	$ 0.03
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Number, Ending Balance	0.03
Maximum [Member]
Weighted Average Exercise Price, Number, Beginning Balance	2.00
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Number, Ending Balance	$ 2.00

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Sales:
Total Sales		$ 12,875
Cost of goods sold		7,725
Gross profit		5,150
Operating expenses	337,273	475,864
Loss from operations	(337,273)	(470,714)
Other expenses
Amortization of debt discount		(50,689)
Financing costs		(51,434)
Interest expense	(9,323)	(4,851)
Total other expenses	(9,323)	(106,974)
NET LOSS	(346,596)	(577,688)
Net loss attributable to non-controlling interest	22,129	3,759
Loss from deconsolidation of non-controlling interest		(405,383)
NET LOSS ATTRIBUTABLE TO WELLNESS CENTER USA, INC.	$ (324,467)	$ (979,312)
BASIC AND DILUTED LOSS PER SHARE	$ (0.00)	$ (0.01)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED	107,497,077	100,952,569
Trade [Member]
Sales:
Total Sales		$ 7,675
Consulting Services [Member]
Sales:
Total Sales		$ 5,200

Subsequent Events (Details Narrative) - USD ($)				3 Months Ended	4 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Oct. 02, 2016	Dec. 31, 2019	Jan. 24, 2020	Mar. 25, 2020	Jan. 06, 2020	Jan. 01, 2020	Sep. 30, 2019
Loans payable to officers and shareholders		$ 534,250		$ 534,250					$ 399,250
Lease expiration date				Feb. 28, 2024
StealthCo [Member] \| Non Cancellable Lease Agreement [Member]
Lease expiration date			Sep. 30, 2021
Lease term			5 years
Board of Directors [Member]
Unexpired stock warrants, extension period		1 year
Subsequent Event [Member]
Debt instrument, payment terms					Due one year from the date of issuance
Number of securities called by warrants								66,000,000
Incremental fair value of warrants	$ 700,000
Subsequent Event [Member] \| Minimum [Member]
Exercise price of warrants								$ 0.12
Subsequent Event [Member] \| Maximum [Member]
Exercise price of warrants								$ 0.40
Subsequent Event [Member] \| September 30, 2020 [Member]
Number of securities called by warrants								20,000,000
Subsequent Event [Member] \| September 30, 2020 [Member] \| Minimum [Member]
Exercise price of warrants								$ 0.15
Subsequent Event [Member] \| September 30, 2020 [Member] \| Maximum [Member]
Exercise price of warrants								$ 0.25
Subsequent Event [Member] \| StealthCo [Member] \| Ownership Agreement [Member]
Non-cancellable lease payment							$ 11,000
Subsequent Event [Member] \| Unsecured Loans [Member]
Debt instrument, interest rate, stated percentage						8.00%
Subsequent Event [Member] \| Officers and Shareholders [Member]
Loans payable to officers and shareholders						$ 235,000

Shareholders' Equity (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
Shareholders' Equity (Details Narrative) - USD ($)	Dec. 31, 2019	Dec. 31, 2019	Sep. 30, 2019	Jan. 02, 2018	Jun. 30, 2010
Common stock, shares authorized	200,000,000	200,000,000	200,000,000
Number options to purchase of common stock	62,500
Options exercisable term	2 years 7 months 21 days
Unvested compensation	$ 314,812	$ 314,812
Aggregate intrinsic value	$ 3,257,434	3,257,434	$ 3,255,121
Stock Option [Member]
Stock based compensation		$ 65,738
Employee [Member]
Number options to purchase of common stock	62,500
Fair value of stock options	$ 2,313
Stock option exercise price per share	$ 0.04	$ 0.04
Options exercisable term	5 years
2010 Non-Qualified Stock Option Plan [Member]
Common stock, shares authorized				30,000,000	7,500,000
2010 Non-Qualified Stock Option Plan [Member] \| Stock Option [Member]
Aggregate intrinsic value
Shares of stock options remaining available for issuance	14,962,262	14,962,262
Aggregate intrinsic value for warrant shares outstanding

Summary of Significant Accounting Policies (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended
	Nov. 15, 2018	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Oct. 02, 2019	Sep. 30, 2019
Deferred revenue
Measurement of tax benefit, percentage of realized upon settlement, minimum, description			More than 50 percent
Non-controlling interest's share of accumulated losses of joint venture	$ 405,383
Loss from deconsolidation of non-controlling interest				405,383
Noncontrolling interest, description		Pursuant to the Joint Venture Agreement, the venture will be conducted through NEO. PSI and GEN2 will be the members of NEO, owning 50.5% and 36.0%, respectively, of the Units issued in connection with the organization of NEO. An additional 13.5% of such Units will be reserved for issuance as incentives for key employees and consultants. Until such shares are distributed, the Company controls 68% of the joint venture and GEN2 the remaining 32%. PSI and GEN2 will manage NEO's day-to-day operations. PSI will contribute PSI technology to NEO and GEN2 will contribute $700,000. Repayment of the investment by GEN2 will begin through and upon the date which NEO has realized and retained cumulative net income/distributable cash in the amount of $300,000.
Contributed capital		$ 700,000
Joint venture percentage			51.00%
Additional paid-in capital			$ 23,868,885			$ 23,777,647
Non-controlling interest			395,520			393,149
Operating loss			(337,273)	$ (470,714)
Distributable cash			300,000
Right-of-use assets			22,697		$ 27,841
Lease liabilities			22,697		$ 27,841
NEO [Member]
Contributed capital			50,000
Additional funding			700,000
GEN2 [Member]
Investments to others			$ 975,000			$ 925,000
Joint venture percentage			39.00%
Employees and Consultants [Member]
Additional units reserved for issuance		13.50%
Individual [Member]
Joint venture percentage			10.00%
Psoria-Shield, Inc [Member]
Ownership percentage			50.50%
Gen 2 Funding, Inc [Member]
Ownership percentage			36.00%
Proceeds from investment			$ 700,000
Illinois Limited Liability Company [Member]
Additional paid-in capital			497,250
Non-controlling interest			477,750
Operating loss			$ 45,162
Stock Option [Member]
Antidilutive securities excluded from computation of earnings per share			15,037,738	17,587,738
Warrants [Member]
Antidilutive securities excluded from computation of earnings per share			66,484,049	68,192,442

Shareholders' Equity - Schedule of Assumptions Used for Options Granted (Details)	3 Months Ended
	Dec. 31, 2019 $ / shares
Equity [Abstract]
Exercise price	$ 0.04
Expected dividends
Expected volatility	157.60%
Risk free interest rate	1.60%
Expected life of options	2 years 6 months

Proposed Sale of Stealthco, Inc. (Details Narrative) - USD ($)			3 Months Ended	12 Months Ended
	Dec. 31, 2021	Sep. 03, 2019	Dec. 31, 2018	Sep. 30, 2019	Dec. 31, 2019
Common stock new issue value			$ 10,000
Share Exchange Agreement [Member] \| DTI Holdings Inc [Member]
Due from related party					$ 500,000
Due from related party in addition					$ 500,000
Agreement description		On September 3, 2019, the Company's Board of Directors unanimously approved, subject to stockholder approval: (1) execution and delivery of a proposed Share Exchange Agreement with DTI Holdings, Inc. ("DTI") relating to the share exchange and transfer of certain assets of StealthCo, Inc. ("SCI") pursuant to the terms and conditions of a Memorandum of Agreement in substantially the form of the copy presented to the Board ("Agreement"). As of September 18, 2019, holders of a majority of the outstanding shares of voting capital stock have executed written stockholder consents approving this action. The Agreement provides, among other things, that: (1) DTI will pay the Company $500,000 upon the execution of a definitive share exchange agreement ("Share Exchange Agreement") which the parties will endeavor to negotiate and execute as quickly as possible, and not later than October 15, 2019; (2) DTI will pay the Company an additional $500,000 within seven days following the completion date of the transfer of all assets and/or full ownership of SCI to DTI, with such date to occur within 120 days following execution of the Share Exchange Agreement; (3) DTI will issue to the Company 3,112,000 shares of DTI common stock and will guaranty that the value of the 3,112,000 shares of DTI common stock will have a value of at least $4.50 per share ($14,004,000, in the aggregate), as of December 31, 2021; (4) To the extent that the value of the DTI common shares, as of December 31, 2021, is less than $4.50 per share ($14,004,000, in the aggregate), DTI will issue additional shares of DTI common stock, at the then current fair market value, in an amount sufficient to cause the resulting aggregate value of all shares of DTI common stock issued to the Company to be $14,004,000, in the aggregate; (5) DTI will assign the assets transferred by SCI, including trademarks, intellectual properties, and patents, to its subsidiary, Femtobitz, Inc., a Delaware corporation, and will pay to the Company 1% of annual gross revenue arising from or relating to operation of Femtobitz, Inc.; and (6) Upon closing of the share exchange, the Company's Chairman will be appointed an advisory board member of DTI and a board member of Femtobitz, Inc. As of September 18, 2019, stockholders holding a majority of our outstanding common stock approved the share exchange and the Company began discussions and negotiations with DTI, which are currently on-going. There can be no assurance that the proposed transaction will be concluded successfully on the terms described or any alternate terms that may be proposed hereafter.
Share Exchange Agreement [Member] \| Femtobitz, Inc. [Member]
Annual gross revenue				1.00%
Share Exchange Agreement [Member] \| Forecast [Member] \| DTI Holdings Inc [Member]
Common stock new issues	3,112,000
Common stock value per share	$ 4.50
Common stock new issue value	$ 14,004,000

Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total WCUI Deficit [Member]	Non-controlling Interest [Member]	Total
Balance at Sep. 30, 2018	$ 100,952	$ 22,450,252	$ (22,974,740)	$ (423,536)	$ (401,624)	$ (825,160)
Balance, shares at Sep. 30, 2018	100,952,569
Common shares issued for cash	$ 143	9,857		10,000		10,000
Common shares issued for cash, shares	142,857
Shares issued upon conversion of note payable	$ 2,483	171,300		173,783		173,783
Shares issued upon conversion of note payable, shares	2,482,441
Fair value of additional shares issued to conversions of note payable		51,434		51,434		51,434
Fair value of vested stock options		85,951		85,951		85,951
Fair value of common stock issued for services	$ 120	9,480		9,600		9,600
Fair value of common stock issued for services, shares	120,000
Termination of non-controlling interest agreement			(405,383)	(405,383)	405,383	(405,383)
Contribution of capital by joint venture partner		255,000		255,000	120,000	375,000
Net loss			(573,929)	(573,929)	(3,759)	(577,688)
Balance at Dec. 31, 2018	$ 103,698	23,033,274	(23,954,052)	(817,080)	120,000	(697,080)
Balance, shares at Dec. 31, 2018	103,697,867
Balance at Sep. 30, 2019	$ 107,497	23,777,647	(25,362,287)	(1,477,143)	393,149	(1,083,994)
Balance, shares at Sep. 30, 2019	107,497,077
Fair value of vested stock options		65,738		65,738		65,738
Termination of non-controlling interest agreement
Contribution of capital by joint venture partner		25,500		25,500	24,500	50,000
Net loss			(324,467)	(324,467)	(22,129)	(346,596)
Balance at Dec. 31, 2019	$ 107,497	$ 23,868,885	$ (25,686,754)	$ (1,710,372)	$ 395,520	$ (1,314,852)
Balance, shares at Dec. 31, 2019	107,497,077

Document and Entity Information	3 Months Ended
Document and Entity Information	Dec. 31, 2019 shares
Document And Entity Information
Entity Registrant Name	Wellness Center USA, Inc.
Entity Central Index Key	0001516887
Document Type	10-Q
Document Period End Date	Dec. 31, 2019
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	107,497,077
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020